¾«ÉñÔÚÏßÍø - 2007ÄêWPAÉϺ£ÇøÓòÐÔ¹ú¼Ê»áÒéôßÖлª¾«Éñ²¡Ñ§»áѧÊõÄê»á »áÒéÂÛÎÄ»ã±à
SYMPOSIA µÚÒ»Ò³ µÚ¶þÒ³ µÚÈýÒ³ µÚËÄÒ³ µÚÎåÒ³ µÚÁùÒ³  
  • S34 - Clinical Psychopharmacological Study over Past 5 Years in China

    Chairs: Niufan Gu, Chinese Mainland
    Jerrold Rosenbaum, United States

    Clinical trial, psychotropic drugs, therapeutic drug monitoring, metabolic syndrome, antipsychotics, antidepressants, antianxiety drug, China

  • S34-1

    A Randomized Double-blind Multi-center Study Comparing Bupropion SR with Fluoxetine in Chinese Patients with Depression

    Yifeng Shen 1

    1 Shang Mental Health Center , Shanghai , Chinese Mainland

    Purpose: To compare efficacy and safety parameters of 6 weeks' treatment with 300mg/day bupropion SR with that of 20mg/day fluoxetine in Chinese patients with depression.

    Methods: This study was conducted in 4 sites in China , in accordance with the Declaration of Helsinki and the guideline for GCP.

    Eligible patients were within 18-65 years old, with a CCMD-3 diagnosis of Depression and a minimum total score of 18 on HAMD17. After a 1-week run-in period with placebo treatment, patients were randomized to 6 week of double-blind treatment with bupropion SR (300mg/d) or fluoxetine (20mg/d). The initial dose was 150mg bupropion SR or 10mg fluoxetine per day. Patients who completed 6 weeks of treatment entered a 1-week run-out period with the initial dose.

    Efficacy analyses were conducted on ITT population and safety analyses were conducted on the all-patients-treated set. Response was defined as a ¡Ý50% decrease in the HAMD total score from baseline and remission was defined as a HAMD total score ¡Ü8.

    Results: A total of 237 patients entered the double-blind period. Of these, 3 patients in bupropion SR group and 2 patients in fluoxetine group had no post-baseline assessment. The ITT population thus comprised 117 patients in the bupropion SR group and 115 patients in the fluoxetine group. A total of 210 patients completed the study. There were no clinically relevant differences at baseline between the two treatment groups on the basis of demography or disease severity.

    The incidence of withdrawals was low: 8.5% in the bupropion SR group and 10.4% in the fluoxetine group. The proportions of patients who withdrew due to adverse events were 0.85% versus 1.74%. The proportions of patients who withdrew due to lack of efficacy were 3.42% versus 4.35%. There were approximately equal numbers of patients in both treatment groups who were responders (69.23% vs 67.83%) or remitters (35.04% vs 45.22%) at week 6.

    A total of 63.25% of patients in the bupropion SR group and 62.61% of the patients in the fluoxetine group reported TEAEs during the clinical trial with no significant difference (P>0.05). Similarly, there were 52.14% patients in study group experienced adverse reactions and 52.17% in controlled group. Besides, there were no apparent trends within or between treatment groups with respect to laboratory values, ECG, weight, or vital signs.

    Discussion: The study showed clear treatment-related improvements in HAMD scores in both treatment groups during this clinical trial. On the basis of the primary efficacy endpoint, the efficacy of bupropion SR (300mg/d) was similar to fluoxetine (20mg/d). This is in line with results seen in some foreign studies investigating bupropion's efficacy. This study also supported the opinion that bupropion SR had the same tolerability profile as SSRIs.

    On the basis of a summery of 6 randomized, double-blind controlled clinical trials evaluating bupropion SR versus SSRIs for depression in adults, it has been suggested that Bupropion SR and SSRIs (SSRI comparators were fluoxetine, sertraline, and paroxetine) have similar effectiveness; however, bupropion SR was associated with less nausea, diarrhea, somnolence, and sexual dysfunction. The reason of no significant difference in adverse reaction could be found between two groups in study might be in relative small sample.

    In conclusions, this study showed bupropion SR was an effective safe newer antidepressant for Chinese adult patients with depression.

  • S34-2

    ·ÖÁÑÖ¢ 5HT3D ÊÜÌå»ùÒò¶à̬ÐÔÓëÀûÅàͪÖÎÁÆ·´Ó¦µÄ¹ØÏµ - Association between 5HT3D Receptor Gene Polymorphisms and Therapeutic Response to Risperidone in Schizophrenic Patients

    Huafang Li 1 , Shunying Yu 1 , Zhiguang Lin 1 , Yiren Weng 1 , Jicheng Jiang 1 , Ye Zhang 1 , Niufan Gu 1

    1 Shanghai Mental Health Center , Shanghai , Chinese Mainland

    Objective: The serotonin type 3 (5-HT(3) receptor is the only ligand-gated ion channel receptor for serotonin (5-HT), and plays an important role in modulating the inhibitory action of dopamine in mesocorticolimbic. A variety of antipsychotics inhibit ion fluxes through 5-HT3 receptors in a noncompetitive manner. As risperidone is a widely used atypical antipsychotic agent, this study aimed to exmaine the relationship between 5HT3D receptor gene polymorphisms and therapeutic response to risperidone in schizophrenic patients.

    Methods: Three hundred eighty-two patients including 204 male and 178 female were recruited from the Shanghai Mental Health Center inwards. All patients met DSM-IV criteria for schizophrenia, and had Clinical Global Impression-Severity of illness (CGI-S) score >=4 at baseline. Patients were treated with 2¨C6 mg of risperidone, and after 8 weeks treatment, the clinical response were assessed by Clinical Global Impressions¨Cimprovement I (CGI¨CI) scale. CGI¨CI score >=3 was considered as responder, and CGI¨CI score <3 as non-responder. Seven tagSNPs (rs6779545, rs7628618, rs939334, rs1467257, rs10937159, rs939335, and rs7613237) selected from CHB(Chinese Han Beijing) database in HAPMAP website and one non-synomoyous SNP(rs6443930) were genotyped by Taqman Assay (ABI) on ABI 7900 or SnaP shot on ABI 3730 in all patients.

    Results: after eight weeks treatment, 203 patients responded to risperidone, while 179 patients did not. There were no differences between the responder group and non-responder group as regards gender and age. No significant difference was found in allele and genotype of rs6779545, rs939334, rs1467257, rs10937159, rs939335, rs6443930 and rs7613237, but rs7628618 was observed to associated to risperidone response(p=0.012). When patients subgrouped to EOS (onset age <=18 years old) and AOS (onset age >18 years old), rs7628618 genotype was found more significantly associated with risperidone response in AOS subgroup(p=0.012), and rs939334 and rs6443930 was found associated with response in EOS subgroup(p=0.0251, 0.015).

    Conclusion: the 5HT3D receptor gene variant may help to predict risperidone treatment efficacy.

  • S34-3

    Serotonin Concentrations May Decrease in the Platelet of Treatment Resistant Depression Patient after the Risperidone Augment

    Xia Li 1 , Jun Cai 1 , Zheng Lu 1 , Hua-fang Li 1 , Gui-hua Pang 1

    1 Shanghai Mental Health Center , Shanghai Jiao Tong University , Shanghai , Chinese Mainland

    Objectives: To explore the platelet serotonin concentration in the treatment-resistant depression patients at baseline and 4 weeks after low dose risperidone as an augment combining with the ongoing antidepressants. At same time, the efficacy of the augmentative strategy was assessed.

    Method: The serotonin concentrations in the 38 patients with treatment-resistant depression were measured before (baseline) and 4 weeks after risperidone was added, at the same point Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA) scores were rated as well.

    Results: The seretonin concentrations in the platelets of TRD patients were significant lower than those of responsible depressed patients (99.9 ¡À118.5ng/10 9 vs 242.8 ¡À174.4 ng/10 9 , P £¼ 0.01), and positively related to two factors: current episode duration, retardation scores of HAMD. However, 4 weeks after risperidone was added, the serotonin concentrations were nearly significant lower compared to the baseline(p=0.05). The scores of HAMD, HAMA and their factors after risperidone augmentation were significant lower compared to the baseline(p £¼ 0.05). The serotonin concentrations after risperidone augmentation were positive correlated to the current episode duration, retardation scores of HAMD, the total scores of HAMA and the mental anxiety scores of HAMA, while negative correlated to the reductions of HAMD and sleeping factor scores. The reductions of the serotonin concentrations were negative correlated to the episodes while positive correlated to the reductions of retardation scores of HAMD.

    Conclusion: The low platelet serotonin concentration may be one of the biochemical characters in patients with TRD. While patients with treatment-resistant depression response to the augmentative strategy of low dose risperidone combining with antidepressants, the serotonin concentration in the platelet may even lower. The platelet serotonin concentrations may correlate to some symptoms such as anxiety and retardation. There may be correlation between the deductions of the platelet serotonin concentrations and the improvement of the retardation symptoms.

    Key words: Risperidone; Serotonin; Platelet; Treatment-resistant depression

  • S35 ¨C Psychotherapy

    Chairs: Zhuoji Cai, Chinese Mainland
    Edmond H.T. Pi, United States

    S35-1

    Psychogenic Bodyfocusing

    Friedrich Zikes 1

    1 Psychotherapy ¨C life- & social counseling, Vienna , Austria

    Psychogenic Bodyfocusing ¨C method

    ? meaning and understanding of psychogenic and body focused

    ? no new school but a new setting

    ? combinations with several psychotherapeutic schools are possible

    ? access on two levels at the same time -: psyche and cell body

    ? short-therapy setting

    ? priority of high-level compliance

    Psychogenic Bodyfocusing ¨C procedure

    ? first contact ¨C exploration ¨C diagnosis ¨C agreements

    ? starting compliance between partners

    ? patients are dressed in sports outfit or underwear

    ? relaxation to a semi-hypnotic state of alpha-level oscillation

    ? access on two levels according patient`s offer

    ? keeping operation level in spite of body contact

    ? meta language is acceptable, but need to be decoded

    ? imaging and affirmation programmes are instruments of support

    ? steps out of alpha-level-state (8-12Hz)

    Psychogenic Bodyfocusing ¨C an interactive process

    ? priorities of treatment ¨C psyche or body?

    ? use different methods of body manipulation

    ? compliance in context with interacting bio-energetic fields

    ? transactions between different charges of ¡°emotional signature fields¡±

    ? energetic methods of measurement in terms of mental defence-methods

    ? transfer and counter-transfer in body focused therapies

  • S35-2

    ÐÄÀíÖÎÁÆÔÚÈö¹þÀ­É³Ä®ÒÔÄÏ·ÇÖÞµÄÁÆÐ§ - Effectiveness of Psychotherapy in Subsaharan Africa

    Mohammed Said Jidda 1 , Musa Abba Wakil 1 , Abdulaziz Mohammed Olarenwaju 1

    1 Federal Neuropsychiatric Hospital Maiduguri nigeria, Mental Health, Maiduguri, Nigeria

    ±³¾° £º ÐÄÀíÖÎ ÁƶԾ«ÉñÕϰ­µÄÁÆÐ§ÔÚÎ÷·½ÊÀ½çÒѾ­µÃµ½È·ÈÏ £¬ µ«ÊǶԷÇÖÞÈ˶øÑÔ £¬ »¹ÊÇÒ»ÖÖİÉúµÄÖÎÁÆ·½·¨¡£

    Ä¿µÄ £º »Ø ¹ËÔÚÈö¹þÀ­É³Ä®ÒÔÄÏ·ÇÖÞÐÄÀíÖÎÁÆÁÆÐ§µÄÎÄÏס£

    ·½·¨ £º ÔÚ Medline, PsychINFO, CINAHL ÉÏ×öϵ ͳµÄ¼ìË÷ £¬ ´ËÍ⻹×öÁËÒýÎļì Ë÷ÒÔ¼° Êé±¾ºÍÔÓÖ¾µÄ¼ìË÷¡£Ñ¡ÔñÄÇЩÔÚÌâÄ¿»òÕªÒªÖÐÃèÊöÁËÔÚ·ÇÖÞµÄÐÄÀíÖÎÁƵÄÑо¿£¬²¢¶ÔÑо¿µÄÖÊÁ¿½øÐзÖÀà¡£

    ½á¹û£º ¹² ¼ìË÷ÁË 1261 ƪÎÄÏ×£» 4 ¸öÊDz¡Àý ±¨µÀ£¬ 4 ¸öÊÇËæ»ú ¶ÔÕÕÑо¿£¬ÓÐÒ»¸öÀàËÆÊµÑéÐÔÑо¿¡£ÔÚ 5 ¸öÓÐÏà ¹Ø×ÊÁϵÄÑо¿ÖУ¬ 4 ¸ö ÏÔʾÑôÐÔ½á¹û£¬ÒÔ¼°ÐèÒª¶ÔÎ÷·½µÄģʽ½øÐÐһЩÊÊÓ¦¡£

    ½áÂÛ£º ÔÚÈö¹þÀ­É³Ä®ÒÔÄÏ·ÇÖÞ ¶ÔÐÄÀíÖÎÁÆÁÆÐ§µÄ¸ßÖÊÁ¿Ñо¿»¹ºÜÉÙ£¬µ«ÏÖÓеÄÉÙÁ¿Ñо¿´ó²¿·Ö¿Ï¶¨ÐÄÀíÖÎÁƵÄÁÆÐ§¡£

    Background: Psychotherapy has been shown to be effective in the treatment of mental disorders in the western world but,viewed as an alien method of treatment to Africans.

    Aim: To review litterature on the effectiveness of psychotherapy in Sub-saharan Africa.

    Method: A systematic search of Medline, PsychINFO, CINAHL,were undertakken along with citation searches in addition to text books and journal were used. Studies were selected if psychotherapy treatment in Africa were described in the title or abstract. The study quality was rated.

    Results: The search produced over 1261 articles; 4 were case reports,4 randomised controlled trials and a quasi experimental. Of the 5 with relevant data 4 revealed a positive outcome and, the need for some adaptation of the western model.

    Conclusion: High quality data examining the effectiveness of psychotherapy in Sub-saharan is quite sparse however what few quality data are available reveal mostly positive outcome.

  • S35-3

    ²ÉÓùÚ×´¶¯ÂöÅÔ·´îÇÅÊõºó»¼ÕߵļÒÍ¥¿´»¤ - Family Caregivers Experiences of Patients with Coronary Artery Bypass Grafting Surgery

    Khosrow Tavakol 1 , Fatemeh Pashashei Sabet 2 , Abdolah Rezaei 2

    1 Nursing Faculty, Isfahan University of Medical Sciences, Health Department, Isfahan, Iran, Islamic Republic of, 2 Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

    ±³¾° £º ¹Ú×´ ¶¯ÂöÅÔ·´îÇÅÊõÊÇÍì¾È»¼ÕßÉúÃüµÄÒ»¸öÓÐЧ´ëÊ©¡£µ«Êõºó»¼ÕßÔÚÀëÔººó½«»áÓöµ½ºÜ¶àÎÊÌâ £¬ ÈÕ³£Éú»îÒ²½«ËæÖ®¶ø¸Ä±ä¡£ËûÃǵĽ¡¿µ·þÎñÐèÒª¿ÉÄܲ»Äܵõ½ºÜºÃµÄÂú×ã¡£ÕÕÁÏÕâЩ»¼ÕߵļÒÍ¥»¤¹¤ÓÐЩÔõÑùµÄ¾­ÑéÒ²ÐèÒªÁ˽⣬ÒÔ±ãÈÕºóÏò¸ü¶àµÄ¼ÒÍ¥»¤¹¤Ðû´«¡£ Ä¿µÄ£º ±¾¶¨ÐÔÑо¿Ö÷Òª ΪÁËÁ˽âÕÕÁϲÉÓùÚ×´¶¯ÂöÅÔ·´îÇÅÊõµÄ»¼ÕߵļÒÍ¥»¤¹¤ÔÚ»¼ÕßÊÖÊõǰºóÓÐЩÔõÑùµÄ¿´»¤¾­Ñé¡£

    ·½·¨£º ²ÉÓö¨ÐÔÑо¿ Éè¼Æ¡£Ä¿±êÑù±¾ 10 ÈË£¬°üÀ¨ 8 ¸ö¼ÒÍ¥ »¤¹¤ºÍ 2 ¸ö »¤Ê¿¡£²ÉÓÃÉîÈë·Ã̸ÐÎʽÊÕ¼¯ÐŠϢ£¬ ¹éÄÉ·¨·ÖÎö×ÊÁÏ¡£

    ½á¹û£º ÊÜ µ÷²éÕßÖ÷ÒªÔÚÒÔϼ¸¸ö·½Ãæ´æÔÚ¹²Í¬µãÈç 1 £©µ£ÐÄ»¼ÕߵĽ¡¿µ£¬ 2 £©µ£ÐÄ»¼ÕßÔÚ¼ÒÍ¥¡¢Éç»áºÍ ¾­¼ÃÉú»î·½ÃæµÄÀ§ÄÑ£¬ 3 £©µ£ÐĽ¡¿µÐ¡ ×éÓë¼ÒÍ¥»¤¹¤Ö®¼äµÄ¹ØÏµ¡£

    ½áÂÛ£º ¼ÒÍ¥ »¤¹¤ÊÇËùÓв»Í¬³Ì¶È´îÇÅÊõ»¼ÕßµÄÓÐÁ¦Ö§Öú£¬Ó¦¸Ã³ä·Ö¿Ï¶¨¼ÒÍ¥»¤¹¤µÄ×÷Óá£

    Introduction: Coronary artery bypass graft Surgery is a Life saving intervention but patients under coronary artery bypass graft who care for them after discharge, will encounter many Issues and changes to their usual daily routine. They may have unmet needs and health Services may not be Sufficiently Seam less or adequate to anticipate and address these needs. little is known about family Caregivers experiences of patient's with Coronary artery bypass grafting Surgery may help health Care teams to meet family caregivers needs.

    Aim: This qualitative. Study explored family Caregivers experiences of patients with Coronary artery bypass at the time before and after patient¡äs Operation.

    Method: this research is a qualitative design and has done in way of pharmacology. A purposeful Sample of 10 participants was obtained that included 8 family Caregivers and 2 Nurses. Deep Interview has clone for gathering of information and data analysis was done through colizis method.

    Results: The finding of this Study showed Flue principle Concepts have been explored that expresses experiences of participants in research Such as , 1)worry about patients condition 2)disturbance in family , Social and economic life 3) worry a bout ship between health team & the family eave givers

    Conclusion: This finding Showed the important Role of: Family Caregivers to Support patient with corny artery bypass in all Stages Accord to the Findings, Support of family Caregivers Should be a priority.

  • S36 - ¶«ÑǵØÇø¾«ÉñÒ©Îï´¦·½Ä£Ê½ £¨ REAP £© Ñо¿ ¡ª ¿¹¾«Éñ²¡ Ò©µÄ´¦·½Ï°¹ßÑо¿×¨Ìâ - Research on East Asia Psychotropic Prescription Pattern (REAP Study) -Focus on Antipsychotic Drug Prescription in East Asia

    Chairs: Yanling He, Chinese Mainland
    Naotaka Shinfuku , Japan

    ´Ó 1999 ÄêÆð £¬ ÈÕ±¾Éñ »§´óѧ¹ú¼ÊҽѧÑо¿ÖÐÐĺÍÐÂ¼ÓÆÂ¹úÁ¢´óѧҽѧԺÁªÊÖ·¢ÆðÁËÉñ¾­¾«ÉñҽѧÁìÓòµÄÑо¿¡£À´×ÔÖйú´ó½¡¢Ïã¸Û¡¢ÈÕ±¾¡¢º«¹ú¡¢ÐÂ¼ÓÆÂºĮ́ÍåµÈ¹ú¼ÒºÍµØÇøµÄ¾«Éñ¿ÆÒ½Éú¡¢Ò©Àíѧ¼Ò¡¢Á÷Ðв¡Ñ§¼Ò¹²Í¬²Î¼ÓÁ˶«ÑǵØÇø¿¹¾«Éñ²¡Ò©Îï´¦·½Ï°¹ßµÄ¹ú¼ÊºÏ×÷Ñо¿¡£Õâ¸öÑо¿¼ò³ÆÎª REAP-AP1 £¬¹² µ÷²éÁË 2399 ÀýסԺ¾«Éñ·ÖÁÑÖ¢»¼ÕßµÄ ´¦·½ÓÃÒ©Çé¿ö¡£µÚ 12 ½ìÊÀ½ç¾«Éñ²¡Ñ§´ó»á£¨ºá ±õ£¬ 2002 Äê 8 Ô 24 ÖÁ 29 ÈÕ£© ±¨¸æÁËÕâЩÊý¾ÝµÄ³õ²½·ÖÎö½á¹û¡£ÈýÄêºóÓÖÔÚÏàͬµØÇø½øÐÐÁËÀàËÆµÄÑо¿£¬³ÆÎª REPA-AP2 £¬Ä¿µÄÊÇ±È ½ÏÕâЩ¹ú¼ÒºÍµØÇøÈýÄêÀ´µÄ´¦·½ÓÃÒ©±ä»¯Çé¿ö¡£±¾×¨Ìâ»áÖ÷Òª±¨¸æ REPA-AP2 µÄ ½á¹û£¬Í¬Ê±¶Ô REPA µÄ¸Å¿ö×ö¸ö½é Éܲ¢Ì½ÌÖ½ñºóÈçºÎ¿ªÕ¹ÀàËÆµÄ¹ú¼ÊºÏ×÷Ñо¿¡£

    Since 1999, Kobe University School of Medicine International Center for Medical Research and Singapore National University School of Medicine have collaborated to organize research in the field of neuropsychiatry. Psychiatrists, pharmacologists, epidemiologists and researchers from East Asian countries organized an international collaborative research to survey prescription patterns for inpatients with schizophrenia in Mainland China , Hong Kong , Japan , Korea , Singapore and Taiwan . It is briefly called REAP-AP1. The initial analysis of the data involving 2,399 cases was reported at the 12th World Congress of Psychiatry, Yokohama , 24-29 August 2002. Three years later, a similar survey was carried out in the same region as REAP-AP2 to make comparison possible for the prescription patter change along with the time. In this symposium, the results of REAP-AP2 with focus on comparisons will be reported together with an overview of the research and the discussion on the future collaborative research on psychotropic medications in the region.

  • S36-1

    Origin and Development of REAP Study

    Chay Hoon Tan 1 , Mian-Yoon Chong 2 , Gabor S Ungvari 3 , Tianmei Si 2 , Eun Kee Chung 4 , Sim Kang 1 , Shu-yu Yang 5 , Naotaka Shinfuku 6

    1 National University Hospital, Singapore, Singapore, 2 Chang Gung Memorial Hospital-Kaohsiung Medical Center and Chang Gung University, Taiwan, Department of Psychiatry, Shanghai, Chinese Mainland, 3 Chinese University of Hong Kong, Hong Kong, Chinese Hong Kong, 4 Seoul National Mental Hospital, Seoul, Korea, Republic of, 5 Kaohsiung Medical University, Kaohsiung, Chinese Taipai, 6 of Human Sciences, Seinan Gakuin University, Fukuoka, Japan

    Abstract text has not been submitted

  • S36-2

    оÉÒ©Ö®¼äµÄÑ¡Ôñ ¡ª¡ªREPA Ñо¿ - Choosing Among Old and New Antipsychotics: Research on East Asia Psychotropic Prescriptions (Reap)

    Mian-Yoon Chong 1 , Chay Hoon Tan 2 , Gabor S Ungvari 3 , Tianmei Si 4 , Eun Kee Chung 5 , Sim Kang 2 , Shu-yu Yang 6 , Naotaka Shinfuku 7

    1 Chang Gung Memorial Hospital-Kaohsiung Medical Center and Chang Gung University, Taiwan, Department of Psychiatry, Shanghai, Chinese Taipai, 2 National University Hospital, Singapore, ww, Singapore, 3 Chinese University of Hong Kong, Hong Kong, Chinese Hong Kong, 4 Peking University, Beijing, China, Beijing, Chinese Mainland, 5 Seoul National Mental Hospital, Seoul, Korea, Seoul, Korea, Republic of, 6 Kaohsiung Medical University, Kaohsiung, Taiwan, Kaohsiung, Chinese Taipai, 7 School of Human Sciences, Seinan Gakuin University, Fukuoka, Japan, Fukuoka, Japan

    ÕýÎÄ £º ±³¾°¼°Ä¿µÄ £º ´Ë ÏîÑо¿ÊÇΪÁ˶Զ«ÑǵØÇø¿¹¾«Éñ·ÖÁÑÖ¢Ò©Îï´¦·½Ä£Ê½½øÐÐÆÀ¹À £¬ ²¢½øÒ»²½Ñо¿Ôì³É¸÷ģʽ֮¼ä²î±ðµÄÓ°ÏìÒòËØ¡£

    ·½·¨ £º ÔÚÖйú´ó ½¡¢Ïã¸Û¡¢ÈÕ±¾¡¢º«¹ú¡¢ÐÂ¼ÓÆÂºĮ́ÍåÕâÁù¸ö¹ú¼ÒºÍµØÇø £¬ ÓÚ 2001 ÄêºÍ 2004 ÄêÏà ¼Ì½øÐÐÁ˾«Éñ·ÖÁÑ֢סԺ²¡ÈË´¦·½Ä£Ê½µ÷²éÑо¿¡£Óñê×¼Õï¶Ï¼Ç¼·½Ê½ÊÕ¼¯Êý¾Ý£¬°üÀ¨»¼ÕßµÄÉç»áºÍÁÙ´²ÌØÕ÷ ¡¢¾«ÉñÖ¢×´¡¢²¡Òò¡¢ Ò©Îï²»Á¼·´Ó¦¡£±È½ÏºÍ·ÖÎöÁË¿¹¾«Éñ²¡Ò©´¦·½Ï°¹ßµÄÇ÷ÊÆºÍ±ä»¯¡£½á¹û£º´Ó 31 ¸öÖÐÐĹ²²É¼¯ 2398 Àý£¨ 2001 Ä꣩¡¢ 2136 Àý£¨ 2004 Ä꣩סԺ²¡ÈË£¬ÐÔ ±ðºÍÄêÁäÎÞÏÔÖø²îÒì¡£×ÜÌåÉÏ¿´£¬ÈÕ±¾²¡ÈËÄêÁä½Ï´ó£¬²¡³Ì½Ï³¤¡£±È½ÏÕâÁ½ÄêµÄÓÃÒ©Çé¿ö£¬·¢ÏÖµÚ¶þ´ú¿¹¾«Éñ²¡Ò©Î SGA £©Ê¹ÓÃÓÐËùÔö¼Ó , ´Ó 45.5% ÉÏÉýÖÁ 64.2% £¬Ïà·´£¬µÚÒ»´ú Ò©ÎïʹÓÃÓÐËùϽµ£¬´Ó 67.8% ½µÖÁ 53.5% ¡£ÁíÍ⣬ ¸´·½ÓÃÒ©ºÍ¸ß¼ÁÁ¿ÓÃÒ©Ç÷ÏòÓÚ¼õÉÙ£¬·Ö±ðÓÉ 45.7% ½µÖÁ 26.5% ¡¢ 17.9% ½µÖÁ 6.5% ¡£ÓÐЩ¹ú¼Ò ¼äµÄ´¦·½Ä£Ê½Ò²²»Í¬£¬ÈÕ±¾Ï°¹ß¸ß¼ÁÁ¿¼°¸´·½ÓÃÒ©£¬ÐÂ¼ÓÆÂϰ¹ß×¢Éä¸ß¼ÁÁ¿Ôм¤ËØ£¬Öйú´ó½½Ï¶àʹÓÃÂȵªÆ½¡£¶àÔª»Ø¹é·ÖÎöÏÔʾ SGA µÄʹÓÃÓëÅ®ÐÔ¡¢Äê Áä½ÏÇá¡¢¹ú¼Ò¡¢³öÏֻþõÖ¢×´ºÍÒõÐÔÖ¢×´Óйء£

    ½áÂÛ£º ±¾ ÏîÑо¿Ö¤Ã÷£¬¶«ÑǵØÇø¸÷´¦·½Ä£Ê½Ö®¼ä´æÔÚһЩ¹²Í¬Ö®´¦£¬¶øÇÒ SGA ʹÓÃÓÐÔö¼Ó Ç÷ÊÆ¡£È»¶ø£¬¸÷ÖÐÐÄ¿¹¾«Éñ²¡Ò©ÎïʹÓÃÇé¿öÊÇÓвî±ðµÄ£¬ÕâÓÉÐí¶àÒòËØÒýÆð£¬ÆäÖаüÀ¨¸÷¹úÎÀÉú±£½¡Ìåϵ¡¢Ò©ÎïµÄÓÐЧÐÔºÍÒ©Îï·ÑÓá£

    Background/Objectives: This study aims to assess the prescription pattern of antipsychotics for schizophrenia in East Asia , further to analyze factors that could affect these differences.

    Methods: Two consecutive surveys on the prescription patterns for schizophrenic inpatients were conducted in 2001 and 2004 in 6 East Asian countries: China , Hong Kong , Japan , Korea , Singapore and Taiwan . The data were collected using a standardized protocol including patients' social and clinical characteristics, psychiatric symptoms, course of illness, and adverse effects of medications. The trend and change of antipsychotic prescriptions were compared and analyzed.

    Results: samples comprised of 2,398 (2001) and 2,136 (2004) patients from 31 centers, with no significant sex and age differences. In general, Japanese patients were much older and had longer duration of illness. There was a significant increase use of second generation antipsychotics (SGA) (45.5% vs 64.2%) with reciprocal decrease use of first generation antipsychotics (67.8% vs 53.5%) between 2001 and 2004. In addition, decreasing tendency of polypharmacy (45.7% vs 26.5%) and high dosage used antipsychotics (defined by over 1000mg of chlorpromazine equivalent per day; 17.9% vs 6.5%) were also observed. Prescription patterns differed with some countries: Japan had higher dosage and antipsychotic polypharmacy; Singapore had high utilization of depot injections while China had high prescription of clozapine. Multivariate regression analyses showed that females, younger age, country, presence of hallucinations and negative symptoms were related to the use of SGA.

    Conclusions: study demonstrated some common characteristics and an increasing trend of the use of SGA in East Asia . However, the use of antipsychotics differed among centers and was influenced by a variety of factors and among them, the prevailing health care system, the availability of drugs and the costs of drugs.

  • S36-3

    ¶«ÑǵØÇø¿¹¾«Éñ²¡Ò©ÎïÁªºÏÑо¿ËùÃæÁÙµÄÌôÕ½ - Future Challenges for Collaborative Research on Psychotropic Medications in East Asia

    Ee Heok Kua 1

    1 National University of Singapore , Singapore , Singapore

    REPA ¹¹Ë¼ÓÚÆßÄêǰ £¬ Ëü¿É¿´×÷ÊÇ ¶«ÑǵØÇø¿¹¾«Éñ²¡Ò©Îï´¦·½Ä£Ê½ÁªºÏÑо¿µÄÀï³Ì±®¡£Ñо¿µÄÄ¿µÄ²»½ö½öÖ¹ÓÚÑо¿ £¬ Ò²ÊÇΪÁËÌá¸ßÒ©ÎïÁÆÐ§ºÍÒ½ÁƱ£½¡ÖÊÁ¿¡£Ñо¿»ñµÃÁ˹ØÓÚ Õû¸ö ¶«ÑǵØÇøµÄ´¦·½ÓÃҩϰ¹ßÕâЩ·Ç³£±¦¹óµÄ×ÊÁÏ¡£ÏÂÒ»½×¶Î£¬ REPA Ãæ ÁÙµÄÌôÕ½°üÀ¨ÎÀÉú¾­¼Ãѧ¡¢³É¹û·ÖÎö¡¢ÈËÖÖÆðÔ´Ñо¿Õ⼸·½Ãæ¡£µ«ÊÇÓйؾ«Éñ²¡»¼ÕßÕæÊµµÄÉú»î×ÊÁÏ»¹ÊǺÜȱ·¦µÄ¡£Ò»Ð©½ôÆÈµÄÎÊÌâ°üÀ¨ÖÎÁƵÄÒÀ´ÓÐÔ¡¢·ÑÓᢼÒÍ¥Ö§³Ö¡¢ÐÄÀíÖÎÁÆ¡¢·´Ó¦ÐÔµÄÃñ×å²îÒì¡¢¾«ÉñÎÀÉú½ÌÓý¡¢ÉçÇø·þÎñµÈµÈ¡£Í¨¹ý¶«ÑǵØÇøÁÙ´²Ò½ÉúµÄ¹²Í¬Å¬Á¦ £¬ ËûÃǽ«¸æËßÈ«ÊÀ½çÔÚÎÒÃǵÄÕïËùºÍÒ½ÔºÀïÈçºÎΪ²¡ÈË·þÎñ¡£

    It was a milestone in East Asian psychiatry when REAP was conceived 7 years ago as a collective enterprise to study antipsychotic prescriptions. The objective in the collaboration was not merely to promote research but also to improve pharmacotherapy and patient care. The results yielded invaluable data on the prescriptive habits in the whole region.

    In the next phase, the exciting challenges for REAP include:

    1 Health economics

    2 Outcome studies

    3 Ethnogenetic research

    There is a paucity of data on the naturalistic or ¡®real life' study of psychiatric patients. The pressing issues are treatment adherence, cost, family support, psychological therapies, ethnogenetic differences in response, psychoeducation, community services, etc. The combined effort of clinicians in East Asia will provide important information to the world on how patients are being cared for in our clinics and hospitals.

  • S36-4

    Öйú´ó½µØÇø¿¹¾«Éñ·ÖÁÑÖ¢Ò©Îï´¦·½Ä£Ê½×·×Ùµ÷²é - Following up Investigation Antipsychotic drugs Prescription for Inpatients with Schizophrenia in China

    Tianmei Si 1 , Yanling He 2 , Wei Hao 3

    1 Peking University Institute of Mental Health, Beijing, Chinese Mainland, 2 Shanghai Mental Health Center, Shanghai, Chinese Mainland, 3 Xiangya Hospital, Zhongnan University, Hunan, Changsha, Chinese Mainland

    ¾«Éñ¿ÆÒ½ÉúµÄ ´¦·½Ä£Ê½Öð½¥Êܵ½Ô½À´Ô½¶àµÄÐÂÒ©ÖÖÀàºÍËûÃÇ×ÔÉí½ÓÊܵĴóÁ¿µÄÅàѵµÄÓ°Ï졣ΪÁËÑо¿¶«ÑǵØÇø¿¹¾«Éñ²¡Ò©ÎïµÄ´¦·½Ä£Ê½ºÍÓ°ÏìÒòËØ £¬ ÎÒÃÇÓÚ 2001 Äê 7 Ô¡¢ 2004 Äê 7 ÔÂÏà ¼Ì½øÐÐÁ˾«Éñ·ÖÁÑ֢סԺ²¡ÈË´¦·½Ä£Ê½µ÷²é¡£ÕâÀﱨ¸æµÄÊÇ 04 ÄêµÄ µ÷²é½á¹û¡£·½·¨£ºÀûÓñê×¼Õï¶Ï·½·¨£¬ÔÚ³¤É³¡¢±±¾©¡¢ÉϺ£ÕâÈý¸öÖÐÐĵ÷²éÁË´Ó 7 Ô 1 ÈÕÖÁ 7 Ô 31 ÈÕÆÚ ¼ä½ÓÊÜÖÎÁƵľ«Éñ·ÖÁÑÖ¢²¡ÈË¡£ÊÕ¼¯°üÀ¨ÁÙ´²ÌØÕ÷ºÍÒ©ÎïÖÎÁÆ·½ÃæµÄÊý¾Ý£¬Ñо¿µÃµ½±±¾©´óѧ¾«ÉñÎÀÉúÑо¿ËùÒ©Îï´¦·½Î¯Ô±»áµÄÅú×¼¡£½á¹û£º¹²µ÷²é·ûºÏÌõ¼þµÄ²¡ÈË 504 Àý£¬ÆäÖÐ ³¤É³ 102 Àý¡¢±±¾© 200 Àý¡¢ÉϺ£ 202 Àý¡£Å®ÐÔÕ¼ 48.2% ¡£²¡ÈËÄê Áä´Ó 13 Ëê¿çÖÁ 88 Ë꣬ƽ¾ùÄêÁäΪ 38.88 Ë꣨±ê×¼²îΪ 14.64 Ë꣩¡£³¤É³µÄ²¡ÀýÓëÆäÓàÁ½¸öµØ·½µÄÏà±È£¬¾ßÓнÏÇáµÄÄêÁäºÍ½Ï¶ÌµÄ²¡³Ì¡£ 65% µÄ²¡ÈË Îª²¡³Ì³¬¹ý 5 ÄêµÄÂýÐÔ²¡ÈË£¬²¡ÈËסԺ´ó Լʮ¸öÔ¡£ 84.5% µÄ²¡ÈËÉç»á¹¦ÄÜÓ빤×÷ÄÜÁ¦ÊÜ Ëð¡£ 72.4% µÄ²¡ÈË ÎªÒõ ÐÔÖ¢×´£¬ 55.4% µÄ²¡ÈË ÎªÑôÐÔÖ¢×´¡£ËÄ·ÖÖ®ÈýµÄ²¡ÈËÊǵ¥Ò»¸øÒ©£¬ 23.4% µÄ²¡ÈË ÁªºÏÓÃÁ½ÖÖÒ©£¬ÓÐÈýÀý»¼ÕßÁªºÏÓÃÈýÖÖÒ©¡£ÔÚÕâЩ´¦·½ÖУ¬ 75.6% µÄ ҩΪ·ÇµäÐÍÒ©Î°´¸øÒ©´ÎÊý¼ÆË㣬ÆäÖÐÂȵªÆ½Õ¼ 40.3% £¬ÀûÅà ͪռ 28.77% £¬ à­Áòƽռ 7.14% £¬°ÂµªÆ½Õ¼ 4.96% ¡£Ê¹ÓõäÐÍ Ò©ÎïµÄ´¦·½Õ¼ 39.7% £¬ÆäÖÐ ÂȱûàºÕ¼ 13.69% £¬Êæ±ØÀûÕ¼ 8.16% £¬ ·ÜÄ˾²Õ¼ 5.36% £¬ ÂȱûàºÆ½¾ùÈÕÓÃÁ¿Îª 416.3mg-233.4mg £¬µÈµÈ¡£Óë 2001 Äê µ÷²é½á¹ûÏà±È£¬ 2004 ÄêÖзǵäÐÍ Ò©ÎïʹÓÃÔö¼Ó£¬ÈÕÓÃÁ¿Ò²Ôö¼ÓÁË¡£Èý¸öÖÐÐĵÄÁÙ´²×ÊÁϺʹ¦·½ ģʽµÄ²»Í¬ ÏÔʾµÄ½áÂÛΪ£º¿¹¾«Éñ²¡Ò©ÎïµÄ´¦·½Ä£Ê½Ëæ×ž­¼ÃºÍÒ©ÀíѧµÄ·¢Õ¹²»¶ÏÔڸı䡣

    Background: New medication availability and more education course have the deep influence to the prescription pattern of psychiatrists. In order to study the prescription pattern of psychotropic drugs and analyze the influence factors in East Asia, we conducted the first survey in July, 2001 and this following up survey in July, 2004 on the prescription patter for inpatients with schizophrenia in Asian countries. This is the report of following up survey in July, 2004 from China .

    Methods: Using the standardized protocol, schizophrenic patients who admitted for treatment from 1st to 31st of July 2004, were surveyed at 3 centers in China . Data collected included the clinical characteristics and the antipsychotics treatment of the patients. This research was approved by the Ethical Committee of Medical Research of Peking University Institute of Mental Health.

    Results: 504 cases meeting the inclusion were surveyed from 3 centers, 102 from Changsha , 200 from Beijing and 202 from Shanghai . 48.2% were female. There was a wide age distribution, from 13 to 88 years, with mean age of 38.88 (s.d. 14.64). Changsha had the mean ages younger, and the duration of illness was shorter than Beijing and Shanghai . 65% were chronic patients with more than 5 years duration of illness. Patients had been staying in hospital for nearly ten months. 84.5% patients had impaired social and professional function and 72.4 % experienced the negative symptoms, and 55.4% had the positive symptoms in the past month.

    233.4 mg/day. ¡À Three quarters patients were treated with one antipsychotics (monopharmacy). 23.4% used two antipsychotics and 3 cases were treated with three kinds of drugs. Among the antipsychotics prescribed, 75.6% were atypical drugs, clozapine(40.3%), risperidone(28.97%), quetiapine(7.14%) and olanzapine(4.96%) by the frequency. 39.7% used typical drugs, chlorpromazine(13.69%), sulpride(8.06%), perphanazine(5.36%), haloperidone(4.56%) and others. Mean chlorpromazine equivalent dose was 416.3 Compared with results from the survey in July 2001, frequency of atypical drugs increased, and the daily dose (CPZ-equivalent dose) of antipsychotics increased also. The patient's clinical profile and antipsychotic prescription from 3 centers showed significant different.

    Conclusion: Antipsychotic prescription pattern is changing with social economic development and understanding the pharmacology of antipsychotics.

  • S36-5

    ¿¹¾«Éñ·ÖÁÑÖ¢Ò©Îï´¦·½ÖеÄÒ©Îï¼ÁÁ¿ÎÊÌâ ¡ª¡ª2001 ÄêÓë 2004 ÄêÏà±È½Ï - High and Low Dose Antipsychotic Prescriptions in Schizophrenia- a 2001 and 2004 Comparative Research on East Asia Psychotropic Prescription (REAP) Study

    Sim Kang 1

    1 National University Hospital , Singapore , Singapore , Singapore

    ¿¹¾«Éñ·ÖÁÑÖ¢ Ò©Îï´¦·½ÖеÄÓÃÒ©¼ÁÁ¿ÎÊÌâÔÚ¶«Ñǹú¼ÒÖÐÑо¿µÃÓÈÆä¶à £¬ ÎÒÃÇÔø¾­±¨µÀ¹ýÔÚÖÎÁÆÖÐʹÓø߼ÁÁ¿ÕßÕ¼ 17.7% ¡£ÔÚ ÕâÏîÑо¿ÖУ¬ÎÒÃÇ·Ö±ðµ÷²éÁ˸߼Á Á¿£¬µÍ ¼ÁÁ¿µÄʹÓÃÇé¿ö£¬ËüÃǵÄÁÙ´²¹ØÁªÐÔÒÔ¼°ÕâÁ½Äê¼äµÄ±ä»¯Ç÷ÊÆ¡£¼ÙÉè¶«ÑǵØÇøÔÚ´ËÆÚ¼ä¸ß¼ÁÁ¿£¬µÍ¼ÁÁ¿ÓÃÒ©Çé¿ö¶¼ÊÇÏÈÔöºó¼õ¡£·½·¨£ºÔÚÁù¸ö¹ú¼ÒºÍµØÇøÓÚ 2001 Äê³éÈ¡¾«Éñ·ÖÁÑÖ¢²¡ÈË 2399 Àý£¬ 2004 Äê³éÈ¡ 2136 Àý£¬¸ß ¼ÁÁ¿¡¢µÍ¼ÁÁ¿ÕâÁ½ÖÖ·½Ê½¶¼Ó᣽á¹û£ºÁ½ÄêµÄÊý¾Ý±È½ÏÏÔʾ£¬µÍ¼ÁÁ¿ÓÃÒ©Ôö¼Ó£¬ÓÉ 24.8% ÉýÖÁ 44% £¨ P<0.001 £©£¬¸ß ¼ÁÁ¿ÓÃҩϽµ£¬ÓÉ 17.9% ½µÖÁ 6.5%(P<0.001) ¡£¶àÔª logistic »Ø ¹é·ÖÎöÏÔʾ£ºµÍ¼ÁÁ¿ÓÃÒ©ÓëÄêÁäÔö¼Ó (OR 1.02,95%CI 1.01-1.03,P<0.001) £¬µÚÒ»´ú¿¹¾«Éñ²¡ Ò©ÎïʹÓüõÉÙ (OR 0.65,95%CI 0.53-0.78,P<0.001) ÓÐ ¹Ø£»¸ß¼ÁÁ¿ÓÃÒ©ÓëÄêÁä½ÏÇá (OR 0.98,95%CI 0.97-0.99,P<0.001) £¬µÚÒ»´ú¿¹¾«Éñ²¡ Ò©ÎïʹÓÃÔö¼Ó (OR 3.51,95%CI 2.47-4.90,P<0.001) ÓÐ ¹Ø¡£Í¬Ñù£¬ÔÚÐÂ¼ÓÆÂ£¬µÍ¼ÁÁ¿ÓÃÒ©Ç÷ÏòÔö¶à£¨ 28.7% ÉýÖÁ 59%,P<0.001 £©£¬¸ß ¼ÁÁ¿ÓÃÒ©Ç÷Ïò¼õÉÙ£¨ 20% ½µÖÁ 6.6%,P=0.002 £©¡£¶àÔª»Ø ¹é·ÖÎöÏÔʾ£ºµÍ¼ÁÁ¿ÓÃÒ©ÓëµÍˮƽÔм¤ËØÊ¹ÓÃÓÐ¹Ø (OR 0.36,95%CI 0.25-0.54,P<0.001) £¬¸ß ¼ÁÁ¿ÓÃÒ©ÓëÄêÁäϽµÓÐ¹Ø (OR 0.97,95%CI 0.95-0.99,P=0.037) ¡£ ½áÂÛ : ¾«Éñ·ÖÁÑÖ¢ Ò©ÎïÖÎÁÆÖиߵͼÁÁ¿ÓÃÒ©·¢ÉúÃ÷ÏԱ仯¡£Òò´Ë£¬ÎÒÃÇÐèÒª½øÐÐÒ©ÎïÁ÷Ðв¡Ñ§Ñо¿À´¸üºÃµØ×ÝÏòÆÀ¹ÀÒ©Îï´¦·½Ä£Ê½¼°ÆäÓ°ÏìÒòËØ¡£

    Background: Low and high dose antipsychotic use in schizophrenia are relatively understudied especially within East Asia. We have previously reported an overall rate of high dose antipsychotic use (17.9%) in schizophrenia. In this follow up study, we seek to examine the use of low (defined as CPZ mg equivalent doses below 300) and high dose (defined as CPZ mg equivalent doses above 1000) antipsychotic use, their clinical correlates as well as determine trend changes between the two time periods (2001 and 2004). We hypothesized that there was an increase and corresponding decrease in the use of low and high dose antipsychotic respectively over time in East Asia .

    Methods: High and low dose prescription use for a sample of 2136 patients with schizophrenia from six countries and territories ( China , Hong Kong , Korea , Japan , Taiwan , Singapore ) were evaluated in 2004 and compared with those of 2399 patients in 2001.

    Results: Overall, data comparisons between 2001 and 2004 showed a significant increase in low dose (24.8% to 44.0%, p<0.001) antipsychotic use and decrease in high dose (17.9% to 6.5%, p<0.001) antipsychotic use. Using a multiple logistic regression model, low dose antipsychotic use was associated with increased age (OR 1.02, 95%CI 1.01-1.03, p<0.001), less use of first generation antipsychotic (OR 0.65, 95%CI 0.53-0.78,p<0.001) and high dose was associated with younger age (OR 0.98, 95%CI 0.97-0.99, p=0.035), increase in first generation antipsychotic use (OR 3.51, 95%CI 2.47-4.90, p<0.001). In Singapore , a similar trend prevailed from 2001 to 2004 for low (28.7% to 59.3%, p<0.001) and high dose (20.0% to 6.6%, p=0.002) antipsychotic use. Multiple regression analyses revealed that low dose use was associated with less depot use (OR 0.36, 95%CI 0.25-0.54, p<0.001) and high dose use was associated with decreased age (OR 0.97, 95%CI 0.95-0.99, p=0.037).

    Conclusions: Significant positive trend changes were found in the prescription of low and high dose antipsychotic in schizophrenia, thus lending support to the usefulness of such pharmcoepidemiology studies to evaluate longitudinal prescription patterns as well as the factors impacting such patterns.

  • S37 - Depression: Treatment Advances and Implications for Care

    Chairs: Jerrold Rosenbaum, United States
    Jonathan Worth, United States
    Taoyuan Xu, Chinese Mainland

    Purpose ¨C to compare and contrast what is learned about the etiology, diagnosis and treatment of depression from the fields of psychopharmacology, neurotherapeutics and psychotherapy.

  • S37-1

    Neurotherapeutics: Past, Present and Future

    Lawrence Park , United States

    Abstract text has not been submitted

  • S37-2

    Pharmacotherapeutic Approaches for the Depressed Patient: First Line and Next Step Treatments

    Jerrold Rosenbaum, United States

    Abstract text has not been submitted

  • S37-3

    Effective Psychotherapies for Depression: Evidence-Based Approaches and Novel Applications

    Timothy Petersen, United States

    Abstract text has not been submitted

  • S37-4

    The Collaborative Care Model to Improve Recognition and Treatment of Depression in the Medical Settings

    Albert Yeung, United States

    Abstract text has not been submitted

  • S37-5

    Contribution V to the Sympsium "Depression: Treatment Advances and Implications for Care"

    Liang Shu, Chinese Mainland

    Abstract text has not been submitted

  • S38 - ¾«Éñ¿ÆÒ½Ê¦Åàѵ - Psychiatry Training Program

    Chairs: Xin Yu, Chinese Mainland
    Enrique Bobles, United States

  • S38-1

    ÑÇÖÞµØÇø¾«Éñ¿ÆÒ½Ê¦µÄÅàѵÓëרҵÈËÔ±·¢Õ¹ - Professional Development and Training of Psychiatrists in Asia

    N Sartorius

    International Association for the Improvement of Mental Health Programmes, Geneva , Switzerland

    ¶àÊý ÑÇÖÞ¹ú¼ÒÖо«Éñ¿ÆÒ½Ê¦ £¨ °üÀ¨ÆäËû¾«ÉñÎÀÉú¹¤×÷ÈËÔ± £© Õ¼Õû¸öÈ˿ڵıÈÀý¶¼ºÜµÍ £¬ ¶øËûÃÇÔÚ¹ú¼ÒÖаçÑݵĽÇɫȴÐèÒª¾«ÉñÎÀÉú·þÎñ·¢Õ¹ÍêÉÆ¡¢ÈËÔ±³ä×ã¡£Òò ´ËÓбØÒª ΪËûÃÇÉè¼ÆÒ»ÖÖ²»Í¬ÓÚÅ·ÖÞÒÔ¼°ÆäËû¹¤Òµ»¯·¢´ï¹ú¼ÒµÄÅàѵÏîÄ¿¡£¶øÕ⻹²»Êǹؼü¡£ÔÚ·¢´ïÓë·¢Õ¹Öйú¼Ò£¬±ÏÒµºó¼ÌÐø½ÌÓýÓëÑо¿Éú½ÌÓýµÄ±ÈÖØºÜС£¬ÕâʹµÃ¾«Éñ¿ÆÒ½Ê¦ºÜÄѵ£¸ºÆðÁìµ¼¾«ÉñÎÀÉú·þÎñ·¢Õ¹£¬Âú×ã¹úÄÚÐèÇóÓëÏÖ×´µÄÖ°Ôð¡£±¾ÎĽ«¹Ø×¢ÄÇЩÐèÒª¼ÓÇ¿µÄ¿Î³Ì £¬ ÒÔʹ±ÏÒµÉúÄܹ»¸üºÃµØÓ¦¶Ô¹«ÖÚµÄÐèÇó¡£

    The ratio psychiatrists/population is low in most Asian countries and the roles of psychiatrists (and of other mental health workers) would therefore have to be different from the roles that these professionals have in countries in which the mental health services are well developed and adequately staffed. To make this possible it would be necessary to design their training in a manner different from that prevailing in European and other highly industrialized and developed countries. This however is not the case. Graduate and postgraduate training are still constructed in a very similar way in developed and developing countries and, as consequence psychiatrists only rarely assume leadership in the development of a model of mental health care that would correspond to the needs and conditions in their countries. The presentation will focus on elements of curricula that would need to be strengthened in order to make graduates better able to respond to the needs of their populations.

  • S38-2

    ¾«Éñ¿Æ ¡° Ë«»ù ¡± ÅàѵÔÚÖйú¸÷µØµÄʵ¼ù - Psychiatric Basic Training in China

    Yifng Xu

    Shanghai Mental Health Center , Shanghai , Chinese Mainland

    ¡° Ë«»ù ¡± µÄÄÚÈÝÊÇ ¡° »ù±¾Öª ʶ ¡± ºÍ ¡° »ù±¾¼¼ÄÜ ¡± £¬ Õâ±¾À´ÊÇһλҽʦ´ÓÊÂij¸öרҵ±ØÐëÕÆÎյĻù±¾ÄÚÈÝ £¬ µ«ÊÇÓÉÓÚÎÒ¹úµÄҽѧ½ÌÓýºÍסԺҽʦÅàѵÌåϵµÄ²»ÍêÉÆ £¬ »ù²ãҽʦ¶ÔÕâÁ½ÏîÄÚÈݵÄÕÆÎÕ³Ì¶ÈÆÕ±é½Ï²î £¬ ¾«Éñ¿ÆÒ²²»ÀýÍâ £¬ ¶øÇÒÇé¿ö ±ÈÆäËûѧ¿ÆÏà±È¸ü¼ÓÔã¸â¡£ ΪÁ˸ıäÕâÖÖ×´¿ö£¬ÖйúÎÀÉú²¿×éÖ¯ ÁËÒ»¸öÖ÷Òª Õë¶Ô»ù²ã¾«Éñ¿ÆÒ½ÉúµÄר¿ÆÅàѵÏîÄ¿£¬Óɱ±¾©´óѧ¾«ÉñÎÀÉúÑо¿ËùµÈËĸöÅàѵÖÐÐľßÌåÖ´ÐÐÅàѵÈÎÎñ¡£

    ÏîÄ¿´Ó 2002 Äê ¿ªÊ¼£¬Ã¿ÄêÒ»ÆÚ£¬ÓÉËĸöÅàѵÖÐÐĸ÷Ö´ÐÐ 1 ¸ö°à£¬ ÿ°àÅà ѵ¸ßÄêסԺҽʦÒÔÉϵÄÒ½ÉúÔ¼ 50 ÈË£¬È«ÄêÅà ѵԼ 200 ÈË¡£ 2003 ÄêÓÉÓÚ SARS ¶øÖжϣ¬µ½½ñÄê 9 Ô¹² ¾Ù°ì 5 ÆÚ 19 ¸ö°à£¬Åà ѵ×ÜÈËÊýÔ¼ 1000 ÈË¡£

    ÏîÄ¿´Ó¿ªÊ¼¾ÍÓëÖйú¾«Éñ¿Æ×¨¿ÆÒ½Ê¦ÅàѵÌåϵµÄ½¨Á¢Í¬²½£¬ÆäÅàѵ¾­ÑéÖ±½Ó±»ÔËÓõ½Öƶ¨Öйú¾«Éñ¿Æ×¨¿ÆÒ½Ê¦Åàѵ´ó¸ÙºÍÅàѵ½Ì²ÄµÄ±àд֮ÖС£

    ¡° ¹æ·¶ ¡± ºÍ ¡° ϵ ͳ ¡± ÊÇ ¸ÃÏîÄ¿µÄ²Ù×÷Ö¸µ¼¡£ÎÒÃÇÁ¦Í¼½¨Á¢ÆðÒ»¸öÄܹ»±»¹ã·º½ÓÊܵľ«Éñ Õϰ­È«³Ì ´¦ÀíµÄÁ÷³ÌģʽºÍ²½Öè¿ò¼Ü£¬Í¬Ê±Ìرð×¢ÒâÕë¶Ôÿһ¸ö²½ÖèµÄ¾ßÌåϸ½Ú½øÐÐÅàѵ£¬Ê¹ÊÜѵÕßϵͳµØÕÆÎÕ»ù±¾ÖªÊ¶£¬¹æ·¶µØ²Ù×÷»ù±¾¼¼ÄÜ¡£

    ÔÚ Ö´Ðйý³ÌÖÐÎÒÃÇ·¢ÏÖ£¬»ù²ã¾«Éñ¿ÆÒ½ÉúµÄרҵ̬¶ÈºÍ»ù±¾¼¼ÄܵÄȱÏÝ£¬±È»ù±¾ÖªÊ¶µÄȱ·¦¸üΪͻ³ö¡£Òò´ËÎÒÃÇÖð½¥½«ÅàѵµÄÖØµãתÏò̬¶ÈºÍ¼¼ÄÜ¡£ÔÚÄÚÈÝÉÏ£¬ÓÉÔ­À´µÄ½²¿Î¶àÓÚʵϰ£¬Ñݱä³ÉĿǰÁÙ´²¼¼ÄÜʵϰºÍ¹ÛĦռ 70% ¡£ÔÚ½Ìѧ·½·¨ÉÏ£¬ÒÔ ÏÖ³¡¹ÛĦר¼Ò²é·¿¡¢Â¼Ïñ·ÖÎöÓëÌÖÂÛ¡¢½ÇÉ«°çÑÝ¡¢²¡·¿ÊµÏ°ÎªÖ÷£¬½²´ó¿ÎΪ¸¨¡£¾ßÌåµÄ·½·¨ÊÇ£ºÎ§ÈÆÁÙ´²Êµ¼Ê²¡ÀýµÄÍêÕû´¦Àí¹ý³Ì½øÐÐÅàѵ£¬½«ÁÙ´²ÕïÁƹý³ÌµÄÿһ¸ö²½ÖèºÍϸ½Ú·Ö²ð½Ìѧ£¬ È»ºóÕûºÏ³É ¹æ·¶»¯µÄÍêÕû¹ý³Ì¡£ÁíÍ⻹Ôö¼ÓÁËÁÙ´²·¨ÂɺÍÂ×ÀíÎÊÌâµÄ¿Î³Ì¡£

    ´Ó 2005 ÄêµÄµÚÈýÆÚ ¿ªÊ¼£¬¸÷ÅàѵÖÐÐĽ«ÅàѵµØµãÑ¡ÔñÔÚ¶þÏß³ÇÊУ¬Óëµ±µØµÄÄ¿±êÒ½Ôº¹²Í¬¾Ù°ìÏîÄ¿£¬ÕâÑù²»½öÀ©´óÁ˱¾ÏîÄ¿µÄÓ°Ï죬¸üÖØÒªµÄÊÇÅàÑøÐµÄÅàѵ»ùµØºÍ½Ìʦ¶ÓÎ飬ҲΪĿ±êÒ½Ôº´øÀ´ÁËÉç»áÐ§Òæ¡£

    The ¡®basic training' includes basic skills and basic knowledge which should be implemented in the phase of psychiatric residency training. However, due to the lack of systemic training curriculum of psychiatric residency training in China , most of Chinese psychiatrists are trained in a sort of ¡®master-apprentice' way, which results in a disparity in terms of qualification and practice capacity. In order to improve this situation, the Ministry of Health initiated a training program targeting doctors working in provincial psychiatric hospitals. The training program is undertaken by four prestigious psychiatric institutions in Beijing , Shanghai , Hunan , and Sichuan . The program started in 2002. It is an annual training program which includes four workshops, 50 trainees per workshop. Until now, more than one thousand doctors were recruited. Meanwhile the training curriculum for psychiatrist is in drafting process and the experience from the ¡®basic training program' is much helpful for the development a more focusing and more practical curriculum. We keep trying to set up a paradigm which stresses the standardization and systemization. A framework which includes every detail in the diagnosis and management of psychiatric disorders is repeatedly practiced so that the participants can learn how to interview the patient and structure the therapeutic strategy What we have learnt from the training program is that the trainees are much worse in the attitude and skills than that of basic knowledge. To improving the professional attitude and skills, we try to integrate more practice into the workshop rather than lectures. The practice consists of grand round, observation of teaching videos, role play, and group discussion in psychiatric ward. Vignette analysis provides a good example of making clinical diagnosis, establishing management plan, and dealing with other issues such as ethical and legal issues. The workshops now extend to smaller cities and co-organize with local psychiatric hospitals. Therefore it brings a more in depth impact to the local psychiatric institution and more training opportunities for doctors from remote areas.

  • S38-3

    ÈçºÎ½«ÐÄÀíÖÎÁÆÕûºÏµ½¾«Éñ¿ÆÒ½Ê¦Åàѵ¿Î³ÌÖÐ - How to Integrate the Psychotherapy Training into Psychiatry Training Program

    Wen-Shing Tseng 1

    1 University of Hawaii , School of Medicine , Department of Psychiatry, Honolulu , United States

    ËäÈ»½üÄêÀ´ÉúÎᆱÉñҽѧ £¬ °üÀ¨¾«ÉñÒ©Îïѧ £¬ ÓÐÏÔÖøµÄ·¢Õ¹ £¬ ¶Ô¾«ÉñÒ½ÁÆÓÐÃ÷ÏԵĸĽø £¬ ÌØ±ðÊǶÔÑÏÖØ ÐԵľ«Éñ¼²²¡ £¬ ¿ÉÊÇÈÔÈ»ºÜÓÐÐèÒªÍÆÕ¹ÐÄÀíÖÎ ÁÆ £¬ ÌØ±ðÊǶÔÇá¶ÈÐԵľ«Éñ¼²²¡»ò»¼Ò»°ãÐÄÀíÎÊÌâµÄ²¡ÈË¡£Óо­ÑéÓëÔ¶¼ûµÄר¼ÒÃǶ¼¿Ï¶¨ÏÖ´ú¾«ÉñҽѧÐèÒª¹ã·ºÇÒÕûºÏÐԵİüº¬ ¡° ÉúÎï - ÐÄÀí - Éç»áÓëÎÄ»¯ ¡± È¡Ïò¡£ÔÚ¾«Éñ¿ÆÒ½ ʦÅàѵ¿Î³ÌÖÐÐèÒªÓÐÏ൱µÄ·ÝÁ¿Õë¶Ô²¢·ÖÅäÓÚÐÄÀíÖÎÁƵÄѵÁ·£¬ÕâÑùÿλÊÜѵµÄ¾«Éñ¿ÆÒ½Ê¦¶¼¿ÉÒÔѧϰµ½ÈçºÎÕë¶ÔËùÓв¡ÈËÈ¥Ö´ÐÐËùÐèµÄÐÄÀíÖÎÁÆ¡£ÕâÊǶÔÈκÎÉç»á¶¼ÊÇÒ»ÑùµÄÒªÇóÓë¿´·¨£¬¶ø±¾±¨¸æ½«¾ÍÖйúµÄÇé¿öΪÀý×ÓÀ´ÌÖÂÛ¡£

    ΪÁËÌṩÊʵ±µÄÐÄÀíÖÎÁƵÄѵÁ·£¬Ê×ÏÈÒªÓÐһЩ»ù±¾¶øÖØÒªµÄÌõ¼þ¡£¼´£º¾«ÉñҽѧµÄÈ¡ÏòÒª³¬Ô½ ( ÏÖÏó ) ÃèÊöÐԵľ«Éñҽѧ¶ø¸»ÓÐÐÄÀíÈ¡ÏòµÄ ¶¯Ì¬ÐÔ¾«Éñҽѧ¡£³ýÁËÃèÊöÐÔµØÕë¶Ô²¡ÈËËù±íÏÖµÄÖ¢×´¡¢²¡Çé¡¢·ÖÀàÕï¶ÏÓëÒ©ÎïÖÎÁÆÒÔÍ⣬»¹µÃÄÜ¾Í ¡° ÈË ¡± µÄ½Ç¶ÈÈ¥Á˽Ⲣ°ÑÎÕ²¡ÈË£¬°üÀ¨£º¸öÈ˵ÄÉú»î¡¢ÐÄÀí×´ ̬£¬¼°ÈçºÎȥЭÖú²¢´¦ÀíÐÄÇéÉϵÄÎÊÌ⡣ͬÑùºÜÖØÒªµÄ»ù±¾Ìõ¼þ¾ÍÊÇ£¬¾«ÉñҽѧµÄÅàѵҪÓÐÃ÷È·µÄ¡¢ÕûÌåÐÔµÄϵͳ£¬°´ÄêÓмƻ®ÐÔ¡¢³É³¤ÐԵĽøÐУ¬²¢ÇÒÓгä·ÖµÄÅàѵµÄ¿Î³Ì¡£²»½öÊÇ´ø½ÌµÄÒ½Ôº£¬ÆÕͨµÄÒ½ÔºÒ²¸ÃÈç´Ë£¬²ÅËãÊÇÕý¹æµÄÌṩÁËסԺҽʦµÄÅàѵ¡£

    ÓÉÓÚÐÄÀíÖÎ ÁÆÊǺÜÖØÒª¶ø¸´ÔÓµÄÁÙ´²ÖªÊ¶Óë¾­Ñ飬ÅäºÏ×ÅÕûÌåµÄÅàѵ¿Î³Ì£¬ÖÁÉÙÒªÓÐÈý·ÖÖ®Ò»µ½¶þ·ÖÖ®Ò»µÄʱ¼ä·ÖÅäÓÚÐÄÀíÖÎÁƵÄÅàѵ£¬²¢ÇÒ°´Äê¶øÓÐ Öð ²½ÐԵݲÅÅÅà ѵµÄÒªµãÓëÄÚÈÝ¡£ÒÔ×î¶ÌµÄÈýÄêÅàѵÆÚ¼äΪÀýÀ´Ëµ£¬Í·Ò»Äê×îºÃÒª×¢ÖØÈçºÎÓÐÉî¶ÈµÄÁ˽âÈ˵ÄÐÄÀíÓëÈ˸ñ·¢Õ¹¡¢ÐÐΪµÄÐÔÖÊ¡¢²¡ÀíµÄ¶¯Ì¬ÐÔÔ­Àí¡¢ÒÔ¼°ÐÄÀíÖÎÁÆ»á̸µÄ»ù±¾Ô­ÔòÓëÒªÁì¡£½Ó×Å£¬µÚ¶þÄê¾ÍµÃ×¢ÖØÑ§Ï°£ºÐÄÀíÖÎÁƵĻù±¾Ñ§Àí£¬¸÷ÖÖ²»Í¬Ä£Ê½µÄÐÄÀíÖÎÁÆ£¬°üÀ¨·ÖÎöÐÔ¡¢ÈÏÖª - ÐРΪÐÔ¡¢È˼ÊÐÔÖÎÁÆ £¨È磺¼ÒÍ¥¡¢»éÒöÓëȺÌåÖÎ ÁÆ£©¡£ÖÁÓÚµÚÈýÄê¾ÍµÃѧϰÐÄÀíÖÎÁƸ߶ȵÄ֪ʶÓëѧÀí£¬²¢ÇÒ¶®µÃÈçºÎÄÜÊìÁ·µÄ²Ù×÷³¤ÆÚÐÔ¡¢¶ÌÆÚÐÔµÄÖÎÁÆÖÎÁÆ£¬¶Ô¸÷ÖÖ²»Í¬¾«Éñ²¡ÀíÓëÐÔ¸ñµÄÖÎÁÆÒªÁ죬ÈçºÎ¿¼ÂÇÎÄ»¯ÓëÕÜѧ˼ÏëÉϵÄÒòËØ£¬ÒÔ¼°ÈçºÎÆ·ÉóÖÎÁƵÄЧ¹ûµÈ¡£

    Òò ΪÐÄÀí ÖÎ ÁƵÄÊ©ÐУ¬²»µ«ÒªÓÐ֪ʶ£¬Ç¿µ÷ѧÀíµÄÁ˽⣬»¹µÃѧϰʵ¼ÊÉϵļ¼ÇÉÓëÒªÁ죬Òò´Ë£¬ÐÄÀíÖÎÁƵÄÅàѵҪÒÔ¶àÑùÐÎʽÀ´½øÐУ¬²¢ÇÒѧÀí֪ʶÓëʵ¼Ê¾­Ñé²¢ÖØ¡£ÅàѵµÄ¿Î³Ìͨ³£Ã¿ÖÜÒª°üÀ¨£º¾ÍÌâ½²½âÓëÌÖÂÛµÄרÌâÌÖÂۻᡢ¸ö°¸ÌÖÂۻᡢÒÔ¼°¶½µ¼¡£¾«Éñ¿ÆÒ½Ê¦ÒªÑ§Ï°ÈçºÎÖÎÁÆ×¡ÔºµÄÑÏÖØ²¡ÈË£¬µ«Ò²±ØµÃѧϰÈçºÎÕïÖÎÃÅÕïµÄÇá¶È²¡ÈË£¬¾­ÑéÈçºÎÖÎÁƸ÷ÖÖ²»Í¬²¡ÇéÓëÐÔ¸ñµÄ²¡»¼Õߣ¬¸üҲҪѧϰÈçºÎÊʵ±µØÅäºÏÐÄÀíÓëÒ©ÎïµÄÖÎÁÆ£¬ÓÐЧµØÒ½ÁƲ¡ÈË¡£

    ×ܹé˵À´£¬Ã¿¸ö¾«Éñ¿ÆÒ½Ê¦¶¼ÒªÔÚÆäÅàѵ¹ý³ÌÀï½ÓÊÜÐÄÀíÖÎÁƵÄѵÁ·¡£ÕâÑù£¬Ã¿¸ö¾«Éñ¿ÆÒ½Ê¦£¬³ýÁ˶®µÃÈçºÎ¿ªÒ©ÖÎÁƲ¡ÈËÒÔÍ⣬»¹ÄÜÌṩ ÿ ¸ö²¡ÈËËùÐèµÄÐÄÀíÉ쵀 ¸¨µ¼ÓëÖÎÁÆ¡£Ò²¾ÍÊÇ˵£¬ÐÄÀíÖÎÁƲ»ÊǽÓÊÜÌØ±ðѵÁ·µÄÐÄÀíÖÎÁÆÊ¦²Å¿ÉÒÔÊ©ÓëµÄÌØÊâÁÆ·¨£¬¶øÊÇÿ¸ö¾«Éñ¿ÆÒ½Ê¦¶¼Ðè¶®µÃ²Ù×÷µÄ»ù±¾Ò½ÁÆ·½·¨¡£ÈçºÎ½¨Á¢ÓÐϵͳÅàѵµÄ¹ÛÄÅàÑøËùÐèµÄ½Ìʦ£¬ÈçºÎ¸ü¸ÄÅàѵµÄÖÆ¶È£¬ÊÇÒªÖðÄêÈ¥¸Ä½øµÄÆÈÇпÎÌâ¡£

    In spite of the recent remarkable advance in biological psychiatry, including psychopharmacology, improving tremendously the psychiatric care of patients, particularly for those suffering from major psychiatric disorders, there is still a great need to promote psychotherapy for caring of patients suffering from minor psychiatric disorders or emotional problems. Most of the competent clinicians agree that modern psychiatry needs to be biological-psychological-sociocultural oriented and comprehensive in nature. Furthermore, there is a need of emphasis of psychotherapy training as a significant part of the training program so that each psychiatrist trained will know how to provide psychological therapy for patients. This is true for most societies but discussion will be geared mainly for the situation in China as example.

    In order to provide adequate psychotherapy training, there are several major premises. The psychiatry needs to be dynamically oriented, beyond descriptive orientation. Knowing how to comprehend a patient as a person with personal life and how to work on emotional matter is very important beyond focusing merely on patient's symptoms, diagnosis and medication descriptively. Equally important is that there is a need to have a systematic training program available for the residents in training. During the course of training, there needs to be a clearly defined stage and program of training with identified goals for each year to advance progressively.

    Integrated with such systematically developing training program, there is a need to have a sufficient part of time devoted to the training of psychotherapy, at least one third to half of the total training time. The emphasis of training needs to be progressive yearly. Let us take three year period of training as example. For the first year , it is suggested to focus on comprehensive and in depth understanding of human mind, the nature of human behavior, life development, and the principle and skill of psychiatric interview. For the second year, emphasis needs to be concentrated on the understanding of: the basic principle of psychotherapy; different models of psychotherapy, including analytic, cognitive-behavior, and interpersonal therapy (such as family, couple or group therapy); and practice of long-term as well as short-term psychotherapy. For the third year, the stress can be laid on the advanced knowledge and experiences of psychotherapy, therapy for patients of various pathology, including evaluation of psychotherapy, culture and philosophical aspects of psychotherapy.

    Because of the nature of the psychotherapy, which need address not only the knowledge of theory, but also the actual clinical experiences, the teachings need to be carried out in multiple formats simultaneously. This includes the didactic teaching of various topics, case-conference, and clinical supervision. The trainees need to experience psychotherapy of inpatients, outpatients, for patients of various psychopathology.

    The final goal of the training is to make every psychiatrist know how to carry out psychotherapy in addition to pharmacotherapy or other forms of treatment. In another word, psychotherapy is not for specialists to carry out but for every psychiatrist to perform.

  • S39 - Éç½»½¹ ÂÇÖ¢µÄÑо¿ÏÖ×´ £¨ ¹éÊô½¹ÂÇÕϰ­ £© - Current Research Situation in Social Anxiety

    Chairs: Wei Zhang, Chinese Mainland
    Dominic Lee, Chinese Hong Kong

    Ö÷ϯ £º ÕÅΰ Éç½»½¹ ÂÇÕϰ­×Ô 1985 Äê Leibowitz Ìá³öÒÔÀ´ £¬ ¾ÍÓÐѧÕß Ô¤ÑÔËü½«ÊÇ 21 ÊÀ ¼Í×î³£¼ûµÄÐÄÀíÕϰ­Ö®Ò»¡£¾ÝÃÀ¹ú¹úÁ¢¹²²¡ÂÊÑо¿ÖÐÐÄ£¨ NCS £© µ÷²é½á¹û±íÃ÷£¬Éç½»½¹ÂÇÕϰ­ÖÕÉí»¼²¡ÂÊ£¨ 13.3 £¥£©ÊÇ ½ö´ÎÓÚÒÖÓôÖ¢£¨ 17.4 £¥£©¡¢¾ÆÒÀ Àµ£¨ 14.1 £¥£©µÄµÚÈýλ³£ ¼û²¡¡£Éç½»½¹ÂÇÕϰ­Í¨³£Æð²¡ÄêÁäÔÚ 13¡ª24 ËêÖ®¼ä£¬Æ½¾ù 20 Ëê×óÓÒ£¬Æ½¾ù²¡³Ì 20 Äֻ꣬ÓÐ 1/4 µÄ»¼ÕßËæÄê ÁäÔö³¤¶øºó»º½â¡£²¡³ÌµÄÂýÐÔ»¯¡¢Ö¢×´µÄÍ´¿à¡¢Éç»á¹¦ÄܵÄËðº¦ÑÏÖØ Ó°Ï컼ÕßµÄÉú´æ¡¢Éú»î ÖÊÁ¿¡£½üÄêÀ´£¬¹úÄÚÍâѧÕß´Ó¶à¸ö½Ç¶È¶ÔÉç½»½¹ÂÇÕϰ­½øÐÐÁËÑо¿£¬µ«ÈÔ´æÔÚ²»ÉÙÐë´ý½øÒ»²½Ñо¿µÄµØ·½¡£

    1 ¡¢ SAD ³£±» ¹ýµÍÕï¶Ï£¬Ðí¶àÇé¿öÏÂÉç½»½¹ÂÇÕϰ­ÒªÔçÓÚÆäËû¾«Éñ¼²²¡µÄ³öÏÖ£¬µ«Í¨³£ÊÇºÍÆäËû¼²²¡·¢Éú¹²²¡ºó²Å±»·¢ÏÖ¡£¹À¼ÆÖ»Óв»µ½ËÄ·ÖÖ®Ò»µÄ»¼Õß½ÓÊÜÁËÕýÈ·µÄÕï¶ÏºÍÊʵ±µÄÖÎÁÆ¡£¶ø´óÁ¿Ö¤¾Ý±íÃ÷£¬Éç½»½¹ÂÇÕϰ­µÄÔçÆÚ·¢ÏÖºÍÖÎÁÆ¿ÉÔ¤·À²¡³ÌµÄÂýÐÔ»¯¡¢¸ÄÉÆ»¼ÕßµÄÉç»á¹¦ÄÜ¡£

    2 ¡¢Éç½»½¹ ÂÇÕϰ­¹²²¡Âʸߣ¬ 80 £¥µÄ SAD ÖÁÉÙÓëÒ» ÖÖÆäËü¾«ÉñÕϰ­¹²²¡£¬ 50%SAD Óë GAD £¬ PD ¹²²¡£» 85.2% ÓëÎï ÖÊÀÄÓù²²¡£» 33% µÄ SAD ͬ ʱ ·ûºÏÖØÐÍÒÖÓôµÄ Õï¶Ï£» 59%-67.8% ÓëÈ˸ñÕϰ­¹²²¡£¬ÇÒ°éÓÐÈ˸ñÕϰ­µÄÉç½»½¹ ÂÇÕϰ­³öÏÖÒÖÓôÇéÐ÷£¬½¹ÂǺ͹¦ÄÜÊÜËð½ÏÓëÆäËû¹²²¡¸üÑÏÖØ¡£¹²²¡¼ÓÖØÁ˼²²¡µÄÑÏÖØ³Ì¶ÈºÍ¼²²¡¸ºµ££¬ÑÏÖØÓ°Ï컼ÕßµÄÉúÃüÖÊÁ¿¡£ Wittchen µÈ£¨ 1996 Ä꣩²ÉÓÃÉç»á¹¦ÄÜ Îʾíµ÷²éÁËÉç½»½¹ÂÇÕϰ­µÄÉú»îÖÊÁ¿£¬½á¹û±íÃ÷ÔÚÇéÐ÷±í´ï¡¢Éç»á¹¦ÄܺÍÉúÃü»îÁ¦Èý·½ÃæÃ÷ÏÔÊÜË𣬠50 £¥µÄ»¼Õß ÑÏÖØ»òÃ÷ÏÔË𺦡£µ«¹²²¡µÄ×÷ÓûúÖÆÉÐδÃ÷ÁË£¬ÊÇ·ñ¾ßÓÐÏàͬµÄÒÅ´«±³¾°¡¢Æð²¡ÒòËØÐë´ý½øÒ»²½Ñо¿¡£

    3 ¡¢Éç½»½¹ ÂÇÕϰ­²¡Òò²»Ç壬¾ÝÑо¿ÐÄÀíÉç»áÒòËØÕ¼ 2/3 £¬ ÒÅ´«ÒòËØÕ¼ 1/3 ¡£µ«Éç½»½¹ ÂÇÕϰ­ µÄ²¡ÀíÐÄÀí»úÖÆÈÔ²»Çå³þ£¬²»Í¬µÄѧÕß´Ó¶à¸ö½Ç¶È ½øÐÐÁËÑо¿£¬µ«Î´ÄÜÍêÈ«½âÊͲ¡ÀíÐÄÀí»úÖÆ¡£ 4 ¡¢Éç½»½¹ ÂÇÕϰ­»¼Õß¶ÔÖÎÁÆ·´Ó¦²»Ò»£¬Ô¤ºó²»Ò»£¬ÊÇ·ñ´æÔÚ²»Í¬ÑÇÐÍÈÔÐè½øÒ»²½Ñо¿¡£

    ´Ë´ÎÊÊ·ê¹ú ¼Ê¾«Éñ²¡Ñ§Äê»á£¬Óлú»áÄâ¾ÍÏÂÁÐÄÚÈÝÏò¹ú¼ÊͬÐнøÐн»Á÷ѧϰ¡£

    1 ¡¢ ÕÅΰ½ÌÊÚ£ºÉç½»½¹ÂÇÕϰ­µÄÖйúÏÖ×´¼°Á÷Ðв¡Ñ§µ÷²é

    2 ¡¢ ÕÅп­½ÌÊÚ£ºÖйúÉç½»½¹ÂÇÕϰ­ÎïµÄÐÄÀíÖÎÁÆ·½·¨

    3 ¡¢ÎâÞ±Àò½ÌÊÚ£ºÉç½»½¹ ÂÇÕϰ­µÄ²¡ÀíÐÄÀí»úÖÆÑо¿¼°³õ²½·ÖÐÍ

    4 ¡¢ ¹¨ÆôÓ½ÌÊÚ£ºÉç½»½¹ÂÇÕϰ­µÄ¹¦ÄÜÄÔÓ°ÏñÑо¿

    ÆÚÍûͨ ¹ýÉÏÊöµÄרÌⱨ¸æ´Ù½ø¶ÔÉç½»½¹ÂÇÕϰ­µÄ¹Ø×¢ÓëÑо¿¡£

  • S39-1

    ÖйúÉç½»½¹ÂÇÕϰ­µÄÏÖ×´¼°Á÷Ðв¡Ñ§µ÷²é - Epidemiology Survey on Social Anxiety Disorder in China

    ΰ ÕÅ 1

    1 ËÄ´¨´óѧ »ªÎ÷Ò½ÔºÐÄÀíÎÀÉúÖÐÐÄ , ³É¶¼ , Chinese Mainland

    Éç½»½¹ ÂÇÕϰ­»¼²¡Âʸߣ¬ÊǼÌÖØÐÍÒÖÓô (17.4%) ºÍ¾Æ¾«ÒÀ Àµ (14.1%) Ö®ºóµÄµÚÈý³£ ¼û¾«ÉñÕϰ­£¬ÇÒ¹²²¡Âʸߣ¬ 80 £¥Óë Öá¢ñ¹²²¡£¬ 59.0 £¥£­ 67.8 £¥Óë Öá¢ò¹²²¡¡£Æð²¡ÄêÁä¶àÔÚ 13¡ª24 Ë꣬ƽ¾ù 20 Ëê×óÓÒ£¬Æ½¾ù²¡³Ì 20 Äê×óÓÒ£¬Ò»°ã²»ÄÜ×ÔÎÒ »º½â£¬Ô¼ 25 £¥µÄ»¼ÕßËæÄê ÁäÔö³¤»º½â£¬·¢²¡ÂÊÅ®ÐÔ£¨ 59% £© ÏÔÖø¸ßÓÚÄÐÐÔ£¨ 41% £©£¬Éç»á¹¦ÄÜȱÏÝ£¬¼²²¡ ¸ºµ£ÑÏÖØ£¬²»µ½ 1/4 µÄ»¼Õß½ÓÊÜÁËÕýÈ·µÄ Õï¶ÏºÍÊʵ±µÄÖÎÁÆ¡£ 2004 Äê ÕÅΰµÈ¶Ô³É¶¼ÊÐ 11-24 Ëê 2279 ÃûѧÉú²ÉÓà SCID £­¢ñ¶¨Ê½Ò» ¶ÔÒ»¼ì²é£¬·¢ÏÖ»¼²¡ÂÊ 8.15 £¥£¬¹²²¡ÂÊ 30.87 £¥£¬¹²²¡»¼ÕßÖÐÐľ³Õϰ­ 73.91 £¥£¬½¹ ÂÇÕϰ­ 58.70 £¥£¬Îï ÖÊʹÓÃÕϰ­ 10.87 £¥£» ·¢ÏÖÉú³¤»·¾³¡¢¼ÒÍ¥¾­¼ÃÇé¿ö¡¢¸¸Ä¸½ÌÑø·½Ê½¡¢È˸ñÒòËØ¡¢ÒÅ´«µÈÊÇÆäΣÏÕÒòËØ¡£ÑôÐÔ¼Ò×åÊ·ÂÊ 11.21% ¡£Ëæºó ¶ÔÉç½»½¹ÂÇÕϰ­Ò»¼¶Ç×ÊôµÄÑо¿·¢ÏÖ£¬Éç½»½¹ÂÇÕϰ­Ò»¼¶Ç×ÊôÉç½»½¹ÂǵÄ×´¿ö±ÈÕý³£¶ÔÕÕ×éµÄÒ»¼¶Ç×Êô¸ü¼ÓÃ÷ÏÔ£»Éç½»½¹ÂÇÕϰ­»¼ÕßÐÔ¸ñ¸üÇãÏòÓÚ¾«ÉñÖÊ¡¢ÄÚÏò¡¢ÇéÐ÷²»Îȶ¨£¬Éç½»½¹ÂÇÕϰ­µÄÒ»¼¶Ç×ÊôÓëÕý³£Ïà±ÈÐÔ¸ñ¸ü¼ÓÇãÏòÓÚÄÚÏò£»Éç½»½¹ÂÇÑо¿×é¼°ÆäÒ»¼¶Ç×ÊôµÄÐÄÀí½¡¿µ×´¿öÆ«²î£»Éç½»½¹ÂÇ»¼ÕßÐÔ¸ñÄÚÏò£¬ÈÝÒ×±íÏÖ³öÔÚ¹«¹²³¡Ëù½²»°Ê±¸ü¼Ó½¹ÂÇ£¬ÆäÇéÐ÷²»Îȶ¨ÈÝÒ×ÔÚÉç½»Öие½½¹ÂǺͺ¦Å£»Éç½»½¹ÂÇ»¼ÕßµÄÒ»¼¶Ç×ÊôÄÚÏòµÄÐÔ¸ñÒýÆðÔÚ¸÷¸öÉç½»³¡ºÏÖеĽ¹ÂǺ¦Å¡£Ä¿Ç°ÕýÔÚ½øÐÐÉç½»½¹ÂÇÕϰ­»¼ÕߵŦÄÜÄÔÓ°Ïñ¡¢µçÉúÀí¡¢Ò©ÀíÒÅ´«Ñ§¼°ÖÎÁÆ·½°¸ÓÅ»¯µÄÑо¿¡£

    Social anxiety disorder have high prevalence rate. Following is the third common mental disorders after major depression (17.4%) and alcohol dependence (14.1%), and the disease has a high rate of 80% and a total of axis I disease, 59.0% -67.8% and axis II comorbidity. More rapid onset age 13 -24 years old, with an average age of 20 or so, the average duration was 20%, generally not self-mitigation, About 25% of patients with age growth eased, the incidence of women (59%) was significantly higher than that of males (41%), social dysfunction, a serious disease burden, less than 1 / 4 of the patients receiving the correct diagnosis and appropriate treatment. In 2004, such as Chengdu, 2,279 11-24 -year-old students using SCID - I scheduled one-on-one check - found prevalence rate 8.15%, a total of 30.87% rate of the disease, patients were comorbidity with mood disorder 73.91%, Anxiety Disorders 58.70%, substance use disorders 10.87%; found that the growth environment, family economic situation, Parenting styles, personality factors such as their genetic risk factors. Positive family history of the rate of 11.21%. Then right a social anxiety disorder relatives, the study found. a social anxiety disorder social anxiety of relatives of the situation than the normal control group of relatives of a more obvious; Patients with social anxiety disorder personality more inclined to spiritual quality, introverted and emotional instability, social anxiety disorder and relatives of a normal compared to the more inclined to character; Social Anxiety Study Group and relatives of a mental health deviation; Patients with social anxiety introverted personality, easily displayed in public places is more speech anxiety, emotional instability easily felt in social anxiety and fear; Patients with social anxiety to the relatives of a lead character in various social occasions anxiety fear. Ongoing social anxiety disorder patients with functional brain imaging, and electrophysiology, genetics and pharmacological treatment plan optimization studies.

  • S39-2

    Éç½»½¹ÂÇÕϰ­µÄÈÏÖªÐÐΪ¼¯ÌåÖÎÁÆ·½·¨Óë³õ²½½á¹û - Social Anxiety Disorder of Cognitive Behavioral Group Therapy with Preliminary Results

    XinKai Zhang 1

    1 Shanghai Mental Health Center , Shanghai , Chinese Mainland

    Ä¿µÄ : ̽ ÌÖÈÏÖªÐÐΪ¼¯ÌåÖÎÁÆ £¨ CBGT £© ·½·¨ÖÎ ÁÆÉç½»½¹ÂÇÕϰ­ £¨ SAD £© µÄ¾ßÌå·½·¨ÓëÖÎ ÁÆÐ§¹û¡£

    ¶ÔÏóºÍ·½·¨ : ÉϺ£ÊÐÐÄÀí×É Ñ¯ÖÐÐľÍÕïµÄ SAD »¼ÕßÖÐ×ÔÔ¸²Î¼Ó CBGT Õß £¬ ·ûºÏ DSM-IV ¹ØÓÚ SAD µÄ Õï¶Ï±ê×¼ £¬ ÐÔ±ðÄêÁä²»ÏÞ £» ¼Ç¼»¼ÕßµÄÒ»°ã×ÊÁϼ°²¡Ê·×ÊÁÏ £¬ °üÀ¨×ÉѯºÅ¡¢ÐÕÃû¡¢ÐÔ±ð¡¢ÄêÁä¡¢Ö°Òµ¡¢ÎÄ»¯¡¢»éÒö¡¢¼Ò×åÊ·¡¢²¡³Ì¡¢Æð²¡ÄêÁä¡¢ÓÕ·¢ÒòËØ¡¢²¡Ç°ÐÔ¸ñ¡¢¼ÈÍùÖÎÁÆÇé¿öµÈ¼° MMPI ²âÊÔ £» ²Î¼Ó¼¯ÌåÖÎÁÆµÄ SAD ÕßÖÎ ÁÆÆÚ¼ä¾ùδ·þÓÃÖÎÁÆ SAD Ò©Îï £¬ Èç¼´ÍùÓùýÒ©ÕßÐè¾­Á½ÖܵÄÒ©ÎïÇåÏ´ÆÚ £¬ ÆäÖÐ 6 ÀýÒò˯Ãß²»ºÃÓÚÒ¹ ¼ä˯ǰ²»¶¨Ê±·þÓÃС¼ÁÁ¿°²¶¨ÀàÒ©ÎïÖúÃß¡£ CBGT µÄ ʵʩ£ºÃ¿¸öÖÎÁƼ¯Ì壨С×飩 6-8 ÈË£¬ÓÉÒ»ÃûÐÄÀíÖÎ ÁÆÊ¦Ö÷³ÖÖÎÁÆ 8 ÖÜ£¬ ÿÖÜÈÕÉÏÎç 2.5 С ʱ¡£ÄÚÈݰüÀ¨£º»¼Õß×ÔÎÒ²¡Çé½éÉÜ¡¢ÈÏÖªÖØ½¨ £¨ Èϱð×Ô¼ºµÄ×Ô¶¯¸ºÐÔÏë·¨ºÍºËÐÄÐÅÄ£¬¿Ö¾å¶ÔÏó·Ö¼¶£¬·ÅËÉѵÁ·£¬Éç½»¼¼ÇÉѵÁ·£¬ÏµÍ³±©Â¶ºÍÏÖ³¡±©Â¶ÖÎÁÆ¡£Ã¿´ÎÖÎÁƺóÓмÒÍ¥×÷Òµ¡£ÖÎÁÆÇ°½øÐÐ LSAS Á¿±í£¨ Liebowitz Éç½»½¹ ÂÇÆÀ¶¨Á¿±í£©ÆÀ¶¨£»Ã¿´ÎÖÎÁÆÇ°½øÐÐ×÷Òµ¼ì²é£»ÆäÖÐÄÚÈݿɸù¾ÝѧԱ·´À¡Çé¿ö×÷Êʵ±µ÷Õû¡£ÁÆÐ§ÆÀ¶¨ÓÉÆäËüÁ½Î»ÐÄÀíÖÎÁÆÊ¦½øÐУ¬Ö÷ÒªÆÀ¶¨¹¤¾ßΪ LSAS ¡£ ¼Æ×Ü·Ö¡¢¿Ö¾åÒò×Ó·Ö¡¢»Ø±ÜÒò×Ó·Ö£¬Í³¼Æ·ÖÎöÓÃÅä¶Ô T ¼ìÑé·½·¨¡£

    ½á¹û : ·ûºÏÈë ×éÌõ¼þµÄ 58 ÀýÖÐ Õï¶ÏΪ SAD-I ÐÍ 25 Àý¡¢ II ÐÍ 23 Àý¡¢ III ÐÍ 10 Àý£¬ÄÐ 34 Àý¡¢Å® 24 Àý£¬ÐÔ ±ð±È 1.42:1 £¬Äê Áä 16-48 Ë꣨ 25.95¡À6.10 Ë꣩£¬²¡³Ì 6 ¸öÔ -19 Ä꣨ 7.17¡À4.75 Ä꣩£¬Æð²¡Äê Áä 11-34 Ë꣨ 18.81¡À4.56 Ë꣩£¬³õÖÐÎÄ»¯ 6 Àý¡¢¸ßÖÐ / ÖРר 20 Àý¡¢´ó רÒÔÉÏ 32 Àý£¬Î´»é 37 Àý¡¢ÒÑ»é 20 Àý¡¢ÀëÒì 1 Àý£¬¾«Éñ¼²²¡¼Ò×åÊ· 4 Àý£¬ ÓÕ·¢ÒòËØÔ­Òò²»Ã÷Õß 20 Àý£¬ÓÐÐÄÀíÉç»áÒòËØÕß 30 Àý£¬ÇûÌå¼²²¡¼ÓÐÄÀíÉç»áÒòËØÕß 5 Àý£»²¡Ç°¸öÐÔ 51 Àý ΪÄÚÏò¡¢ 1 ÀýÍâÏò¡¢ 6 ÀýÖÐ ¼äÐÍ£»¼ÈÍùÓùýÒ©ÎïÖÎÁÆÕß 24 Àý£¬ÐÄÀíÖÎ ÁÆÕß 8 Àý£¬ Ò©ÎïºÏ²¢ÐÄÀíÖÎÁÆÕß 26 Àý¡£ LSAS Á¿±í ÆÀ·Ö£º×Ü·ÖÖÎÁÆÇ°ºó 75.89¡À28.82 ºÍ 47.00¡À23.71 £¨ t=12.60 £¬ p<0.01 £©£»¿Ö¾åÒò×Ó·ÖÖÎ ÁÆÇ°ºó 39.28¡À13.12 ºÍ 25.39¡À12.42 £¨ t=8.267 £¬ p<0.01 £©£»»Ø±ÜÒò×Ó·ÖÖÎ ÁÆÇ°ºó 36.39¡À16.44 ºÍ 22.17¡À13.29 £¨ t=8.067 £¬ p<0.01 £©£¬¾ùÓРͳ¼ÆÑ§ÏÔÖøÐÔ²îÒì¡£

    ½áÂÛ£º CBGT ÖÎ ÁÆ SAD ÓÐºÜºÃµÄ ÁÆÐ§£¬ÓÈÆä¶Ô SAD µÄ»Ø±ÜÐРΪЧ¹ûËÆ¸üÏÔÖø£¬ÖµµÃÍÆ¹ã¡£

    Objective: To investigate cognitive behavioral group therapy (CBGT) efficacy for treating social anxiety disorder (SAD ) and the specific treatment methods.

    Targets and methods: Shanghai psychological counseling centers for treatment in patients with SAD voluntary CBGT, meet DSM-IV diagnosis of SAD standards, sex irrespective of age; Records of the patients general information and history information, including advisory, name, sex, age, occupation, culture, marriage, family history, course of illness, age of onset, inducing factor, premorbid personality, grandfather, and so on and treatment of MMPI; participate in group therapy treatment of SAD during the treatment of SAD did not take drugs, If that is used to the drug subject to a two-week drug washout period. Six cases of sleep well at night before bed without taking regular small doses of drugs Zhumian stability. CBGT implementation: each treatment group (Group) 6-8, and from a psychological therapists presided over eight weeks of treatment, every Sunday at 2.5 hours. Include: self-disease patients, the cognitive restructuring (identification of negative automatic thoughts and core beliefs). fear object classification, relaxation training, social skills training, and on-site system exposed exposure treatment. After each treatment a family operation. Before treatment LSAS Scale (Liebowitz Social Anxiety Rating Scale) evaluation; each treatment operation before inspection; content feedback from trainees under the circumstances make appropriate adjustments. Clinical assessment by the other two psychological therapists, the main tool for assessing LSAS. Total score, the fear factor, the factor scores evaded, statistical analysis using paired T test.

    Results: The results meet the entry conditions of the Group of 58 cases were diagnosed as SAD-25 patients with type I, type II in 23 cases, Type III 10 cases, 34 were male and female 24 cases, the sex ratio was 1.42:1. aged 16 -48 years (25.95 ¡À 6.10 years), duration of six months -19 (7.17 ¡À 4.75), onset age 11 -34 years (18.81 ¡À 4.56 years), junior middle school education six cases, the high school / secondary school in 20 cases, college or 32 cases, unmarried 37 cases, 20 cases of married, divorced one cases, family history of mental illness four cases. unknown factors induced 20 cases, psycho-social factors, and 30 cases physical disease plus psycho-social factors were five cases; Personalized disease before 51 cases of introverted, an exception to, the middle-six cases; always used the drug treatment, 24 cases Psychological treatment eight cases, drug therapy with 26 patients. LSAS scores : scores before and after treatment 75.89 ¡À 28.82 and 47.00 ¡À 23.71 (t = 12.60, p "0.01); fear factor scores before and after treatment 39.28 ¡À 13.12 and 25.39 ¡À 12.42 (t = 8.267 , p. "0.01); evading factor scores before and after treatment 36.39 ¡À 16.44 and 22.17 ¡À 13.29 (t = 8.067 , p. "0.01), both statistically significant differences.

    Conclusions: The treatment of SAD CBGT had good results, especially for the avoidance behavior SAD effect seems even more markedly, worth promoting.

  • S39-3

    Contribution III to the Symposium "Current Research Situation in Social Anxiety"

    Weili Wu, Chinese Mainland

    Abstract text has not been submitted

  • S39-4

    Contribution IV to the Symposium "Current Research Situation in Social Anxiety"

    Qiyong Gong, Chinese Mainland

    Abstract text has not been submitted

  • S40 - ÄÑÖÎÐÔÒÖÓôÕϰ­ÉúÎïѧ»úÖÆ¼°ÆäÁÙ´²ÌØÕ÷ - The Biological Mechanisms and Clinical Features of the Treatment-resistant Depression

    Chairs: Xueli Sun, Chinese Mainland
    Haroon Rashed Chaudhry , Australia

    ¾Ý ͳ¼Æ £¬ ÄÑÖÎÐÔÒÖÓôÕϰ­ÎªÒÖÓôÕϰ­µÄ 30% £¬ ÔÚ±¾´Î»á ÒéÉÏËùÌÖÂÛµÄ ¡° ÄÑÖÎÐÔÒÖÓô ¡± ÊÇÖ¸²ÉÓÃÁ½ ÖÖ»òÁ½ÖÖÒÔÉϲ»Í¬ÀàÐ͵Ŀ¹ÒÖÓô¼Á×ãÁƳ̡¢×ã¼ÁÁ¿µØÖÎÁƺóÈÔ²»ÄÜÈ¡µÃÃ÷ÏÔÁÆÐ§µÄ²¡Àý¡£ÄÑÖÎÐÔÒÖÓôÔì³É»¼ÕßÁÙ´²Ö¢×´µÄ¾ÃÖβ»Óú£¬Ôì³ÉÒÖÓôÕϰ­µÄÂýÐÔ»¯Ç÷ÊÆÔö¼Ó£¬Ôì³É»¼ÕßµÄ×ÔɱÂÊÔö¼Ó£¬ÖµµÃ¸ß¶ÈÖØÊÓ¡£±¾´Î»áÒ齫¾ÍÁ½ÄêÀ´¶ÔÓÚÄÑÖÎÐÔÒÖÓôµÄÁÙ´²¡¢Éñ¾­Éú»¯¡¢ÄÔÓ°Ïñѧ½á¹û½øÐб¨µÀºÍÌÖÂÛ¡£

    According to statistics, refractory depression takes 30% of depression.In this meeting we discussed the ¡°refractory depression¡± refers to the cases for which we used two species or two or more antidepressants of different chemical structure, after adequate dose , the full course of treatment £¬ and the therapeutic effect is still valid or little . It is noteworthy that refractory depression causes the clinical symptoms easy to relapse, causing increasing trend of chronic depression, causing increasing suicide rate of patients.. The meeting will report and disscuss the clinical symptoms, neurobiochemical and brain imaging results of refractory depression in our two years' research.

  • S40-1

    ÄÑÖÎÐÔÒÖÓôµÄÓÅ»¯ÖÎÁÆ·½°¸Ñо¿ - The Study on the Optimized Treatment Plan to the Treatment-resistant Depression

    ¾² Àî 1

    1 ËÄ´¨´óѧ »ªÎ÷Ò½ÔºÐÄÀíÎÀÉúÖÐÐÄ , ³É¶¼ , Chinese Mainland

    ÒÔÎÄÀ­ ·¢ÐÂ×÷Ϊ»ù±¾ÖÎÁÆÒ©Îï £¬ ÒÔ¼××´ÏÙËØ¡¢µç³é´¤ÖÎÁÆ¡¢·ÇµäÐÍ¿¹¾«Éñ²¡Ò©Îï¡¢ÈÏÖªÖÎÁÆ×÷Ϊ¸¨ÖúÖÎÁÆÊÖ¶Î £¬ ¶Ô 400 Àý ÄÑÖÎÐÔÒÖÓôÕϰ­»¼Õß·Ö×é½øÐÐÖÎÁÆ £¬ ¾ùÈ¡µÃÃ÷ÏÔÁÆÐ§¡£ÖÎÁÆÖÐÓÐÒÔϼ¸µãÖµµÃ×¢Ò⣺ ¢ÙÎÄÀ­ ·¢Ð¶ÔÓÚÄÑÖÎÐÔÒÖÓôÕϰ­µÄÖÎÁÆ±ÈÆäËüÖÖÀàµÄ¿¹ÒÖÓô¼Á¶ÔÓÚÄÑÖÎÐÔÒÖÓôµÄÖÎÁÆÁÆÐ§¸üΪÃ÷ÏÔ£¬ÔÚ´Ë»ù´¡ÉÏ£¬ÆäÓÅ»¯·½°¸ÒÀ´ÎÊÇÎÄÀ­·¢Ð + µçÁÆ£»ÎÄÀ­·¨Ð + ÈÏÖªÖÎÁÆ£»ÎÄÀ­·¨Ð + ̼Ëá ï®ÖÎÁÆ£»ÎÄÀ­·¨Ð + ¼××´ÏÙËØÖÎ ÁÆÒÔ¼°ÎÄÀ­·¢Ð + ·ÇµäÐÍ¿¹¾«Éñ²¡ Ò©ÎïÖÎÁÆ¡£ ¢ÚÒÔÍù ÄÑÖÎÐÔÒÖÓôÕϰ­Ê×Ñ¡¿¹ÒÖÓô¼ÁµÄÖÖÀà¡¢ÖÎÁƵÄ×㹻ʱ¼äÒÔ¼°¶ÔÓÚ»¼ÕßµÄÐÄÀí¸ÉÔ¤¾ùÓÐÃÜÇйØÏµ£¬ÖµµÃ×¢Òâ¡£ ¢Û ¶ÔÓÚÒÖÓô»¼ÕߵĿ¹ÒÖÓô¼ÁÖÎÁÆ£¬ÔÚ¼ÁÁ¿×ã¹»µÄÇé¿öÏ£¬ÁƳÌÓ¦ÔÚ 6-8 ÖÜ¡£ ¢Ü ÔÚ ¹æ·¶ÖÎÁƵÄÇé¿öÏ £¬ ¶àÊý»¼Õß¿ÉÒÔÈ¡µÃÂúÒâµÄÖÎÁÆÐ§¹û¡£

    Venlafaxine as a basic therapeutic medicine, thyroxine, electroconvulsive therapy, atypical antipsychotics and cognitive therapy as a means of treatment, 400 patients with refractory depression treated, we have achieved significant effect. The following points are worthy of note in the treatment: ¢Ù Compared with other types of antidepressants,venlafaxine has more obviously therapeutic effect. On this basis,the optimized programs one by one are venlafaxine + electrotherapy,venlafaxine + cognitive therapy,venlafaxine + lithium carbonate therapy,venlafaxine + thyroxine treatment, as well as venlafaxine+atypical antipsychotic treatment. ¢Ú It is noteworthy that previous types of antidepressant of first choice, sufficient treating time and the psychological intervention to patients are closely related. ¢Û Treatment using antidepressants should last 6 -8 weeks,at circumstances of sufficient dose. ¢Ü In the case of standarized treatment, the majority of patients can achieve a satisfactory therapeutic effect.

  • S40-2

    ÄÑÖÎÐÔÒÖÓôµÄÉñ¾­ÄÚ·ÖÃÚÑо¿ - The Study on the Neuroendocrine of the Treatment-resistant Depression

    ѧÀñ Ëï 1

    1 ËÄ´¨´óѧ »ªÎ÷Ò½ÔºÐÄÀíÎÀÉúÖÐÐÄ , ³É¶¼ , Chinese Mainland

    ²ÉÓöàÖÐÐÄ¡¢Ç°Õ°ÐÔ¡¢·Ö ²ã¡¢Ëæ»ú¶ÔÕÕÑо¿ºÍ¶ÓÁÐÑо¿Éè¼ÆÏà½áºÏµÄÁÙ´²Ñо¿·½·¨¡£¸ù¾ÝÄÉÈë¡¢Åųý±ê×¼£¬¹²ÊÕ¼¯ 1092 Àý¡£ÓÚÓà ҩǰ²É¼¯¾²ÂöѪ£¬¶ÔÄÉÈë¶ÔÏó½øÐÐ HPA ÖáºÍ HPT ÖáÏà¹ØÉú»¯Ö¸±ê¼ìÑ飬ͬʱ¶ÔÈë×é¶ÔÏó½øÐÐÁÙ´²Ö¸±êÆÀ¶¨¡£½á¹ûÏÔʾ£º ¢±ÒÖÓôÖ¢»¼ÕßÉñ ¾­ÄÚ·ÖÃÚÒì³£ÂÊ´ïµ½ 59.4% £»¢²ÒÖÓôÖ¢»¼Õß ÁÙ´²ÌØÕ÷Ó벻ͬÉñ¾­ÄÚ·ÖÃÚÖá¾ßÓÐÏà¹ØÐÔÒÔϼ¸µãÖµµÃ×¢Ò⣻ ¢Ù HPA ÖáÒì³£×éÒÖÓôÖ¢»¼Õß¶à°éÓм¤Ô½Ö¢×´£» ¢Ú HPT ÖáÒì³£×éÒÖÓôÖ¢»¼ÕßÌåÖØ¸Ä±ä²»Ã÷ÏÔ£¬¶à°éÓÐ˯ÃßÕϰ­¡¢³Ù´¿Ö¢×´ºÍ½¹ÂÇÖ¢×´£¬³£³öÏÖ×Ôɱ¹ÛÄ ¢Û HPG ÖáÒì³£×éÒÖÓô Ö¢»¼Õß¶à ·¢ÓÚÄêÁ䯫´óµÄÅ®ÐÔ£¬ÇûÌåÖ¢×´¶àÃ÷ÏÔ£» ¢Ü HPA ÖáºÍ HPT Öá¾ùÒì³£×éÒÖÓôÖ¢»¼Õß¶à°éÓÐÌåÖØ¼õÇáºÍÃ÷ÏÔ×ÔÔðºÍ³ÙÖÍÖ¢×´£» ¢ÝÕý³£ ×éÒÖÓôÖ¢»¼Õß¶à·¢ÓÚÇàÉÙÄ꣬¿ì¸Ðȱʧ֢״Ã÷ÏÔ¡£ÒÖÓôÖ¢ÒÔÉñ¾­ÄÚ·ÖÃÚÖá¸Ä±ä½øÐзÖÐÍÖµµÃ×¢Òâ¡£ ¢³²»Í¬Éñ ¾­ÄÚ·ÖÃÚÖá¸Ä±äµÄÒÖÓôÖ¢¶Ô¿¹ÒÖÓôÒ©ÎïµÄ·´Ó¦Ï¼¸µãÖµµÃ×¢Ò⣺ ¢Ù HPA ÖáÒì³£×éÒÖÓôÖ¢»¼Õß¶Ô´ïÌåÀÊ¡¢ÉáÇúÁÖ¡¢°¢Ã×ÌæÁÖ¡¢ÅÁÂÞÎ÷¶¡¡¢Î÷̪ÆÕÀ¼¡¢Ã×µªÆ½ÒÔ¼° SNRI ÀàÒ©ÎïÖÎÁÆÓÅÓÚÆäËûÒ©Î ¢Ú HPT ÖáÒì³£×éÒÖÓôÖ¢»¼Õß¶Ô·úÎ÷¶¡¡¢±ûÃ×ມ¢ÂȱûÃ×àºÒÔ¼° SNRI ÀàÒ©ÎïÁÆÐ§ÓÅÓÚÆäËûÒ©Î ¢Û HPG ÖáÒì³£×éÒÖÓôÖ¢»¼ÕßÑ¡ÓÃÉáÇú ÁÖ¡¢ SNRI ÀàÒ©ÎïÒÔ¼°¼¤ËصÄÌæ´úÖÎÁÆÁÆÐ§ÓÅÓÚÆäËûÀàÒ©Î ¢Ü HPA ÖáºÍ HPT ÖáͬʱÒì³£µÄÒÖÓôÖ¢»¼ÕßÑ¡Óà SNRI ÀàÒ©ÎïÁÆÐ§ÓÅÓÚÆäËûÀàÒ©Îï¡£

    This study was a prospective hierarchies random control study, executed in several centers. 1092 patients entered the study. The venous blood was collected before overdose. Neuroendocrine axle biochemistry detection were implemented, so as clinic index evaluation. Data management was performed by the department of medical statistics of Public Health school, Sichuan University . Results: 1. The depression patients in neuroendocrine abnormity make up 59.4% of the total. 2. Correlation of clinical features and neuroendocrine diversity of depression patients. ¢Ù Agitate symptom often existed in HPA axle abnormal group. ¢Ú The weight diversity was not obvious suffered HPT axle abnormal depression frequently, Sleep disorder and anxiety often exist in HPT axle abnormal group. ¢Û Elder women suffered HPG axle abnormal depression frequently, The symptom of somatic often exist in HPG axle abnormal group. ¢Ü Self-reproach and delay symptom often existed in the HPA axle and HPT axle abnormal group. ¢Ý The adolescent fuffered the normal neuroendocrine group, Patients of the normal neuroendocrine group were often combined with anhedonia. Antidepressant response to depression of different neuroendocrine abnormity is different, 3.So as following can be seriously regarded. ¢Ù The depression patients in HPA axis abnormity have better response to fluoxetine ¡¢ imipramine ¡¢ clomipramine and SNRI rather than other antidepressants. ¢Ú The depression patients in HPT axis abnormity have better response to fluoxetine ¡¢ imipramine ¡¢ clomipramine and SNRI rather than other antidepressants. ¢Û The patients in HPG axis abnormity have better response to sertraline ¡¢ SNRI and hormone replacement therapy rather than other antidepressants. ¢Ü The depression patients in both HPA and HPT axis abnormity have better response to SNRI rather than other antidepressants.

  • S40-3

    ÄÑÖÎÐÔÒÖÓôÖ¢Ó°ÏñѧÑо¿ - Summary of the Key Technologies R&D Program in MRI

    Qiyong Gong 1 , Ke Zou 1

    1 ËÄ´¨´óѧ »ªÎ÷ҽԺҽѧӰÏñ¿Æ , ³É¶¼ , Chinese Mainland

    ´Ó 2005 Äê 8 ÔÂÖÁ 2006 Äê 10 Ô 9 ÈÕ £¬ ¹²ÓÐ 77 È˲μÓÁ˱¾ ¿ÎÌâÓ°ÏñѧµÄ´Å¹²ÕñÑо¿¡£°üÀ¨·ÇÄÑÖÎÐÔÒÖÓôÖ¢»¼Õß 50 ÈË£¬ ÄÑÖÎÐÔÒÖÓôÖ¢»¼Õß 27 ÈË¡£ÆäÖÐ 37 È˲μÓÁËËæ ·ÃɨÃè¡£ËùÓл¼Õß¶¼¶Ô±¾Ñо¿ÖªÇéͬÒâÇÒûÓдŹ²ÕñɨÃèµÄ½û¼ÉÖ¸Õ÷¡£ËùÓл¼Õß¶¼Í¨¹ýÃÀ¹ú GE ¹«Ë¾Éú ²úµÄ 3.0T ´Å¹²Õñ³ÉÏñϵ ͳ £¨ 8 ͨµÀ Í·²¿ÏßȦ£©Íê³ÉÒÔÏÂɨÃèÐòÁУºÈýά½á¹¹Ïà 3D T1 £»²¨ Æ×£»¾²Ï¢¹¦ÄÜ̬£»´Å»¯×ªÒÆ£»ÃÖÉ¢ÕÅÁ¿³ÉÏñ£»ÄÔѪÁ÷£»Ð±Î» T2 ºÍÈÎ Îñ´Ì¼¤¡£Ä¿Ç°£¬²¨Æ×Ñо¿·¢ÏÖÄÑÖÎÐÔÒÖÓôÖ¢»¼ÕßÓҲຣÂí NAA/Cr Ôö Ç¿£¬Ê¹µÃ Ë« ²àº£Âí NAA/Cr ×ó¸ßÓÒµÍ ÕâÒ»ÔÚÕý³£¶ÔÕÕÌåÏÖµÄÌØÐÔÔÚÄÑÖÎÐÔÒÖ ÓôÖ¢»¼ÕßÏûʧ¡£ ¹ØÓÚ DTI £¬ÎÒ ÃÇ·¢ÏÖÏà¶ÔÓÚÕý³£¶ÔÕÕ£¬ÒÖÓôÕý»¼ÕßµÄ×ó²à¶¥Ò¶£¬¶îÒ¶ºÍ¿Û´øÇ°»Ø FA Öµ½µµÍ£»ÓëÖÎÁÆÇ°Ïà±È£¬¶îÒ¶¡¢ò¨Ò¶¡¢¿Û´øÇ°»ØÒÔ¼°º£ÂíµÈ´¦ÖÎÁƺó FA ÖµÔö¸ßµÄ»¼Õß·´Ó³³ö½ÏºÃµÄÁÆÐ§£»¿Û´øÇ°»ØµÄ FA ÖµÓëÒÖÓôÖ¢×´µÄÑÏÖØ³Ì¶È³ÊÕýÏà¹Ø¡£¹ØÓÚ¾Ö²¿ÄÔѪÁ÷£¬ÎÒÃÇ·¢ÏÖÄÑÖÎÐÔÒÖÓôÖ¢»¼ÕßË«²à¶îҶѪÁ÷½µµÍ£¬Ã»Óз¢ÏÖѪÁ÷Ôö¼ÓµÄÄÔÇø£»¶ø·ÇÄÑÖÎÐÔÒÖÓôÖ¢»¼Õß×ó²à¶îÒ¶ºÍ×ó²àò¨ÕíÇøÑªÁ÷½µµÍ£¬±ßԵϵͳѪÁ÷Ôö¼Ó¡£¹ØÓÚ FMRI £¬ÎÒ ÃÇ·¢ÏÖÇéÐ÷ͼƬ¶ÔÄѶȽϵ͵ÄÈÎÎñÓ°Ïì¸üΪÃ÷ÏÔ¡£ÕâЩÑо¿½á¹û˵Ã÷¶îÒ¶£¬¶¥Ò¶£¬ò¨Ò¶µÄ¸Ä±äÓëÒÖÓôÖ¢¹ØÏµÃÜÇУ¬Ò²Ó³Ö¤Á˶îÒ¶ - ±ßÔµ»·Â·ÔÚÒÖÓôÖ¢²¡ÀíÉúÀíÖеÄÖØÒªµØÎ»¡£Ïà¶ÔÓÚ·ÇÄÑÖÎÐÔ»¼Õߣ¬ÄÑÖÎÐÔÒÖÓôÖ¢»¼ÕßÓжÀÌØµÄÓ°Ïñѧ±íÏÖ£¬ËüÃǵ½µ×ÄÜ·ñ×÷ΪÅжÏÔ¤ºóµÄÖ¸±êÐèÒª½øÒ»²½Ñо¿¡£

    A total of 77 patients with major depression £¨ MD £© participated in the MRI study from August, 2005 to October, 2006, including 50 non- treatment-resistant depression (nTRD) patients and 27 treatment- resistant depression (TRD) patients. Thirty-seven patients participated in the follow-up scan. All subjects were provided written informed consent after detailed explanation of the study and without mental indwelling. MRI examinations were conducted on a 3.0-Tesla MRI scanner (Signa, GE Medical Systems) for all the subjects using a standard 8-channel phase array head coil to obtain the following sequences: 3D T1; magnetic resonance spectroscopy (MRS); resting state functional MRI; magnetization transfer ratio; diffusion tensor imaging (DTI); FAIR; T2 mapping and functional MRI(fMRI). So far, MRS study found NAA/Cr of the left hippocampus was significantly higher than that of the right hippocampus in controls, while no such significant difference was found in TRD patients. As for DTI, decresed FA values were found in the left parietal lobe, left frontal lobe and left anterior cingulate cortex in depressed patients compared with normal controls; Compared with baseline, patients who responded to treatment showed increased FA values in the frontal lobe, temporal lobe, anterior cingulate cortex and the hippocampus after a 6-week treatment; the FA value in the anterior cingulate cortex correlated positively to the severity of depressive symptoms. About FAIR, decreased cerebral blood flow (CBF) were found in bilateral frontal blood in TRD patients and no regions showed increased CBF; instead, nTRD patients showed decreased CBF in the left frontal lobe and tempo-occipital region and increased CBF in the limbic system. For fMRI study, we found that emotional pictures had greater impact on the easier task. These results suggest that there is close relationship between changes of the frontal lobe, parietal lobe and temporal lobe and MD. They also suggest that the frontal-limbic circuits play an important role in the pathophysiology of depression. Compared with nTRD patients, TRD patients showed unique MRI manifestations. Whether can they be prognostic indicator needs further study.

  • S40-4

    ÄÑÖÎÐÔÒÖÓôÖ¢µÄÏà¹ØÒòËØ - The Study on the Related Factors of the Treatment-resistant Depression

    Xiufeng Xu 1

    1 À¥Ã÷ҽѧԺ¸½ÊôÒ½Ôº¾«Éñ¿Æ , À¥Ã÷ , Chinese Mainland

    ÄÑÖÎÐÔÒÖÓôÖʵĹØ×¢ £¬ ÌØ±ðÊÇÄÇÄÑÖÎÐÔÒÖÓô¸ÅÄîµÄ°ÑÎÕÓдý½øÒ»²½ÉÌȶ¡£Ìá¸ßÒÖÓôÕϰ­µÄÖÎÓúÂÊÓ¦¸Ã×¢ÒâÒÖÓôÕϰ­µÄÉúÎïѧ·ÖÐÍ¡¢¿¹ÒÖÓô¼ÁµÄ×÷ÓûúÖÆ¡¢ÒÔ¼°»¼Õß²¡Òò¼°»¼Õß»úÀíÅбðµÄ¸ö±ð»¯ÎÊÌâ £¬ ÌØ±ðÓ¦¸Ã×¢ÒâµÄÊÇҽѧ¶àѧ¿ÆµÄºÏ×÷ÓëÅäºÏµÄÎÊÌâ¡£

    We should furtherly disscuss and concern the nature of refractory depression , especially the concept of refractory depression.In order to raise the cure rate of depression,we should pay attention to the biological type of depression, the mechanism of antidepressants,the individualized causes and specific mechanism.And special attention should be paid to the issue on multidisciplinary medical cooperation and coordination.

  • S41 - ÒÖÓôÕϰ­ÖÎ ÁƵÄиÅÄî - New Conceptualization for the Treatment of Major Depressive Disorder

    Chairs: Mark Rapaport, United States
    Yiru Fang, Chinese Mainland

    ±¾ רÌâ»áµÄÄ¿µÄÊǾ͵±Ç°¹«ÈϵÄÒÖÓôÖ¢¸ÅÄî¡¢ÖÎÁƺ͹ØÓÚ¶ÔÒ»ÏßÖÎÁƲúÉú×迹µÄÒÖÓôÖ¢»¼ÕߵĴ¦Àí²ßÂԵȷ¢ÆðÌÖÂÛ¡£µÚÒ»¸öÑݽ²¾Û½¹ÓÚÒÖÓôÖ¢¸ÅÄîµÄ±ä»¯ £¬ ½«»Ø¹ËÒÖÓôÆ×ϵÕϰ­µÄ¸ÅÄî £¬ ÕâÖÖ¸ÅÄîµÄÑÓÉì¿ÉÄܵ¼ÖÂÖÎÁÆÄ£Ê½µÄ¸Ä±ä¡£µÚ¶þƪÂÛÎÄÖÐÎÒÃǽ«ÌÖÂÛÒÖÓôÖ¢Ò©ÎïÖÎÁÆ·¢Õ¹µÄ¸ïУ¬°üÀ¨µ±Ç°ÕýÔÚ¿ª·¢µÄÐÂÒ©µÄÖÖÀàºÍ½øÐдóÐ͹ú¼ÊÐÔÊÔÑéµÄз½·¨£¬ºóÕß¶ÔÓÚÈ·±£ÐÂÒ©µÄÓÐЧÐԺͰ²È«ÐÔÀ´ËµÊDZز»¿ÉÉٵġ£µÚÈýƪÂÛÎÄÖÐÎÒÃǽ«¾Í·¢Õ¹ÄÑÖÎÐÔÒÖÓôÖ¢µÄÖÎÁÆÐ²ßÂÔ½øÐÐÌÖÂÛ£¬°üÀ¨½éÉÜ NIMH Ìṩ ×ÊÖúµÄ STAR-D Ñо¿ÒÔ¼°×î½üһЩ̽Ë÷ ÄÑÖÎÐÔÒÖ ÓôÖ¢ÐÂÖÎ ÁÆ·½·¨µÄÑо¿¡£

    The goal of this symposium is to stimulate discussion about the currently accepted concepts of major depressive disorder, its treatment and strategies for taking care of patients whose depression is resistant to initial treatment approaches. The first lecture will focus in on the changing conceptualization of major depressive disorders. This presentation will review the concept of depressive spectrum disorders and how this expansion of the concept of depressive disorders may lead to modifications in treatment patterns. In the second presentation we will discuss innovations in drug development for depressive disorders. There will be discussions of the types of compounds that are currently under development and also innovative approaches to performing large international trials that are necessary to insure the compound is both efficacious and safe. In the third presentation we will discuss the development of new strategies to address treatment-resistant depression. This talk will include both a review of data from NIMH-funded STAR-D study as well as other recent studies investigating novel approaches for treating resistant depression.

  • S41-1

    ÒÖÓôÕϰ­Ð¸ÅÄ¶ÔÖÎÁÆµÄÆôʾ - Reconceptualizations of Depressive Disorder: Implications for Treatment

    Mark Hyman Rapaport

    Cedars-Sinai Medical Center , Department of Psychiatry and Biobehavioral Sciences, Los Angeles , United States

    ÔÚÈ«Çò·¶ ΧÄÚΪ¾«ÉñÕϰ­´´Á¢Ò»¸ö¹«ÈϵÄÃèÊöÐÔ¼²²¡·ÖÀà±ê×¼¶ÔÓÚ»¼ÕߺͿÆÑжøÑÔ¾ß ÓÐÖØ´óµÄÒâ Òå¡£ÕâÒѾ­Ê¹µÃÈ«ÇòµÄÁÙ´²Ò½ÉúºÍÑо¿ÕßÃǶÔÓÚÒÖÓôÖ¢µÄ¸ÅÄîÓÐÁ˹²Í¬µÄÀí½â¡£È»¶ø £¬ ÕâÖÖÆô·¢Ê½µÄÄ£ÐͲ»Ó¦±»µ±×÷½ÌÌõ £¬ ¶øÖ»Äܱ»¿´×÷ÊÇÑÓÕ¹ÒÖÓôÖ¢¸ÅÄîµÄÆÌ·ʯ¡£±¾ÎĽ«»Ø¹Ë×î½üһЩÁîÈËÕñ·ÜµÄз¢ÏÖ£¬ÕâЩ·¢ÏÖÓëÉúÎïѧÑо¿·¢ÏÖåÄÈ»²»Í¬¡£Ñо¿Êý¾ÝÌáʾÒÖÓôÖ¢Ö»²»¹ýÊÇ×é³ÉÒÖÓôÆ×ϵÕϰ­Õâ¸ö¸ü¹ãµÄ¸ÅÄîµÄÒ»¸ö²¿·Ö¡£Öصã½éÉܺÍÌÖÂÛÓйØÒÖÓôÆ×ϵÕϰ­µÄÁÙ´²ºÍÁ÷Ðв¡Ñ§Ñо¿Êý¾Ý¡£×îºóÌýÖÚ½«»á¸ü¼ÓÉîÈëµÄÁ˽âÒÖÓôÖ¢µÄÒìÖÊÐÔÌØµã£¬ÒÔ¼°¶ÔÒÖÓôÕϰ­Õâ¸öÆ×ϵ¼°Æä¿ÉÄܵÄÖÎÁÆ·½·¨¿ªÕ¹¸ü¹ã·ºµÄÑо¿µÄ±ØÒªÐÔ¡£

    Development of a commonly accepted descriptive nosology for psychiatric disorders worldwide has been a tremendous benefit for patients and for research. It has enabled clinicians and researchers throughout the world to share a common understanding of what is meant by major depressive disorder. However, this heuristic model should not be codified but rather used as a stepping stone for more extensive exploration of the concept of major depressive disorder. This presentation we will review some of the more recent exciting but disparate findings from biological studies of depressive disorders. We will also discuss data suggesting that major depressive disorder is only one component of a larger continuum of depressive spectrum disorders. In particular, clinical and epidemiological data about depressive spectrum disorders will be discussed and presented. By the end of the presentation the audience should have more comprehensive understanding of heterogeneity of depressive disorders and why it may be reasonable to pursue more extensive research investigating the spectrum of depressive disorders and potential treatments.

  • S41-2

    ÒÖÓôÖ¢Ò©ÎïÑз¢¸ïР- Innovations in Drug Development of Depressive Disorder

    Amin Kalali

    Medical and Scientific Services, Quintiles CNS Therapeutics, San Diego , United States

    ÒÖÓôÖ¢ Ò©ÎïÑз¢×÷ΪһÏîÌØÊâµÄÌôÕ½ £¬ ÓÐ×ŷdz£¸ßµÄÊÔÑéʧ°ÜÂÊ £¨ ÒѼǼÔÚ°¸ £© ¡£ÕâЩÌôÕ½À´×ÔÕï¶Ï¡¢»¼ÕßµÄÒìÖÊÐÔ¡¢°²Î¿¼ÁµÄ·´Ó¦ºÍÊÜÊÔÕߵĽá¾Ö¹ÜÀíµÈ·½Ãæ¡£

    ÕâʹµÃѧԺÅɺ͹¤ÒµÅɵĿÆÑ§¼ÒÃÇȥѰÇóÊÔÑéʧ°ÜµÄÔ­Òò£¬Í¬Ê±´Ó·½·¨Ñ§ÉϽøÐиĽø¡£

    ½üÊ®ÄêÀ´£¬ÖÐÊàÉñ ¾­ÏµÍ³ÁÙ´²ÊÔÑéµÄ·½·¨Ñ§Ïà¶ÔÖͺ󣬵«ÔÚ²»¾ÃÒÔǰ£¬¸÷·½¶¼ÔÚ¼¯ÖÐÁ¦Á¿À´¸ÄÉÆÕâÖÖÇé¿ö¡£¸ïаüÀ¨¸ü¶àµÄʹÓü¯ÖÐÊý¾Ý¡¢ÆÀ¹À»¼Õߺʹ¿»¯»¼ÕßȺµÄ¼¼Êõ£¬¸üеÄͳ¼ÆÄ£ÐÍÒÔ¼°½á¾Ö¹ÜÀí·½·¨¡£Í¬Ê±Ö÷Ҫת±ä»¹°üÀ¨½øÐÐÈ«Çò»¯µÄÁÙ´²ÊÔÑéºÍÔÚ¼à¹Ü¾ÖÁìµ¼ÏÂÕÐļȫÇò»¯ÊÜÊÔÕߣ¬¶ø²»½ö½ö¾ÖÏÞÓÚÃÀ¹ú»òÕßÅ· ÖÞµÄ ÊÔÑéÖÐÐÄ¡£

    ±¨¸æ½«»Ø¹ËÒÖÓôÖ¢Ò©ÎïÑз¢ÁìÓòµÄ¸ïУ¬Ì½ÌÖÕâЩ¸ïжÔÑо¿Õß¡¢ÁÙ´²Ò½Ê¦ºÍ»¼ÕßµÄÓ°Ïì¡£

    ÔÚ ±¨¸æ½áÊøÊ±£¬ÌýÖÚ½«Á˽âÒÖÓôÖ¢Ò©ÎïÑз¢ËùÃæÁÙµÄÌôÕ½ºÍÓ­½ÓÌôÕ½¿ÉÄܵĽâ¾ö·½·¨¡£

    Drug development in the field of depression has its own particular set of challenges, and there has been a documented high rate of failed trials in this field. Some of these challenges include diagnostic issues, patient heterogeneity, placebo response, and our subjective outcome measures.

    This has stimulated a search by both academic and industry scientists to investigate the causes of failed trials and to try and develop improved methodologies.

    It is true to say that CNS clinical trial methodologies had remained relatively stagnant for decades but in the more recent past, there has been a concerted effort by various stakeholders to improve this situation. Some of these innovations include more use of technology in gathering data and assessing patients, refining patient populations, different study designs, and newer statistical models and outcome measures. There has also been a major shift to global clinical trials rather than just US and EU centric trials, as well as global submissions to regulatory authorities.

    This presentation will review the areas that have witnessed innovation in drug development of depressive disorders, and discuss how these innovations may impact, researchers, clinicians and patients.

    At the end of this presentation the audience will have learnt of the challenges facing drug development in the field of depression and some of the possible innovative solutions that have been developed to meet these challenges.

  • S42 - Ì©¹úÇàÉÙÄêÓ뱩Á¦ רÌâ̸ÂÛ»á - A Symposium on Adolescence and Violence in Thailand

    Chairs: Siriwan Grisurapong , Thailand
    Yasong Du, Chinese Mainland

    ÊÀ½ç·¶ ΧµÄÑо¿Ö¤¾ÝÏÔʾ±©Á¦ÔÚÿ¸öÄêÁä²ãÖж¼ÓÐËùÔö¼Ó¡£¼øÓÚÆä¶ÔÇûÌ彡¿µÓ뾫Éñ½¡¿µµÄÑÏÖØÓ°Ïì £¬ ²»ÉÙÑÇÖÞ¹ú¼ÒÖÆ¶¨ÁËÒ»Ð©ÌØÊâÕþ²ßÓë¸ÉÔ¤´ëÊ©ÒÔ¿ØÖƸ÷ÖÖÀàÐ͵ı©Á¦¡£È»¶ø£¬ÔÚÇàÉÙÄêÁìÓò ÖÐËù×÷µÄ¹¤×÷ÉõÉÙ¡£ ΪÁËÈÏʶÕë¶ÔÇàÉÙÄ걩Á¦µÄз½·¨£¬ÎÒÃǽ«Ì©¹úµÄ¾­Ñé»ã×ÜÆðÀ´²¢¼ÓÒÔ×ܽᡣÔÚÑÐÌÖ»áÉÏÌá³ö´ËÏîÄÚÈݵÄÄ¿µÄÊÇΪÁ˽«´Ë×÷ΪһÖÖ²Ù×÷ģʽÔÚÑÇÖÞ¹ú¼ÒÓëµØÇøÒÔ¼°ÆäËûµØÇøÖй²Ïí¡£

    Ä¿µÄ£º

    1 ¡¢´Ù ½øÊ¹ÓöàÖÖ;¾¶¸ÉÔ¤ÇàÉÙÄ걩Á¦µÄÈÏʶÌá¸ßÓëÕþ²ßÐγɡ£

    2 ¡¢ÌṩÇàÉÙÄ걩Á¦¸É Ô¤Æô¶¯µÄ֪ʶÓë¼¼ÄÜ¡£

    3 ¡¢´Ù ½ø²»Í¬Õþ²ß - Éç»á - ¾­¼Ã»·¾³¸ÉÔ¤Õ߼以ÏàÌÖÂÛ¡¢·ÖÏíÓëѧϰ¡£

    4 ¡¢¹ÄÀøÇàÉÙÄ걩Á¦¸É Ô¤ÖеÄÉîÈë̽Ë÷¡¢Ñо¿ÓëºÏ×÷¡£

    Ô¤ÆÚ½á¹û£º

    1 ¡¢ Ì©¹ú¸É Ô¤ÇàÉÙÄ걩Á¦µÄ¾­Ñé¿É·´Ó³³öÑÇÖÞ¹ú¼ÒµÄÇé¿ö£¬²¢×÷ΪÑÇÖÞ¹ú¼ÒµÄ·¶ÀýΪÆäËû¹ú¼ÒÌṩ¾­Ñé¡£

    2 ¡¢ À´×Ô²»Í¬ÎÄ»¯Óë »·¾³µÄ¸ÉÔ¤Õ߿ɻñµÃµÚÒ»ÊÖµÄЭÖú×ÊÁÏ£¬·ÖÏíÔÚ¸ÉÔ¤ÇàÉÙÄ걩Á¦Öеľ­Ñ飬²¢Ëæ×ž­ÑéµÄÀÛ»ýÌá¸ß²»Í¬¸ÉÔ¤ÕßÖÆ¶¨Õþ²ßÓëÏîĿִÐеÄÓÐЧÐÔ¡£

    World wide evidence-based studies demonstrated that violence has increased its intensity in every population age group. Due to its profoundly effect on physical and mental health, several Asian countries have initiated some specific policies and interventions to respond to each type of violence. However, very little effort had been focused on adolescent age group. In order to identify some innovative ways to deal with violence in adolescence, experience and findings from Thailand had been gathered to draw some lessons learned. This session has been proposed to bring this issue to the arena so that experience can be shared for a practice model among countries in the Asian region and elsewhere.

    The session aims to: 1. Promote understanding and policy formulation on how to respond to issues of violence in adolescence in a variety way.

    2. Provide knowledge and transfer skills in initiating some intervention in adolescence.

    3. Promote discussion, sharing and learning among participants with different politico-socio-economic circumstances.

    4. Encourage for further explorations, actions and collaboration establishment in responses to violence in adolescent age group.

    Expected output / results:

    1. Thai responses to violence in adolescence can reflect and be an example of Asian experience for countries in other regions

    2. Participants from different cultures and circumstances will be beneficial from obtaining first hand information and sharing of skill and experience in dealing with violence among adolescence, and with this enrichment will be able to improve effectiveness of their policies and program implementation.
  • S42-1

    Ì©¹úÉç»á¾­¼ÃÓ뽡¿µÌåϵ¼°ÆäÓëÇàÉÙÄ걩Á¦¼ä¹ØÏµ½éÉÜ - Introduction of Thai Socioeconomic and Health Systems and its Relation to Adolescent and Violence Issues

    Siriwan Grisurapong

    Mahidol University , Faculty of Social Sciences and Humanities, Salaya , Thailand

    Ì©¹úÊÇ ¶«ÄÏÑǵÄÈÈ´ø¹ú¼Ò £¬ ÓµÓÐ 6160 ÍòÈË¿Ú £¬ ÆäÖÐ 20% ¾ÓסÔÚ³ÇÊÐ £¬ ¹²·Ö Ϊ 4 ¸öÇøÓò 76 ¸öÊ¡¡£ 95% ÈË¿ÚÊÇÌ©¹úÈË£¬¼¸ºõ 100% µÄÈ˿ڶ¼ÊÇ·ð½Ìͽ¡£½ü 30 ÄêÀ´ ¸Ã¹úÒ»Ö±´¦ÔÚ¾üÊÂͳÖÎ֮ϣ¬ÖÁ 1992 Äê²ÅÓÉÒ»¸öÃñÖ÷Õþ¸®¹Ü Ͻ¡£¸Ã¹úÈ˾ù GDP Ϊ 6400 ÃÀ½ð£¨ 2001 Êý¾Ý£©¡£ 1997 Äêǰ ¸Ã¹úÈ˾ù GDP ¾ùÓРÿÄê 7-8% µÄ³Ö ÐøÔö³¤£¬¶øÔÚ¸ÃÄê¸ÃµØÇøÔâÊÜÁËÑÏÖØµÄ¾­¼ÃÏ»¬£¬Ì©¹úÒ²²»ÀýÍâ¡£ ×Ô 20 ÊÀ ¼Í 60 Äê´úÒÔÀ´£¬Ì©¹ú ¾­¼Ã³ÖÐøÔö³¤£¬ÕâÖÖ½ø²½ÓµÓÐÇ¿´óµÄ»ù´¡£¬²¢ÌåÏÖÔÚ¾­¼ÃÓëÉç»á·¢Õ¹µÄ¸÷ÏîÖ¸±êÖС£¾¡¹ÜÊÕÈëµÄ·ÖÅä²¢²»¾ùºâ£¬µ«ÊÇÖ¤¾ÝÏÔʾËùÓÐÉç»á¾­¼Ã×éÖ¯ÓëËùÓÐÇøÓòµÄÈ˾ùÊÕÈëÓë¼ÒÍ¥ÊÕÈë¾ùÓÐÏÔÖøÌá¸ß ¡£ ÕâʹµÃÌ©¹úÔ¤ÆÚÉú´æÄêÁäÔö³¤Îª 68.9 Ë꣬ÊǸõØÇøÖÐ×î¸ßµÄ¡£»òÐíÎÒÃÇ¿ÉÒÔÓøüÓÐ˵·þÁ¦µÄÖ¸±ê ¡ª¡ª ÈË Àà·¢Õ¹Ö¸ÊýÀ´ºâÁ¿ÕâЩÔö³¤£¬ÕâÊÇÒ»Ïî×ÛºÏÆÀ¹ÀÖ¸±ê£¬Ëü´Ó 1975 ÄêµÄ 0.612 ²»¶ÏÔö¼Ó Ϊ 2001 ÄêµÄ 0.768 ¡£ ´ËÍ⣬ ¾­¼ÃÔö³¤Ê¹µÃÌ©¹úÔÚÉç»áÓ뽡¿µÁìÓò»ñµÃÏÔÖø½ø²½£¬»ñµÃÕâЩ½ø²½µÄ¹Ø¼üÔÚÓÚ¹ú¼ÒµÄ¼²²¡Ô¤·ÀÓëÖÎÁÆÌåϵÉîÈëµ½Á˹ú¼ÒµÄ¸÷¸ö½ÇÂä¡£ÌåϵµÄ·¢Õ¹Ê¹µÃ¶àÏîÖ¸ÊýÃ÷ÏÔϽµ£¬ÈçÐÂÉú¶ùËÀÍöÂÊ´Ó 1970 ÄêµÄ 74 Àý /1000 ÃûÐÂÉú¶ùϽµ Ϊ 2001 Äê 24 Àý /1000 ÃûÐÂÉú¶ù£¬ 5 ËêÒÔÏÂËÀÍöÂÊ´Ó 1970 ÄêµÄ 102 Àý /1000 ÃûÐÂÉú¶ùϽµ Ϊ 2001 Äê 28 Àý /1000 ÃûÐÂÉú¶ù¡£Óë´Ëͬ ʱ£¬ 1985-2001 Äê ¼äµÄ²ú¸¾ËÀÍöÂÊΪ 44 Àý /100,000 Ãû ²ú¸¾¡£Í¨¹ý¸²¸ÇÂʽüºõ 100% µÄÒßÃç×¢É䣬´ó·ù¶È½µµÍÈý¶È ÓªÑø²»Á¼µÄ·¢Éú£¬ÒÔ¼°¸ÉÔ¤ÆäËûÓ°Ï콡¿µµÄÒòËØÈçÌṩ½¡¿µÒûÓÃË®ÓëºÏÊʵÄÎÀÉúÉèÊ©£¬Ì©¹úʵÏÖÁ˶àÖÖ¼²²¡´«²¥µÄÏÔÖø¼õÉÙ¡£È»¶ø £¬ ½ü¼¸Ê®ÄêÖб©Á¦·¢ÉúÔÚÏÔÖøÔö¼Ó £¬ ÓÈÆäÊÇÔÚÇàÉÙÄêÖС£¾¡¹ÜÖ»ÓкÜÉÙÊý¾ÝÄÜÖ¤Ã÷ÆäÑÏÖØÐÔ £¬ µ«Ò»Ð©ÊÂÀýÖ¤Ã÷ÁËÆä´æÔÚ¡£

    Thailand , a tropical country of Southeast Asia , has a population of about 61.6 million with 20% of it residing in the urban areas. The country is divided into 4 regions and 76 provinces. Ethnically 95% of the population is Thai and almost 100% of Buddhist faith. For almost 3 decades, the country was under military rule and it was in 1992 that a democratic government took office. The country has a GDP per capita (PPP US $) of 6400 (2001 figure), and had seen a sustained growth of 7-8% up until 1997. This was the year when the region saw a severe economic downturn, Thailand being no exception.

    From the 1960s on, Thailand saw a sustained growth in economy. This progress was broad based and finds expression in almost all indicators of economic and social development. Although income gains have not been shared equitably, but evidence suggests that there was a sharp increase in per capita and household income in all socio-economic groups and all regions. (HDR 99). This has resulted in addition to life years with the overall life expectancy at birth being 68.9 years, one of the highest in the regions. Better reflective, perhaps, of the comprehensiveness of these gains across different sectors is the Human Development Index which comprehensively measures, life expectancy, has increased steadily from 0.612 in 1975 to 0.768 in 2001.

    Besides economic growth there was marked improvements in social sectors and health. A key to these improvements is the development of a national system of preventative and curative health care that penetrates all the corners of the kingdom. (HDR 99) The development of decentralized system has made it possible to achieve sharp reductions in many indicators like Infant Mortality Rate which dropped from 74 in 1970 to 24 per thousand live births in 2001 and under five Mortality Rate of 102 in 1970 to 28 per thousand live births in 2001. (HDR 99) Maternal mortality ratio, during the same time, that is, 1985-2001 was 44 per 100,000 live births. Significant reductions in the modes of transmission of many diseases has also been achieved. This has been mainly made possible through nearly 100% immunization coverage, significant reductions in 3rd degree malnutrition and access to other factors which affect health, like provision of safe drinking water and proper sanitation. However, increasing of violence had been remarked during these decades, particularly in the adolescent age group. Although there is very little data to demonstrate its severity, anecdotal evidence confirm its existence.

  • S42-2

    Ì©¹úÇàÉÙÄê·¸×ïÓ°ÏìÒòËØ - Factors Affecting Committed Crimes among Thai Juveniles

    Suree Kanjanawong 1

    1 Mahidol University , Faculty of Social Sciences and Humanities, Salaya , Thailand

    ±¾Ñо¿µÄÄ¿µÄÔÚÓÚ̽ ÌÖ (1) ·¸×ïÔ­Òò £¨ 2 £© ½â¾öÇàÉÙÄê·¸×ïµÄ·½·¨¡£Êý¾ÝÀ´Ô´£¨ 1 £©Í¨ ¹ýʹÓÃÎÊ¾í£¬Ñ¡È¡ 200 ÃûÀ´×ÔÓÚÃû Ϊ Ban Mutita ¡¢ Ban Karuna ¡¢ Ban Ubekka ÒÔ¼° Ban Pranee µÄÇàÉÙÄê Ö°Òµ½ÌÓýÖÐÐļà¹ÜËùµÄÎ¥·¨ÇàÉÙÄ꣬ (2) ͨ ¹ý½øÒ»²½·Ã̸£¬Ñ¡È¡ 4 ÃûÔÚÉÏÊöÖÐÐÄµÄ Î¥·¨ÇàÉÙÄ꣬ (3) ͨ ¹ýʹÓü¯ÖÐÍÅÌå¼¼Êõ£¬Ñ¡È¡À´×ÔÉÏÊöÖÐÐÄµÄ 10 ÃûÕþ¸®¹¤×÷ÈË Ô±°üÀ¨Éç»á¹¤×÷ÕßÓëÁÙ´²ÐÄÀíÖÎÁÆÊ¦¡£²¢Ê¹ÓÃÆµÊý£¬°Ù·Ö±È£¬ËãÊýƽ¾ùÊý£¬±ê×¼²î¶ÔºÏ¸ñÊý¾Ý½øÐÐÃèÊö¡£ ½á¹ûÈçÏ£º (1) Éç»áÓë »·¾³Ô­Òò£º¶àÊýÇàÉÙÄê·¸×ïÕߵĽÌÓýˮƽΪ³õÖлòСѧ£¬»ù±¾ÔÚͬһˮƽ£»¸¸Ä¸µÄ»éÒö×´¿öΪ·Ö¾Ó»òÀë»é£»¾ÓסÔÚÆ¶ÃñÇø£»ÔÚÎÞÏÞÖÆµÄ½ÌÓý·½Ê½Ï³ɳ¤£»¸¸Ä¸¹ØÏµ¶ñÁÓ (2) ¸öÈËÔ­Òò£º¶àÊýÇàÉÙÄê·¸×ïÕß¶¼ ΪÀÛ·¸£¬´ó¶àÊýÊÇÓëÆäͬ °é ½øÐÐÒÔ»ñµÃ²ÆÎïΪĿµÄµÄ·¸×´óÔ¼Ò»°ëµÄÈ˵ÖÖÆÉÏѧ£¬¶Ôѧϰ³É¹¦¸Ðµ½·¦Î¶ÓëÎÞÍû£»ËûÃÇµÄÆÚÍû´ó¶àÊýÊǽðÇ®ÓëÏíÊÜ£»×ñÊØ¼Ò³¤¡¢½ÌʦÓëͬ°é¼ä¹æ·¶Ë®Æ½ÎªÖеȣ»×ÔÎÒ¿ØÖÆÁ¦ÎªÖеȡ£ÐÄÀíµ÷²éÏÔʾÕâЩÇàÉÙÄê·¸×ïÕßÃô¸Ð£¬Óй¥»÷ÐÔ£¬ÍËËõ£¬È±·¦×ÔÐÅ¡£ËûÃÇÔÚÊÊÓ¦¡¢Ð­µ÷È˼ʹØÏµ¡¢¶ÀÁ¢ÉÏ´æÔÚÀ§ÄÑ£¬²¢ÓÉ×Ô±°¸Ð¡£

    The objectives of the study were to study (1) causes of committed crime and (2) measures to solve the committed crime among juvenile delinquents. Data were collected from (1) two hundred juvenile delinquents in the custody of The Juvenile Vocational Training Center, named Ban Mutita, Ban Karuna, Ban Ubekka, and Ban Pranee by using questionnaires, (2) four selected juvenile delinquents from the said Center by using in-depth interview, and (3) ten government officials including social workers, and clinical psychologists who are working in the Juvenile Vocational Training Center by using focus group technique. Frequency distribution, percentage, arithmetic mean and standard deviation were used to describe quantitative data.

    The results from the study are as follows; (1) Social and environmental causes: the educational levels of most of the juvenile delinquents are secondary school and primary school at almost the same rate; parent's marital statuses are separate or divorce; their residents are in slum areas; being brought up with permissive type of child rearing; the relationship between parents is poor (2) Personal causes: most of the juvenile delinquents had ever committed crime before, mostly on property's crime with his friends; about one-half of them reject their schooling, boring or no hope with learning success; an expectation of their outcome mostly in terms of money or enjoyment; a comply to subject norms including parents teachers, and peers are in the moderate level. Self-control is moderate. Psychological reports reveal that these juvenile delinquents are sensitive, aggressive, regressive, and low self-esteem. They also have problems with adjustment, making relationships with other, dependency, and inferiority feeling.

  • S42-3

    ÀûÓÃ×ڽ̽â¾öÇàÉÙÄêÐÔ±©Á¦£º·ð½Ì°¸Àý - Faith-based Advocacy on Adolescent Sexual Violence: A Case of Buddhism

    Luechai Sringernyuong

    Mahidol University , Faculty of Social Sciences and Humanities, Salaya , Thailand

    ºÍÊÀ½çÆäËûµØ·½Ò» Ñù £¬ ÇàÉÙÄêÉúÖ³ÓëÐÔ½¡¿µÎÊÌâ £¨ ARSH £© ÔÚÌ©¹úÈÕÒæ ÑÏÖØ¡£½üÄêÀ´»éǰÐÔÐÐΪ£¬Î´³ÉÄ껳ÔС¢Á÷²ú£¬°¬×̲¡²¡¶¾¸ÐȾÓë°¬×̲¡£¬±©Á¦Ó붾ƷµÈÎÊÌâÕýÁîÈ˵£ÓǵIJ»¶ÏÔö¶à¡£¾¡¹ÜÎÒÃÇÒѾ¡Á¦½â¾öÉÏÊöΣ»ú£¬µ«Àë³É¹¦ÉÐÔ¶¡£±¾Ñо¿ÊÇ UNESCO Ö§³ÖµÄ£¬ÔÚÌ©¹ú Nakorprathom Ê¡ ¿ªÕ¹µÄÒ»ÏîÀûÓÃ×ڽ̴ٽøÇàÉÙÄêÐÔÓëÉúÖ³½¡¿µµÄÑо¿¡£ÆäÄ¿µÄÔÚÓÚ³«ÒéÀûÓ÷ð½Ì½â¾öÇàÉÙÄêÐÔÓëÉúÖ³½¡¿µÏà¹ØÎÊÌâ¡£¸ÃÑо¿°üÀ¨ÐèÇóÆÀ¹À¡¢Ä¼¼¯Éç »á ×ʽð¡¢Åàѵ¡¢¹¤×÷·»Óë½á¹ûÆÀ¹À¡£±¾Ñо¿ÔÚ¸ÃÊ¡µÄ 3 ¸öÇøÄÚ ¿ªÕ¹£¬ÔÚ ARSH µÄ ½øÕ¹Ó븴ÔÓÐÔ£¬·ð½Ì½â¾ö ARSH µÄÏà ¹ØÐÔÓëÖØÒªÒâÒåÉÏÌṩÁËÐí¶àÓмÛÖµµÄÄÚÈÝ¡£×îÎªÖØÒªµÄ¾­ÑéÊÇÈçºÎ¶¯Ô±×Ú½ÌÁìÐ䡢ѧУ½ÌʦÓë¶ùͯÒÔ¼°ÉçÇøÁìµ¼¡£

    Elsewhere alike, adolescent reproductive and sexual health problems (ARSH) have been rising in Thailand . Premarital sex, teenage pregnancy, abortion, HIV/AIDS, violence and drugs are among the problems worryingly increasing during the recent years. Although a lot of efforts have been done to solve the crises but success is still far-reaching. This study is part of a UNESCO's support project on Faith-based Advocacy on Adolescent and Sexual Reproductive Health carried out in Nakorprathom Province central of Thailand . Its aims concentrate on promoting Buddhism as a means to solve adolescent's sexual and reproductive health-related problems. Activities of the project comprise needs assessment, social capital mobilization, training workshop and outcome evaluation. The study took place in 3 districts of this province. The project provides many valuable lessons in regard to the dynamics and complexity of ARSH and the relevance and significance of Buddhism principles in solving ARSH problems. An important lesson learned is the practical aspects of how religious leaders, school teachers and children, and community leaders could be mobilized.

  • S42-4

    ±©Á¦¼°Æä¶ÔÇàÉÙÄ꾫Éñ½¡¿µµÄÓ°Ï죺²âÁ¿ÓëÒâÒå - Violence and its Impact to Adolescent Mental Health: Measurement and Implication

    Siriwan Grisurapong

    Mahidol University , Faculty of Social Sciences and Humanities, Salaya , Thailand

    Ò» ÏîÓÉ WHO ×éÖ¯¶à¹ú¼Ò²ÎÓëµÄ¹ØÓÚÐÔ±©Á¦ £¨ GBV £© µÄÑо¿ ·¢ÏÖ 44-51% Äê ÁäÔÚ 15-19 ËêµÄÌ©¹úÇàÉÙÄê ÔÚËû ÃÇÒ»ÉúÖÐÖÁÉÙ¾­Àú¹ýÒ»´Î GBV ¡£ Ðí¶à¿ÆÑ§Ñо¿·¢ÏÖÇàÉÙÄêÔÚÔâÓö GBV ºó»á³ö ÏÖһЩÐÄÀíÕϰ­£¬Èç´´É˺óÓ¦¼¤Õϰ­£¨ PTSD £©¡¢ÒÖÓôÖ¢ÓëһЩÐРΪÕϰ­¡£µ«ÊÇÌ©¹úÖÁ½ñÈÔδÓÐÑо¿È¥Ö¤Êµ GBV ¶ÔÇàÉÙÄêµÄÐÄÀíÓ°Ïì×´¿ö£¬ÒÔ¼°½¡¿µ»ú¹¹µÄ¸ÉÔ¤´ëʩӦµ±ÈçºÎÌṩ¸øËûÃÇ¡£ Ò» ÏîÑо¿±»ÓÃÀ´µ÷²éÇàÉÙÄêÔâÊÜ GBV µÄ ÑÏÖØ³Ì¶È£¬°üÀ¨µ÷²éËûÃÇ×÷Ϊµ±ÊÂÈË»ò¼ûÖ¤ÈË¡£²¢µ÷²é GBV ÓëһЩÐÄÀíÕϰ­°üÀ¨ ´´É˺óÓ¦¼¤Õϰ­£¨ PTSD £©¡¢ÒÖÓôÖ¢Óë½¹ ÂÇÖ¢µÄÏà¹ØÐÔ¡£ 2004 ѧÄêÌ©¹ú ¶«±±²¿Ä³Ê¡³ÇÊÐÖÐ 2 ¸öÖÐѧµÄѧÉú±»ÓÐÄ¿µÄµÄ Ñ¡Ôñ×÷ΪÑù±¾£¬¹²ÓÐ 466 ÃûѧÉú²Î¼Ó£¬Ëû ÃǵÄÄêÁäΪ 14-17 Ë꣬·Ö±ðΪ 10-12 Äê ¼¶µÄѧÉú¡£Ò»Ïî×ÔÆÀÎÊ¾í±»Ëæ»ú·Ö·¢¸øËûÃÇÀ´É¸Ñ¡ËûÃDZ©Â¶ÓÚ±©Á¦µÄÇé¿ö£¬²¢Ê¹ÓÃÉú»îʼþÁ¿±í¡¢¶ùͯ PTSD Ö¢×´Á¿±í¡¢¶ùͯÒÖÓôÖ¢Á¿±íÓë¶ùͯÇàÉÙÄêÖ¢×´ ¼ì²é±íµÈÐÄÀíÁ¿±íÀ´½ÒʾËûÃǵÄÐÄÀí×´¿ö¡£½á¹ûÏÔʾ¼¸ºõ°ëÊýµÄѧÉú¼ûÖ¤¹ý¿ÖÏÅÓ돴ò£¬ 1/5 µÄѧÉúÔø Ç×Éí¾­Àú¹ý¡£ 1/5 µÄѧÉúÔø ¼û¹ý±ðÈ˱»ÎäÆ÷ÍþвºÍÐÔŰ´ý£¬ 3-8% Ôø±»´òºÍÔâÊÜÐÔŰ´ý¡£ 3/4 µÄѧÉú PTSD ×Ü·ÖÔÚÁÙ½çµãÖ®ÉÏ£¬ 1/3 µÄѧÉúµÄÒÖÓôÓë½¹ ÂÇ×Ü·ÖÔÚÁÙ½çµãÖ®ÉÏ¡£ÔâÊܱ©Á¦Óë PTSD µÄÏà ¹ØÐÔÑо¿·¢ÏÖÁ½ÕßÏà¹ØÏµÊýΪ 0.31 ¡£ ¾¡¹ÜÓÐ ¹ØÇàÉÙÄêµÄ½¡¿µµ÷²éδÏÔʾ³ö ÐÔ±©Á¦ ¶ÔÇàÉÙÄêÐÄÀí´´É˵ÄÓ°Ïì £¬ ÎÒÃÇÒÀȻӦµ±²ÉȡһЩ¸ÉÔ¤´ëʩȥ֧³ÖÄÇЩÔÚ GBV ºó³ö ÏÖÐÄÀíÕϰ­µÄÇàÉÙÄê £¬ ÓÈÆäÊÇ×÷ΪһÏîÒÔѧУΪ»ù´¡µÄÐÔÓëÉúÖ³½¡¿µÏîÄ¿¡£

    A WHO multi-countries study on gender-based violence (GBV) found that 44-51% of Thai adolescent aged 15-19 years had some experience on GBV at least once in their life time. A lot of scientific studies found that adolescent exposed with GBV demonstrated some psychological distress such as Post traumatic Stress Disorder (PTSD), Depression and some behavioral problems. But no effort to identify psychological impact of adolescent exposed to GBV or health service interventions that should be provided to them had been conducted in Thailand yet.

    A research had been conducted to identify the extent to which adolescent are exposed to GBV as either victims or witnesses and its association with some psychosocial dysfunctions including Posttraumatic Stress Disorder (PTSD), Depression and Anxiety. Data collection was carried out during the academic year 2004. Student in 2 middle schools in an urban area of a province in the Northeast of Thailand has been purposively selected as the target group. A self-reported questionnaire has been administered to 466 student aged range from 14-17 years in grade 10-12 who were randomly selected to screen for exposure of violence and the psychosocial scales by using Life Events Scale, child PTSD Symptom Scale, Child Depression Scale and Youth Pediatric Symptom checklist. The results demonstrated that almost half of students had witnessed in threatening, slapping / hitting / punching and beating whereas one-fifth experienced such violence by themselves. One-fifth of students had witnessed threatening by using weapons and sexually abuse whereas 3-8% experienced in being beaten and sexually abused. Three-fourth of students had PTSD scores above the cut-off point. One-third of student had depression and anxiety scores above the cut-off point. Test of correlation showed that exposure to violence had significantly correlated with PTSD at 0.31.

    Since the health programs for adolescent tend to fail to address gender or sexual coercion and its psychological trauma to children. There should be some interventions to support adolescent with psychological distress from GBV, particularly as a school-based sexual and reproductive health programs.

  • S42-5

    Ì©¹úÇàÉÙÄêÔ¼»á±©Á¦ - Dating Violence among Thai Adolescence

    Penchan Sherer

    Mahidol University , Faculty of Social Sciences and Humanities, Salaya , Thailand

    ±¾Ñо¿²ÉÓþßÓдú±íÐÔµÄÑо¿ Éè¼ÆÀ´µ÷²éÔ¼»á±©Á¦µÄ·¢ÉúÓëÑÏÖØÐÔ¡£ Ñо¿ ¶ÔÏóΪ 1269 ÃûÄÐÐÔÓëÅ®ÐÔÇàÉÙÄê £¬ ÆäÖÐ 47.29 % Ϊ¸ßÖÐÉú ,44.90% ΪְУÉú £¬ 7.7% ΪУÍâÈËÔ± £¬ ÄêÁäÔÚ 14 £­ 19 ËêÖ®¼ä¡£½á¹ûÏÔʾ̩¹úÇàÉÙÄêÔâÊܲ» ͬ ÀàÐÍÔ¼»á±©Á¦µÄ·¢ÉúÂÊÆÄ¸ß¡£ 695 ÃûÔø²Î¼Ó Ô¼»áµÄÑо¿¶ÔÏóÖУ¬ 49.2% µÄÄÐÐÔÓë 46.7% µÄÅ®ÐÔÔø±»Ëû Ãǵİé¿ÖÏÅ£¬ 65.8% µÄÄÐÐÔÓë 59% µÄÅ®ÐÔÔø±» ¶Ô·½Å°´ý£¬ 41.9% µÄÄÐÐÔÓë 41.2% µÄÅ®ÐÔÔøÔâÊÜÇûÌåŰ´ý£¬ 43.2% µÄÄÐÐÔÓë 46.7% µÄÅ®ÐÔÔø±»ÐÔŰ´ý£¬´ËÍâ 49.2% µÄÄÐÐÔÓë 46.7% µÄÅ®ÐÔÊÜ ¹ýÑÔÓïÓëÇé¸ÐŰ´ý¡£ÔÚÔâÊÜÔ¼»á¶ÔÏó±©Á¦ºó 50.2% ÄÐÐÔÓë 57.2% µÄÅ®ÐÔÔø ѰÇó°ïÖú¡£ ְУÉúÓëУÍâÈËÔ±ÔâÊܱ©Á¦ÍþвÒÔ¼°ÇûÌåÓëÐÔŰ´ýµÄ·¢ÉúÂʶ¼ÏÔÖø¸ßÓÚ¸ßÖÐÉú¡£Í¬°éÈ˼ʹØÏµÓëÌ©¹úÇàÉÙÄêÔ¼»á±©Á¦µÄ·¢Éú¼äÓÐÃÜÇÐÏà¹Ø ÐÔ¡£ÇàÉÙÄêµÄ»ï°é ¹ØÏµºÜ¼òµ¥£¬µ«ÊÇÈ´ÓкÜÖØÒªµÄÓ°Ïì¡£ÎÞÂÛºÎÖÖÓëÅóÓѵÄÈÕ³£»î¶¯Ëƺõ¶ÔÔ¼»á±©Á¦¶¼ÓиºÐÔÓ°Ïì¡£ÕâÒâζ×ÅÅóÓѼäÕýÐÔµÄÈÕ³£ÐÐΪ°üÀ¨Ñ§Ð£×÷Òµ¡¢ÓéÀÖÓëÌåÓý¶ÍÁ¶¿É¼õÉÙÌ©¹úÇàÉÙÄêÔ¼»á±©Á¦µÄ·¢Éú¡£ ½¡¿µ¹ÜÀíÕ߿ɽ«´Ë×÷ Ϊ»ùÏßÐÅÏ¢ÓÃÓÚÖÆ¶¨ºÏÀíµÄÇàÉÙÄ꽡¿µ·¢Õ¹Õþ²ß¡£Ó¦µ±ÓÉÒÔѧУÓëÉçÇøÎª»ù´¡µÄ»ú¹¹À´ÎªÑ§ÉúÌṩ±ØÒªµÄ½¡¿µ·þÎñ¡£½¡¿µ·þÎñÓ¦µ±°üÀ¨Ö°ÒµÖ¸µ¼ÏîÄ¿ÓëÖ¸µ¼Ìåϵ£¬²¦¿î¸øÉçÇø½¡¿µÓëÉç»á·þÎñ¹¤×÷ÕßÀ´È·±£Ñ§ÉúÔÚ·¸×ïǰ¾ÍÄܵõ½Êʵ±µÄ½¡¿µ·þÎñ¡£Ñ§ÉúÓ¦ÄÜ»ñµÃÖ°Òµ½¡¿µÓë×Éѯ·þÎñµÄÐÅÏ¢ £¬ ÒÔ¼°ÖªµÀËûÃǸÃÈçºÎ»ñµÃÕâЩÐÅÏ¢¡£Õë¶Ô¸ßÖÐÉúµÄ×ÛºÏÐÔ ±©Á¦ Ô¤·ÀÓ¦Ïò¸ßÖÐÉúÌṩ½â¾öÓë°é¹ØÏµÎÊÌâµÄ½»Á÷¹¤¾ßÓë֪ʶ¡£ÈÎºÎÆÀ¹ÀÓë¸ÉÔ¤¶¼Ó¦µ±°üÀ¨Ôö½øÇàÉÙÄê¶ÔʲôӦÔÚÇàÉÙÄêÆÚÓÅÏÈ·¢Õ¹µÄÀí½â £¬ ÒÔ¼°Ìá¸ßÇàÉÙÄê×ö³ö¾ö¶ÏµÄÄÜÁ¦¡£

    The study used a cross-sectional survey design to explore the incidence and severity of violence in dating relationships and to examine the variables related to the perpetuation of abuse in dating relationships among Thai adolescents.

    The sample in this study consisted of 1,269 male and female adolescents from high school ( 47.29 %), vocational school (44.90%)and out of school (7.7%), aged between 14-19 years. The results indicated that a high percentage of Thai youths experience various forms of dating violence in their relationships. Of the 695 participants who dated, 49.2% of the males and 46.7% of the females had been threatened by their partners, 65.8% of the males and 59% of the females had been relationally abused, 41.9% of the males and 41.2% of the females had been physically abused, 43.2% of the males and 46.7% of the females claimed that they had been sexually abused by their partners, while 49.2% of the males and 46.7% of the females reporting being verbally or emotionally abused. Of those who experienced a problem or have concerns about their violent dating relationships, 50.2% of the males asked for help. While 57.2% of the females asked for help.

    The incidence rates of both threaten abuse, physical and sexual violence among adolescents from out of school and vocational school were significantly higher than those from the high school. Interpersonal relationships with peers has a strong association with dating violence among the Thai youth. The relationships with the partners have low loadings in this model, but it seems that the importance of the relationship is some what more influential. The routine activities with friends, seem to negatively influence dating violence ¨C no matter what kind of activity is involved. This means that association with friends around positive routine activities that involve school assignments, entertainment and sport, may have a positive influence on lowering dating violence among the Thai youths.

    The findings can be used as baseline information for health administrators in developing appropriate health policy in the area of adolescent health. Necessary health services for students should be provided in school-based and community based settings. Services should include professional counselling programs and referral systems to appropriate health and social service providers in the community to ensure that students can access appropriate health care before seeking assistance in the criminal justice systems or social service agencies. Students should be provided with information about available professional health and counselling services and information about how they can gain access to these services. Comprehensive violence prevention programs are needed for high school students to provide important communication tools and knowledge for resolving relationship problems. Any assessment and intervention should include understanding of developmental priorities during adolescence and support for adolescents' decision-making skill.
  • S43 - ¾«Éñ²¡ Э»áÑÇÖÞ·Ö»á - Asian Federation of Psychiatric Associations

    Chairs: Naotaka Shinfuku , Japan
    Dongfeng Zhou, Chinese Mainland

    Õâ¸öרÌâÌÖÂÛ»áÖØµã½éÉÜÆðʼÓÚ¿ªÂÞ £¨ 2005 £© WPA »á Òé £¬ ²¢ÔÚ 2007 °Í»ù˹̹À­ºÏ ¶û WPA ÇøÓòÐÔ»á Òé ¡ª¡ª ·¢Õ¹Öйú¼Ò¾«Éñ²¡¹ú¼Ê»áÒéÉÏÐγɵľ«Éñ²¡Ð­»áÑÇÖ޷ֻᡣ ÕâÊÇÑÇÖÞµØÇøµÄ¾«Éñ¿ÆµÚÒ»´Î×ßµ½Ò»Æð £¬ ÒÔʵÏÖ´Ù½ø¾«ÉñÎÀÉúÓ뽡¿µµÄ¹²Í¬Ä¿±ê¡£ ×îºó½« ÌÖÂÛ×î½ü³öÏÖµÄÑÇÖÞ¾«Éñ¿ÆÔÓÖ¾ÒÔ¼°¸øÕâ¸öµØÇø´øÀ´µÄ»úÓö¡£

    This symposium will high light the inauguration of AFPA at the WPA Congress at Cairo in 2005 and finally launched in 2007 February at the WPA Section on Psychiatry in Developing countries international conference at Lahore Pakistan . The broad directions of and vision of the first time Asiian psychiatry becomes united for the important direrction of the enhanced mental health and well-being of all Asia .

    The recent Inaguration of the Asian Journal of Psychiatry and its opportunities to the various regions of Asia will be disscssed

  • S43-1

    AFPA'S¡ª ÑÇÖÞ¾«Éñ²¡Ñ§ÔÓÖ¾ ¡ª ËýµÄ³ÐŵºÍ»ú»á - AFPA'S ¨C Asian Journal of Psychiatry- Its Promises and the Opportunities

    Russell D'Souza 1

    1 Asian Federation of Psychiatric Association, Melbourne , Australia

    ±¾ ±¨¸æ»á½éÉÜ AFPA µÄ ½á¹¹ £¬ ÒÔ¼°ÁªºÏÕâ¸öÖÝËùÓеØÇøÒÔʵÏÖ¼ÓÇ¿ÑÇÖÞ¾«Éñ²¡Ñ§ºÍ¾«ÉñÎÀÉúµÄ¹²Í¬Ä¿±ê¡£ÑÇÖÞ¾«Éñ²¡Ñ§ÔÓÖ¾£¬ËüµÄ½á¹¹£¬ËûµÄÒªÇó£¬ËûµÄÄ¿±êºÍ»ú »á£¬ Ô¤¼ûÖØÒªµÄ¾«Éñ²¡Ñ§ÔÓÖ¾³É¹¦µÄÒòËØ

    This presentation will out line the formation of AFPA and the uniting of all the regions of this vast continent for a united cause of enhancing Asian mental health and Psychiatry. The Asian Journal of Psychiatry its formation, its mandate, its objectives and the opportunities that promise to see the making of a significant Journal of Psychiatry

  • S43-2

    AFPA¡ª ̨Í徫ÉñÎÀÉúÏÖ×´ºÍδÀ´ÌôÕ½ - AFPA- Taiwan's Mental Health Current Status and Future Challenges

    Ming-jen Yang

    Asian Federation of Psychiatric Associations, Melbourne , Australia

    ±¾ ±¨¸æ¸ÅÀ¨ÁË×÷Ϊ̨Íå¶«ÑÇ AFPA'S µÄ¾«Éñ²¡Ñ§ÈºÌåÒ» Ô±µÄ¾«ÉñÎÀÉúµÄµØÎ»ºÍ×ÊÔ´¡£»¹½«ÌÖÂÛδÀ´ÌôÕ½ºÍǰ¾° £¬ ÒÔ¼°´ïµ½ÕâЩָ±êµÄ¼Æ»®¡£

    This presentation will out line the Taiwan a member of the AFPA's East Asian psychiatry group's mental health capacity and resources. Future challenges and vision together with plans to achieve these indicators will be disscussed

  • S43-3

    SAARC ¾«Éñ²¡Ñ§·Ö»áĿǰ״̬ºÍδÀ´µÄ·½Ïò¼°ÌôÕ½ - SAARC Psychiatric Federation Current Status and Future Directions and Challenges

    Subba Reddy

    President SAARC Psychiatric Federation, Melbourne , Australia

    ±¾ ±¨¸æ½éÉÜÓÉ 8 ¸ö³É Ô±¹úµÄµØÇøÐÔ¾«Éñ²¡ºÏ×÷×éÖ¯ £¬ SAARC ÄÏ ÑÇЭ»áÇøÓòÐԵijÉÁ¢¡£½«ÌÖÂÛÖîÈçÓ¡¶È¾«Éñ²¡Ð­»á£¬ÄÏÑǹú¼ÊÂÛ̳֮ÀàµÄ×éÖ¯ÒÔ¼°ÆäËüËùÓйú¼ÒÔÚ¾«ÉñÎÀÉúÓ뾫Éñҽѧ½¨ÉèÖаçÑݵĽÇÉ«¡£Ò²»áÌÖÂÛδÀ´ÌôÕ½ºÍÈ·¶¨µÄ¿ÉÄÜ·½Ïò¡£

    This presentation will out line the inauguration of the SAARC South Asian Association for Regional Cooperation psychiatric Federation with the 8 countries members. The outcomes in the ahead of mental health and psychiatry capacity building the roles played by organizations such as the Indian Psychiatric Society, the South Asian Forum International and its chapters in all the SAARC countries will be discussed. Future challenges and positive possible direction will also be discussed.

  • S43-4

    ÖйúµÄÐÄÀíÎÀÉúºÍ¾«Éñ²¡Ñ§ ¡ª δÀ´µÄ·½ÏòºÍÌôÕ½ - Mental Health and Psychiatry in China ¨C Future Directions and Challenges

    Dongfeng Zhou

    President Chinese Society of Psychiatry, Beijing , Chinese Mainland

    ±¾ ±¨¸æ¸ÅÀ¨ÁËÖйú¾«ÉñÎÀÉúµÄ³É¾Í¡£ËûµÄ½ÇÉ«ÔÚ WPA µÄ 16 Çø £¬ ºÍ AFPA µÄ ¶«ÑÇÇø¡£ÌÖÂÛÖйúÉç»á¾«Éñ²¡Ñ§µÄÌôÕ½ºÍδÀ´ÒÔ¼°ÖйúÐÄÀíÎÀÉúºÍ½¡¿µµÄÌá¸ß¡£

    This presentation will out line the achievements in the are of mental health in China . Its role in zone 16 of the WPA. And the East Asian region of AFPA. The challenges and future directions for the Chinese Society of Psychiatry and the enhanced mental health and well-being of China will be discussed

  • S43-5

    ¶«Ã˾«ÉñÎÀÉú ¡ª ÏÖ×´ºÍÌôÕ½ - ASEAN Mental Health: Current Status and Challenge

    Pichet Udomratn 1

    1 ASAEN Psychiatric Federation, Songkhla , Thailand

    ASEAN ÊÇ ¶«ÄÏÑÇÕþÖΡ¢¾­¼ÃºÍÉç»áȺÌåµÄ¶«ÄÏÑǹú¼ÒÁªÃË £¬ ³ÉÁ¢ÓÚ 1971 Äê¡£ ¶«Ã˳ýÓ¡¶ÈÄáÎ÷ÑÇ¡¢ÂíÀ´Î÷ÑÇ¡¢·ÆÂɱö¡¢ÐÂ¼ÓÆÂºÍÌ©¹ú£µ¸ö´´Ê¼³ÉÔ±¹úÍ⣬ÎÄÀ³¡¢Ô½ÄÏ¡¢ÀÏÎΡ¢ÃåµéºÍ¼íÆÒÕ¯£µ¹úÏȺó¼ÓÈë¸Ã×éÖ¯£¬Ê¹¶«ÃËÓÉ×î³õ³ÉÁ¢Ê±µÄ£µ¸ö³ÉÔ±¹ú·¢Õ¹µ½Ä¿Ç°µÄ£±£°¸ö³ÉÔ±¹ú¡£¶«ÃË£±£°¹úÈË¿ÚÔ¼£µ .2 ÒÚ£¬¶«ÃËλÓÚ¶«ÄÏÑǵÄÐÄÔàµØ´ø£¬¾ùΪÈÈ´øÆøºò£¬µ«ÔÚÕþÖΡ¢×ڽ̡¢ÓïÑÔºÍÈËÖÖÉϲî±ð¾Þ´ó¡£Ä¿Ç°ÔÚ¶«ÃË´óÔ¼ÓÐ 2200 Ãû¾«Éñ²¡Ñ§¼Ò¡£ ¶«Ã˾«Éñ²¡ºÍÐÄÀíÎÀÉúÁªÃËÊÇÑÇÖÞ½ÏÔçµÄÇøÓòÐÔ¾«Éñ²¡Ð­»á£¬ÔÚÌ©¹úÂü¹È³ÉÁ¢ÓÚ 1981 Ä꣬ ¶«Ã˾«Éñ²¡ºÍÐÄÀíÎÀÉúÁªÃËÔÚ 2006 Äêͨ ¹ý¶«Ã˼ÓÈýģʽÒѾ­×ß³ö±¾µØÇøÓëÖйú¡¢º«¹úºÍÈÕ±¾ÁªÏµÆðÀ´£¬²¢ÇÒÔÚ 2007 Äê ¶«Ã˾«Éñ²¡ºÍÐÄÀíÎÀÉúÁªÃË×÷Ϊ´´Á¢Õß¼ÓÈëÁË AFPA ¡£ ¾¡¹ÜÎÒ ÃǵÄÁªÃËÔÚ¹ýÈ¥µÄ 26 ÄêÈ¡µÃÁË Ðí¶à³É¾Í£¬µ«ÊÇÐí¶àÌôÕ½ÒÀÈ»´æÔÚ¡£Òò´Ë£¬¶«Ã˾«ÉñÎÀÉúµÄδÀ´²»»áÒÀÀµÁªÃË»òÕßÈκε¥¸ö¹ú¼ÒµÄ¾«Éñ ²¡ Э»á»òÕßÈκζ«Ã˵ØÇøµÄ¾«Éñ²¡Ñ§¼Ò£¬¶øÖ÷ÒªÒÀÀµÍ³Ò»¶«Ã˵ØÇøËùÓÐÆÕµÄ¾«Éñ²¡Ñ§¼ÒÀ´¿ªÆôÒ»¸öеÄÌá¸ßÈËÃñµÄ¾«Éñ½¡¿µÖ®Â·¡£

    Reference: Udomratn P, Deva MP. ASEAN psychiatry : past, present, and future : ASEAN J Psychiatry 2007 ; 8(1) : 35-39.

    The term ASEAN refers to the political, economic and social grouping of Association of South East Asian Nations formed in 1971. Initially, ASEAN composed of 5 countries i.e. Indonesia , Malaysia , Philippines , Singapore , and Thailand . Later, ASEAN has enlarged its membership to form a larger group of 10 countries of south east Asia that now include Brunei, Cambodia, Laos, Myanmar and Vietnam. Together ASEAN has a population of about 520 million people with a wide range of GNP and incomes. The ASEAN region is geographically situated at the heart of south east Asia and has a generally tropical climate but is extremely diverse in political, religious, linguistic and ethnic origins. There are about 2,200 psychiatrists in the ASEAN countries at present. The AFPMH (ASEAN Federation for Psychiatry and Mental Health), the oldest regional psychiatric association in Asia, was formed in 1981 in Bangkok, Thailand .The AFPMH, has gone beyond the region to forge links with China, Korea, and Japan in 2006 through the ASEAN Plus Three Partnership, and in 2007 the AFPMH joined as a founder member of the newly formed Asian Federation of Psychiatric Association (AFPA). Although, our federation has achieved many successes during the past 26 years but many challenges still remain. Thus, the future of ASEAN mental health does not depend on the federation or any single national psychiatric association or any psychiatrist in the ASEAN region but relies heavily on the unity and commitments of all psychiatrists within the ASEAN to open up a new way to improve the mental health of our people.

    Reference: Udomratn P, Deva MP. ASEAN psychiatry : past, present, and future : ASEAN J Psychiatry 2007 ; 8(1) : 35-39.

  • S44 ¨C Psychoanalysis

    Chairs: Yanchun Yang, Chinese Mainland
    HaiYing Zhang, Chinese Mainland

  • S44-1

    Ðð˵ÓëÚ¹ÊÍ ¡ª ÐðÊÂÖÎÁÆÖеĽ¨¹¹¹ý³Ì - Narrative and Hermeneutics ¡ª The Constructive Process in Narrative Therapy

    Chenhai Zhu 1

    1 Fudan University , Social Work, Shanghai , Chinese Mainland

    ÐðÊÂÖÎ ÁÆÊÇ´ÓÏÖÏóѧÊÓ½Ç £¬ ÓÉ×ÉѯʦÓëµ±ÊÂÈËЭ×÷ £¬ ÔÚÆäÑ¡ÔñºÍÊö˵µÄÉúÃü¹ÊÊÂÖÐ £¬ ÕÒ³öÒÅ©µÄƬ¶Î £¬ ´Ó¶ø ¡° ²úÉú»ò±æÊ¶Á˲»Í¬µÄ¹ÊÊ £¬ ÈÃËûʵÐÐеÄÒâÒå £¬ ´ø¸øËûÏëÒªµÄ¿ÉÄÜÐÔ ¡± µÄ ¹ý³Ì £¨ White & Epston, 2001 £© ¡£ÐðʵÄÄ¿ ±êÖ®Ò»ÊǰÑÈËÀྭÑéÖеķÖÉ¢³É·ÖÕûºÏ³ÉÒ»¸öǰºóÒ»ÖµÄÕûÌ壨 McAdams, 1985 £©£¬Í¬ ʱËüÒ²°ïÖú°Ñδ¾­¼Ó¹¤µÄ¾­Ñé×éÖ¯³É¸üÒ×ÓÚ½ÓÊܵÄÐð˵ÐÎʽ¡£ Halliday £¨ 1973 £©ÔøÖ¸³ö£¬ ÓïÑÔ¾ßÓÐÈý¸ö²»Í¬µÄ¹¦ÄÜ£º¹ÛÄîµÄ¹¦ÄÜ£¨ ideational function £©¡¢½»»¥µÄ¹¦ÄÜ£¨ interpersonal function £©ÓëÎı¾µÄ¹¦ÄÜ£¨ textual function £©£¬¶øÒâ ÒåÔÚÕâÈý¸ö²ãÃæÖн»»ã¡¢´«µÝÓ뽨¹¹¡£ÆäÖУ¬¹ÛÄîÊÇÐðʵĺËÐÄ£¬½»»¥·½Ê½ÌṩÁËÐðʵı³¾°£¬¶øÎı¾ÔòÊÇÐðʵÄÖ÷ Òª ÔØÌå¡£ÐðÊÂÖÎÁƵÄʵÖÊÔÚÓÚ£¬½â¹¹ÄÇЩÊÜÉç»áÂÛÊö¡¢¸ºÏòÁ¦Á¿¼°È¨Á¦½á¹¹ËùÖ§ÅäµÄ¹ÊÊ£¬Í¨¹ýÎÊÌâÍ⻯µÄ·½Ê½£¬Ð­ÖúÆäÏû³ýÎÊÌâËùÒÀÀµµÄ¹ÛÄ´´Ôì³öËùν·ûºÏ×ÔÉíÉú»îÒâÒåµÄ ¡° ¶ÀÒ»ÎÞ¶þµÄÐð ˵ ¡± ¡£ È»¶ø£¬ÔÚ Ú¹ÊÍѧµÄ¿ò¼ÜÏ£¬Àí½â±¾Éí²¢²»¾ßÓп͹ÛÓÐЧÐÔ£¬Àí½â²»½öÊÇÖ÷¹ÛµÄ£¬¶øÇÒ»¹ÊÜÖÆÓÚ¾ö¶¨ËüµÄËùν ¡° ǰÀí½â ¡±¡­¡­ Õâ±ã¹¹³ÉÁ˺£µÂ¸ñ¶ûËùν ¡° Àí½âµÄÑ­ »· ¡± £¨º£µÂ¸ñ ¶û£¬ 1987 £©¡£ÔÚÐðÊÂÖÎ ÁÆÖУ¬Ò²´æÔÚÏàͬµÄÀ§¾³£¬µ±ÇãÌý¡¢Ú¹ÊÍÓëÖØ¹¹Îı¾Ê±£¬×ÉѯʦÎÞ·¨³¬Ô½×ÔÉíµÄÀúÊ·ÐÔ£¬ÕâÓÖÈçºÎ±£Ö¤ÒâÒ彨¹¹ÓëÖÎÁƱ¾Éí²»»á³ÉΪÓÖÒ»¸öÒ컯µÄÁ¦Á¿ÄØ£¿ ¶Ô´Ë£¬Ù¤´ïĬ¶ûµÄ½â¾ö ·½Ê½Êǿ϶¨³É ¼û£¨ Vorurteil £©µÄºÏ·¨ÐÔ£¬´Ó¶øÃ÷È··ñ¶¨ÁËÈË¿ÉÒÔ¸ù¾Ýij ÖÖÌØÊâµÄ¿Í¹ÛÁ¢³¡£¬³¬Ô½ÏÖʵ¾³Óö¶ÔÎı¾¼ÓÒÔÀí½â¡£ËûÓÖ½øÒ»²½Ö¸³ö£¬³É¼û¹¹³ÉÁ˽âÊÍÕßÓë½âÊͶÔÏóµÄÌØÊâÊӽ磨 Horizont £©£¬ËüÊôÓÚÈ˵ÄǰÅжϣ¬¼´ ¶ÔÒâÒåºÍÕæÀíµÄÔ¤ÆÚ¡£Êӽ粻ÊÇ·â±ÕµÄ¡¢¹ÂÁ¢µÄ£¬¶ø´¦ÓÚ²»¶ÏµÄÔ˶¯±ä»¯Ö®ÖС£ÐðÊÂÎı¾Öк¬ÓÐ×÷ÕßÔ­³õµÄÊӽ磬ËüÓë½âÊÍÕߵĵ±ÏÂÊÓ½ç¼ä´æÔÚן÷ÖֵIJî¾à£¬¶øÀí½âµÄ¹ý³Ì£¬¾ÍÊÇ´ï³É ¡° ÊÓ½çÈÚºÏ ¡± µÄ ¹ý³Ì£¬Ò²ÊÇÒâÒ彨¹¹µÄ¹ý³Ì¡£×îÖÕ¹ýÈ¥ºÍÏÖÔÚ¡¢Ö÷ÌåºÍ¿ÍÌå¡¢×ÔÎÒÓëËûÕß¶¼ÈÚΪһÌ壬¹¹³ÉÒ»¸öÎÞÏ޵ġ¢¿ª·ÅµÄͳһµÄÕûÌ壨٤´ïĬ¶û£¬ 1999 £©¡£ ÓÉ´Ë£¬ÔÚÐðÊÂÖÎ ÁÆÖУ¬Çé¾³¡¢Ð­×÷Óë»á»°ÊDz»¿É»òȱµÄÈý´óÒªËØ¡£×ÉѯÓëÖÎÁƵÄÊ×ҪĿµÄÊÇΪµ±ÊÂÈËÌṩһ¸ö°²È«µÄ¡¢ÓÐÀûÓÚÆäÒâÒ彨¹¹µÄÇé¾³£¬´ÙʹËûÃÇÒÔеÄÑ۹ⷢÏÖÓëÀí½â×Ô¼ºµÄ¹ÊÊ£¬Ð­×÷Óë»á»°Ôò¹á´©ÓÚ×Éѯʼĩ£¬ÊÇ×îÖÕ´ï³ÉÖØ¹¹µÄÖØÒªÊֶΡ£ÊÂʵÉÏ£¬Ã»ÓÐ֪ʶ / ¹ÛÄî¿ÉÒÔ¶ÀÁ¢ÓÚ±³¾°»ò½âÊÍÕߣ¬¶ø´Ó»á»°ÖÐËù²úÉúµÄЭÉÌÒ»ÖµĹ۵㣬¹¹³ÉÁ˸ÐÖªºÍ½âÊÍδÀ´Îı¾µÄ·½Ê½£¨ Josselson, 1995 £©¡£ ²Î¿¼ÎÄÏ× 1 ¡¢Âó¿Ë ? »³ÌØ¡¢´÷ά ? °¬ÆÕ˹ ¶Ù (2001): ¡¶¹ÊÊ ? Öª ʶ ? ȨÁ¦ ¡ª¡ª ÐðÊÂÖÎ ÁƵÄÁ¦Á¿¡·£¬ÐÄÁ鹤·» : ̨±± 2 ¡¢ Âí¶¡ ? º£µÂ¸ñ ¶û (1987) £º¡¶´æÔÚÓë ʱ¼ä¡·£¬ÈýÁª³ö°æÉç : ±±¾© 3 ¡¢ ººË¹£­¸ñ°Â¶û¸ñ ? Ù¤´ïĬ ¶û (1999) £º¡¶ÕæÀíÓë·½·¨ ( ÉϾí ) ¡·£¬ÉϺ£ ÒëÎijö°æÉç : ÉϺ£ 4 ¡¢ Halliday, M. A. K. (1973): Explorations in the functions of language. London : Edward Arnold 5 ¡¢ Josselson, R. (1995): Narrative and Psychological understanding, Psychiatry, 58, 330-343 6 ¡¢ McAdams, D. P. (1985): Power, intimacy, and the life story: Personological inquiries into identiry. New York : Guilford Press.

  • S44-2

    ÖйúÈ˵ĶíµÏÆÖ˹Èý½Ç - The Chinese Oedipus Triangle

    Tianbu Zhang 1

    1 Shaanxi Provincial Peoples' Hospital, Xi'an , Chinese Mainland

    ¶íµÒÆÖ˹ ÏÖÏóÊÇÿ¸öÎÄ»¯±³¾°Ïµľ«Éñ·ÖÎöѧ¼Ò̽ÌÖ±¾ÍÁÎÄ»¯²»¿ÉºöÂÔµÄÑо¿Ö÷Ìâ¡£¶ÔÒ»¸öÎÄ»¯ÈºÌåµÄ¶íµÒÆÖ˹ÏÖÏó½øÐÐÑо¿ £¬ ¿ÉÒÔ´ÓÈý¸ö²ãÃæÈëÊÖ¡£ 1 £® ÁÙ´²ÐÄÀí¶¯Á¦Ñ§ÖÎÁÆ»ò¾«Éñ·ÖÎöµÄ°¸Àý£¬¿ÉÒÔÏÔÖø³ÊÏÖ¸öÌåDZÒâʶÖеĶíµÒÆÖ˹³åÍ»¡£ 2 £® ÎÄѧ ¾­µä×÷Æ·£º×÷Ϊ¾­µäµÄÎÄѧ×÷Æ·£¬ÆäÄܹ»±»ÊÀ´úÏà´«£¬ÍùÍùÊÇÒòΪÕâЩ×÷Æ·±»´ó¶àÊýÈ˵ÄÇé¸ÐËù¹²Ãù¡£»»ÑÔÖ®£¬ÊÇËü´¥¶¯ÁËÕâ¸öÎÄ»¯±³¾°ÖÐÈËÃǵļ¯ÌåDZÒâʶÖеÄÄ³Ð©ÖØÖÐÒªµÄÇé½Ú¡£ 3 £® Éñ »°ºÍ´«Ëµ¡£Éñ»°¹ÊÊÂÄÜÆôʾµÄÊÇÈËÃǾ«ÉñÊÀ½çÀï×îΪÉî´¦µÄÄÇЩDZÒâʶµÄÄÚº¬¡£ËüÊÀ´úÁ÷´«µÄ¹ý³Ì£¬¾ÍÊÇÓùÊÊÂÀ´³ÐÔØºÍ´«´ï´æÔÚÓÚÐÄ ÁéÉî ´¦µÄijЩÏàͬµÄDZÒâʶÇé¸ÐÓëÈÏʶ¡£Á÷´«Ëù¾­µÄ¸÷´úÈËÃÇ£¬¶¼ÔÚÓÃ×Ô¼ºµÄÓïÑԺ͸ÐÊܶÔÄÚÐÄDZÒâʶ½øÐнâ¶Á¡£

    ±¾ÎÄÊ×ÏÈ ¶Ô¶íµÒÆÖ˹ÕâÒ»»ù±¾¸ÅÄîµÄÌá³öºÍ·¢Õ¹×÷Á˸ÅÊö¡£

    ±¾Îĵĵڶþ²¿·Ö ×ÛÊöÁ˼¸Î»»ªÈ˾«Éñ·ÖÎöѧÕß¶ÔÖйúÉñ»°ºÍ´«ËµµÄ·ÖÎö¡£

    ±¾ÎĵÚÈý²¿·Ö£¬×÷Õß ¶ÔÖйúÎÄѧÃûÖø¡¶Ë®ä°´«¡·ºÍµäÐÍÈËÎïËν­ºÍÀîåÓ×öÁË·ÖÎö¡£

    ±¾ÎĵÚËIJ¿·Ö£¬×÷ÕßÁÐ ¾ÙÌÖÂÛÁËËĸöÁÙ´²¾«Éñ¶¯Á¦Ñ§ÖÎÁƵݸÀý£¬À´³ÊÏÖµäÐ͵ĶíµÒÆÖ˹Çé½ÚºÍ¶íµÒÆÖ˹Çé¾°

    ±¾ÎĵĵÚÎ岿·Ö£¬×÷ÕßÖ¸³öÐÄÀíÖÎ ÁÆÖÐÉèÖõÄÒâÒ壬ÔÚÁÙ´²ÐÄÀíÖÎÁƹØÏµÉÏÓÌÈçÔÚÖÎÁƵÄÒ½»¼Ë«·½µÄÄÚÐĽ¨Á¢Ò»¸öÈý½Ç¹ØÏµ

    ×ܽ᣺ÖÐ ¹úÈ˵ÄÄÚÐÄÊÀ½çÀÔÚÄÚÔÚ×ÔÎÒ ÈÏͬµÄÐγÉÖÐÓÐ Oedipus Èý½Ç ¹ØÏµ³åÍ»µÄÐÄÀíÌØµã¡£ÎÄ»¯×÷ΪһÖÖ¼¯Ì峬ÎÒµÄÐÎʽӰÏì×Å Oedipus Èý½Ç ¹ØÏµµÄת¹é . ÔÚ Oedipus complex ˮƽÉϽâ¾öÄÚÐÄÈý½Ç³åÍ»µÄµÄ·½Ê½£¬ÖйúÈËÓëÎ÷·½ÈËÓÐЩ²îÒì . ÔÚ Oedipus situation ˮƽÉϵÄÈý½Ç³åÍ»£¬ÖйúÈËÓëÎ÷·½ÈËÏàͬ¡£ÌáʾÎÒ ÃÇ´ÓÁÙ´²ÉÏÀí½âÉñ¾­Ö¢»¼ÕßµÄÐÄÀí±íÏÖ¿ÉÄÜÖÐÎ÷Óб𠣬 È˸ñÕϰ­»¼ÕßµÄÐÄÀí±íÏÖ¿ÉÄÜÒ»Ñù¡£

    The phenomena of Oedipus couldn't be ignored by the psychoanalysts who want to explore their native culture. we could study the Oedipus phenomena in a certain cultural background from the following three dimensions . 1. Cases of clinical psychodynamic psychotherapy or psychoanalysis, from which the individual unconscious Oedipus conflict appears significantly. 2. Literary masterpieces: as classic literary works, which have been passed on from generation to generation, usually they can arouse most people ¡®s emotional resonance. In other words, it touches some important complex in people ? s collective subconscious of this cultural background . 3. Myth stories and legends: They show the deepest unconscious content in people's spiritual world .In the process of spreading, it conveys and bears the same unconscious feelings and understandings in the deep soul. People of all generations would interpret the inner unconscious with their own languages and feelings.

    Firstly , the article gave a brief introduction on the coming out and development of the basic concept- Oedipus.

    The second part of this paper summarized some analysis on Chinese myths and legends by some Chinese scholars.

    In the third part of this paper, I analysed the Chinese classical literature "The Water Margin" and two typical figures Song Jiang and Li Kui.

    In the fourth part, the author discussed four clinical cases of psychodynamic psychotherapy ,which revealed typical Oedipus complex and situation.

    In the fifth part, the author pointed out that in clinical psychotherapy, the significance of treatment setting was like establishing an internal triangular relationship among the therapist and patient.

    Conclusion: In the inner world, Chinese people have the internal characteristics of Oedipus triangular relationship while developing their self-identification. (As a form of group superego Culture has impact on the triangular relationship.) On the level of Oedipus complex ,there are some differences between Chinese and Westerners in resolving the internal triangular conflicts . But on the level of Oedipus situation ,Chinese and Westerners have the same triangular conflicts. So we should keep in mind that in clinical psychotherapy,there might be some difference between Chinese and Westeners in understanding the neurotic patients'psychological performance, but might be the same for the personality disorder patients.

  • S44-3

    Abstract Withdrawn

  • S45 - Session withdrawn

  • S46 - ¾«Éñ¿ÆµÄ ÈÏÖª¹¦ÄÜÓ°ÏñѧÑо¿ - Cognition Study on Psychiatry by Functional Neuroimaging

    Chairs: KaiDa Jiang, Chinese Mainland
    Lingjiang Li, Chinese Mainland

    ÈÏÖª¹¦ÄÜÑо¿Öð½¥Îª¸÷¹ú¾«Éñ¿ÆÁìÓòµÄÑо¿ÕßËùÖØÊÓ £¬ ¶àÖÖ¾«Éñ¼²²¡µÄÈÏÖª¹¦ÄÜȱËðÊÇÆäÖØÒªµÄÁÙ´²ÌØÕ÷¡£¹¦ÄÜÓ°Ïñѧ¼¼ÊõÓë·½·¨ÎªÈÏÖª¹¦ÄÜÕϰ­µÄÉñ¾­»ù´¡Ñо¿ÌṩÁËеÄ;¾¶¡£±¾×¨Ìâ»á×ÅÖØ½»Á÷ÈÏÖª¹¦ÄܵŦÄÜÓ°ÏñѧÑо¿½øÕ¹¡£

    Ö÷ϯ £º ÀîÁè½­ ½­ ¿ª´ï

  • S46-1

    Ê×·¢ÖØÐÔÒÖÓôÖ¢»¼ÕßÇéÐ÷´¦ÀíÕϰ­ºÍÈÏÖª¹¦ÄÜË𺦵ÄÄÔ¹¦ÄÜ»úÖÆ - The Brain Functional Pathological Mechanism on Emotional Processing Bias and Cognition Dysfunction in First-episode Major Depressive Disorder

    Ning Ma 1 , Áè½­ Àî 2 , Á¢ÎÄ Ì· 2 , ¾ü Áõ 3 , ÖÒ ºØ 3 , Ìï×Ð ½¯ 4

    1 Mental Health Institute,Center South University, ChangSha, Chinese Mainland, 2 ÖÐÄÏ´óѧ¾«Éñ ÎÀÉúÑо¿Ëù , ³¤É³ , Chinese Mainland, 3 ÖÐÄÏ´óÑ§ÏæÑŶþÒ½Ôº·ÅÉä¿Æ , ³¤É³ , Chinese Mainland, 4 Öйú¿ÆÑ§Ôº×Ô ¶¯»¯Ñо¿Ëù , ±±¾© , Chinese Mainland

    Ä¿µÄ £º ʹÓÃѪÑõÒÀ ÀµË®Æ½¹¦ÄܴʲÕñ £¨ BOLD-fMRI £© ¼¼ Êõ £¬ ̽ÌÖÊ×·¢ÖØÐÔÒÖÓôÖ¢»¼ÕßÇéÐ÷´¦ÀíÕϰ­ºÍÈÏÖª¹¦ÄÜË𺦿ÉÄܵÄÄÔ¹¦Äܲ¡Àí»úÖÆ¡£

    ·½·¨ £º Ó¦ÓúºÃܶû¶ÙÒÖÓôÁ¿±í £¨ HAMD £© ¡¢ ººÃܶû¶Ù½¹ÂÇÁ¿±í £¨ HAMA £©£¬ ΤÊϼÇÒäÁ¿±íÀí½âºÍÔÙÈÏ·Ö²âÑé¶Ô 27 ÀýÊ× ·¢Î´ÖÎÁƹýµÄÄêÇá³ÉÄêÖØÐÔÒÖÓôÖ¢»¼ÕßºÍ 28 ÀýÕý³£ÈË ½øÐвâÆÀ¡£ fMRI ¼ì²é£¬ÒÀ´ÎΪÇéÐ÷¼ÆÊý Stroop £¨ ecStroop £©¡¢Çé Ð÷Ãæ¿×¡¢ÇéÐ÷ͼƬºÍÌáÈ¡ËĸöÈÎÎñ¡£É¨Ãèºó»¼Õ߸øÓèÎÄÀ­·¨ÐÁÖÎÁƲ¢Ëæ·Ã¹Û²ì°ëÄê£¬Ëæ·Ã½áÊøÊ±ÔٴνøÐÐÉÏÊöÁ¿±íÆÀ¶¨ºÍ¼ÇÒä²âÑé¼° fMRI ¼ì²é¡£

    ½á¹û£º 1. ÒÖÓôÖ¢»¼ÕßµÄ HAMD ºÍ HAMA ÆÀ·ÖÖÎÁƺó½ÏÖÎÁÆÇ°Ã÷ÏÔϽµ£¨ P £½ 0.000 £©£¬µ«Î´´ïÕý³£ÈËˮƽ£¨ P £½ 0.01 £©£»»¼Õß ×éÖÎÁÆÇ°µÄÀí½âºÍÔÙÈϲâÑé·ÖÊýµÍÓÚÕý³£ÈË£¨ P £½ 0.001 £¬ P £½ 0.04 £©£¬ÖÎ Áƺó ½Ó½üÕý³£ÈËˮƽ£¨ P>0.05 £©¡£ 2. fMRI £¨ 1 £© ecStroop ÈÎ Îñ£ºÒÖÓôÖ¢»¼ÕߺÍÕý³£ÈËË«²à¿Û´ø»ØºÍǰ¶îÒ¶¾ùÓм¤»î¡£·¢×÷ÆÚ»¼ÕßÓÒ²à¿Û´ø»ØºÍ×ó²àò¨Öлؼ¤»î½ÏÕý³£È˵ͣ¬×ó²àСÄÔ¼¤»î½ÏºóÕ߸ߣ»»¼ÕßÖÎÁÆÇ°ºó£¬ÖÎÁƺóºÍÕý³£ÈËÖ®¼ä±È½Ïδ¼û¼¤»î²îÒìÏÔÖøÐÔµÄÄÔÇø¡££¨ 2 £©Çé Ð÷Ãæ¿×ÈÎÎñ£ºÒÖÓôÖ¢»¼ÕߺÍÕý³£ÈËÃæ¶Ô±¯ÉËÃæ¿×ʱÊÓÆ¤²ãºÍº£ÂíÅԻصļ¤»î¶¼¸ß£¬ÓÒ²àǰ¶îÒ¶¼¤»î¶¼µÍ¡£·¢×÷ÆÚ»¼ÕßÓÒ²àºó¿Û´ø»ØºÍ×ó²àµºÒ¶¼¤»î½ÏÕý³£È˸ߣ¬Ë«²àǰ¶îÒ¶£¬×ó²à¶¥ÏÂСҶºÍËó×´»Ø£¬ÓҲ๳»ØºÍº£ÂíÅԻؼ¤»î½ÏÕý³£È˵͡£ÖÎÁƺóÓÒ²àǰ¶îÒ¶ºÍ×ó²àò¨Ò¶¡¢Ë«²àÊÓÆ¤²ã¡¢×ó²à»ùµ×Éñ¾­½ÚµÄ¼¤»î½ÏÖÎÁÆÇ°Ôö¸ß£¬²¢ÇÒË«²àǰ¶îÒ¶£¬ÓÒ²à¿Û´ø»Ø¼°ò¨Ò¶µÄ¼¤»î½ÏÕý³£È˸ߡ££¨ 3 £©Çé Ð÷ͼƬÈÎÎñ£ºÒÖÓôÖ¢»¼Õ߸ºÐÔͼƬ½ÏÕýÐÔͼƬ¶ÔË«²àÐÓÈʺ˺Í×ó²à¹³»Ø¼¤»î¸ß£»¶Ô×ó²à¶îÖлأ¬ÓÒ²à¿Û´ø»ØÇ°²¿ºÍºó²¿£¬ÓҲඥҶ£¬Ë«²àµºÒ¶µÄ¼¤»îµÍ¡£·¢×÷ÆÚ»¼ÕßË«²àǰ¶îÒ¶ºÍ×ó²à¹³»Ø¼¤»î½ÏÕý³£È˵͡£ÖÎÁƺóÓÒ²à¶îÖлغÍͬ²àºó¿Û´ø»Ø£¬×ó²àÇðÄԵ碌î½ÏÖÎÁÆÇ°Ôö¸ß£»µ«ÓÒ²à¶îÖлغÍË«²à¶¥Ò¶²¿·ÖÇøÓòµÄ¼¤»î½ÏÕý³£È˵͡££¨ 4 £©ÌáÈ¡ÈÎ Îñ£ºÒÖÓôÖ¢»¼Õ߸ºÐÔͼƬ½ÏÕýÐÔͼƬ¶ÔË«²àǰ¶îÒ¶ºÍ×ó²à¶¥Ò¶£¬×ó²àǰ¿Û´ø»Ø¼¤»î¸ß£»Õý³£ÈË×ó²àǰ¿Û´ø»ØºÍÓÒ²à¶îÄÚ²à»ØÔÚ¸ºÐÔͼƬʱ¼¤ »îµÍ¡£ ·¢×÷ÆÚ»¼ÕßË«²àǰ¶îÒ¶ºÍ¶¥Ò¶£¬Ë«²àÊÓÆ¤²ãµÄ¼¤»î½ÏÕý³£È˸ߡ£ÖÎÁƺóË«²àǰ¶îÒ¶ºÍÊÓÆ¤²ãµÄ¼¤»î½ÏÖÎÁÆÇ°½µµÍ£»µ«Ë«²àǰ¶îÒ¶£¬ÓÒ²à½Ç»ØºÍÓÒ²àÊÓÆ¤²ãµÄ¼¤»î½ÏÕý³£È˸ߡ£

    ½áÂÛ£º 1. ±ßÔµÒ¶¹¦ÄÜÒì³£ÔöÇ¿ºÍ¶î¶¥Ò¶¹¦ÄܼõÍË¿ÉÄÜÊÇÒÖÓôÖ¢¸ºÐÔÇéÐ÷µÄÄÔ¹¦Äܲ¡Àí»ù´¡¡£ 2. Ë« ²àǰ¶îÒ¶ºÍ¿Û´ø»Ø£¬¶¥Ò¶ºÍÊÓÆ¤²ã¹¦ÄÜÒì³£¿ÉÄÜÊÇÒÖÓôÖ¢ÈÏÖª¹¦ÄÜË𺦵ÄÄÔ¹¦Äܲ¡Àí»ù´¡¡£ 3. ÄÔ¹¦ÄÜÒì³£ÊÇÒ»ÖÖ¿ÉÄæÐԱ仯£¬ÔÚÁÙ´²Ö¢×´»º½âºó²¿·Ö»Ö¸´¡£

  • S46-2

    Çá¶ÈÈÏÖªÕϰ­ÀÏÄêÈËÄÔ¹¦ÄÜ´ú³¥ÏÖÏóµÄ´Å¹²ÕñÑо¿ - Brain Functional Compensation in Mild Cognitive Impairment: Evidences from Both Structural and Functional MR Imaging

    Feng Bo 1 , Ö¾¬B ÕÅ 2 , »Ô Óî 2 , ӽ÷ Ê© 2 , ÁÁ Íõ 3 , ÍòÁÖ Öì 4 , Óñ·å ê° 5

    1 China Municipal Hospital Affiliatted to Southeast University, NanJing, Chinese Mainland, 2 ¶«ÄÏ´óѧ¸½ÊôÖдóÒ½ÔºÉñ¾­ÄÚ¿Æ , ÄϾ© , Chinese Mainland, 3 ±±¾©Àí¹¤´óѧ , ±±¾© , Chinese Mainland, 4 Õã½­´óѧÊýѧϵ , º¼ÖÝ , Chinese Mainland, 5 ±±¾© ʦ·¶´óѧÈÏÖªÉñ¾­¿ÆÑ§Óëѧϰ¹ú¼ÒÖØµãʵÑéÊÒ , ±±¾© , Chinese Mainland

    Ä¿µÄ : ÔËÓà ½á¹¹ºÍ¹¦Äܺ˴ʲÕñ £¨ fMRI £© ¶Ô±ÈÑо¿Çá¶ÈÈÏÖªÕϰ­ £¨ MCI £© ÀÏÈËÓ뽡¿µÀÏÈË ÄԽṹ¼°Æä¹¦ÄܲîÒì £¬ ̽ÌÖ MCI ÄÔ¹¦ÄÜ´ú³¥»úÖÆ¡£·½·¨ Ó¦ÓûùÓÚÏñËØµÄÐÎ̬²âÁ¿·½·¨£¨ VBM £© ²â¶¨ 14 Àý MCI ÀÏÈËºÍ 15 Àý½¡¿µÀÏÈË»Ò ÖÊÌå»ý²îÒ죬²¢Óà fMRI ¼ì²âÌØ¶¨ÄѶȵÄÇé½Ú¼ÇÒä ÌáÈ¡ÈÎ ÎñÏà¹Ø¼¤»îÄÔÇøµÄ¹¦ÄÜ¡£½á¹û ½á¹¹Ó°Ïñ ÏÔʾ£º MCI ×é±È½¡¿µÀÏÈË»ÒÖÊÌå»ýÏÔÖø½µµÍ£¬Ö÷ҪλÓÚË«²à¶îÉϻء¢×ó²à¶îÖлء¢ÓÒ²à¶îÏ»ء¢Ë«²àò¨Éϻء¢ÓÒ²àò¨Ï»ء¢ÓҲຣÂíÅԻء¢×ó²à¿Û´ø»Øºó²¿¡¢×ó²àШǰҶ£»¹¦ÄÜÓ°ÏñÏÔʾ£º MCI ×éÓ뽡¿µÀÏÈËÈÎÎñ±íÏÖÏàͬ£¬Ç°Õß¼¤»î½µµÍµÄÄÔÇøÖ÷ÒªÊǺ£ÂíÅԻأ»ÔöÇ¿¼¤»îµÄÄÔÇøÖ÷ÒªÊÇ£ºÇ°¶îҶǰ²à¡¢±³Íâ²à¡¢ÓÒ²àò¨Éϻء¢ÓÒ²àò¨Ï»ء¢ÕíҶƤ²ã¡£½áÂÛ ÔÚ MCI ×éÀÏÈËÄÚ²àò¨Ò¶¼ÇÒäϵͳ½á¹¹Î®Ëõ¡¢¹¦ÄÜϽµ£¬ MCI ×鶯Ա¶îÍâÄÔÇø¼¤»î´ú³¥ò¨Ò¶ÄÚ²à¼ÇÒäϵͳµÄË𺦡£

    ¹Ø¼ü´Ê : Çá¶ÈÈÏÖªÕϰ­£»»ùÓÚÏñËØµÄÐÎ̬²âÁ¿·¨£»¹¦ÄÜºË ´Å¹²Õñ£»Çé ½Ú¼ÇÒäÌáÈ¡£»ÄÔ´ú³¥¹¦ÄÜ

    Objective: The study used structural and functional magnetic resonance (MR) imaging to investigate differences between mild cognitive impairment (MCI) and normal aging, and to explored brain functional compensation in MCI.

    Methods: The voxel-based morphometry (VBM) method was applied on the 3D structural MR images to evaluate the difference in brain regional gray matter volume between MCI and normal aging groups. Brain responses, during a suitable episodic memory recognition task, were also examined and compared between the two groups.

    Results: Compared to normal aging, the MCI subjects had greater atrophy in the bilateral superior and right middle and inferior frontal gyrus, the bilateral superior and right inferior temporal gyrus, and the medial temporal lobe. In addition, the MCI subjects showed significant activation in the bilateral frontal cortex, the right superior and inferior temporal gyrus, the right precuneus and the bilateral occipital cortex when undertake the visual episodic memory recognition task.

    Conclusions: The structional MR imaing comfirmed the gray matter atrophy in memory related brain regions. Furthermore, MCI subjects performed the suitable episodic memory recognition task via recruiting the additional brain regions of the ventrolateral and dorsolateral prefrontal cortex, the right superior and inferior temporal cortex and the occipital cortex, suggesting that the additional effort of MCI subjects' indicated the compensation for memory related brain regions deficits.

    Keywords: mild cognitive impairment; voxel-based morphometry; functional magnetic resonance imaging; episodic memory recognition; compensation

  • S46-3

    ÓïÑÔÊìϤÐÔÔÚÖÐÓ¢ÎÄÈÏÖªÄÔ¹¦ÄÜ»ù´¡ÖеÄÖØÒªÐÔ·ÖÎö - Significance of Language Proficiency in Chinese-English Language Perception

    GuiFeng Hao 1 , Ö¾¬B ÕÅ 2 , ¼Ò²¨ Ê· 3 , Äþ ³Â 3 , ¸Ö ºî 3

    1 China Municipal Hospital Affiliatted to Southeast University, NanJing, Chinese Mainland, 2 ¶«ÄÏ´óѧ¸½ÊôÖдóÒ½ÔºÉñ¾­ÄÚ¿Æ , ÄϾ© , Chinese Mainland, 3 ÄϾ©Ò½¿Æ´óѧ¸½Êô ÄÔ¿ÆÒ½Ôº¾«Éñ¿Æ , ÄϾ© , Chinese Mainland

    Ä¿µÄ £º Ó¦ÓÃ×é¿éÉè¼Æ¹¦ÄܴʲÕñ³ÉÏñ¼¼Êõ £¬ ÔÚÌåÑо¿ÓïÑÔÊìϤÐÔ¶ÔººÓ